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4Summary
T cell tolerance is achieved through multiple mechanisms. In this study we have tried to
characterize tolerance and T cell development in various situations. First, in the setting of bone
marrow transplantation, we could show that radioresistant T cells from immunocompetent mice
protect against the development of syngeneic graft-versus-host disease whereas
immunodeficient mice succumb to autoimmunity. However, co-injection of sorted regulatory T
cells is able to prevent the development of the disease. Second, by further investigating
radioresistant T cells in the thymus of bone marrow chimera, we could show that a small
population of host-derived DN1-2 pro-thymocytes showed similar properties of radioresistance.
Moreover, this small population is able to generate a single wave of developing T cells, which
participate in immune protection of the host before donor-derived T cells can provide protective
immune reconstitution. Third we took advantage of the protective role of regulatory T cells
during syngeneic bone marrow transplantation described above to study γ/δ T cell development
and to investigate the role of the rearranged β chain found in 15% of γ/δ T cells. We could show
that the γ/δ-derived β chain is actually indistinguishable from the β chain isolated in α/β T cells
and is able to take part in the development of fully functional α/β T cells. Finally, we have
generated double transgenic mice by expressing the agonist antigen ovalbumin in specific cell
subsets concomitantly with OVA-specific TCR. Several similar models have been previously
used to study tolerance and development of regulatory T cells. We characterized the tolerant
status of these mice and showed that the choice of the agonist along with the TCR affinity for
the same agonist is playing a significant role in the outcome of double transgenic mice.
5Part I
Sublethally-irradiated, immuno-deficient, C57Bl/6 RAG-2 gene-deleted recipient mice
reconstituted with T cell-depleted bone marrow grafts frequently developed diarrhea, lost weight
and showed signs of auto-immunity, dying between four and seven weeks after reconstitution.
Mice died despite evidence of efficient donor-derived hemato-lymphoid reconstitution and
disease was associated with the presence of IgG anti-nuclear antibodies. Auto-immunity was
initiated by T cells, but could be prevented by transfer of naturally arising regulatory T cells. In
contrast, lethally-irradiated, bone marrow-reconstituted immuno-competent, C57Bl/6 mice
survived without signs of auto-immunity. Survival of immuno-competent mice was shown to be
due to the presence of residual, extra-thymically-located, radio-resistant, functional regulatory T
cells. The importance of regulatory T cells was further shown by the reduced survival of
immuno-competent BM recipients whose CD25+ T cells had been depleted prior to bone marrow
transplantation. The implications of these results in the context of syngeneic graft-versus host
disease following BM transplantation will be discussed.
Part II
It has been known for more than thirty years that in lethally irradiated bone
marrow chimeras, part of the reconstituted T cell compartment is derived from the irradiated
host. However, the detailed origin and functional activity of these host-derived T cells has not
been thoroughly analysed. Here, we generated bone marrow chimeras by reconstituting lethally
irradiated C57BL/6 mice with either syngeneic RAG2-deficient or CD3-epsilon-deficient BM
neither of which is capable of generating T cells and therefore, all surviving T cells were
exclusively host-derived. We show that in the absence of donor-derived cells, host-derived T
cells can reconstitute 35% of the normal T cell pool. By comparing thymectomized versus non-
thymectomized host, we show that host-derived T cells comprised a major (70%) subpopulation
of de novo generated, thymus-derived, polyclonal, naïve cells and a minor subpopulation of
surviving, peripheral, oligoclonal, memory-like cells. Host-derived thymocytes regenerated from
conventional DN1-2 prothymocytes and their differentiation recapitulated normal thymic
ontogeny. Thus, host-derived T cells might provide a first line of defence against infections
during recovery from lymphopenia after BMT. This conclusion is supported by the fact that host-
derived T cells were fully functional.
6Part III
Between 10 and 20% of the peripheral γδ T cells express cytoplasmic TCRβ proteins, but
whether such TCRβ chains can partake in αβ T cell development has never been systematically
investigated. Therefore, we reconstituted the T cell compartment of CD3ε deficient mice with
Pax5-TCRβ deficient pro B cells expressing, via a retroviral vector, TCRβ chains from either
peripheral γδ or αβ T cells. The thymi of recipients reconstituted with pro B cells containing
empty vector were small (10-15 x106 cells), contained few γδ T but no αβ T cells. In contrast,
thymi from mice receiving pro B cells containing γδ or αβ T cell-derived β chains contained 80-
120 x106 cells, and showed a normal CD4, CD8 and αβ TCR expression pattern. However,
regardless of the source of TCRβ chain, 4 weeks after transplantation, mice developed diarrhea,
lost weight and showed signs of autoimmunity dying 5 to 15 weeks following reconstitution.
Autoimmune disease induction could be prevented by co-transfer of regulatory T cells thereby
allowing the functionality of the generated T cells to be assessed. Results obtained show that
TCRβ chains from γδ T cells can efficiently take part in αβ T cell development. The implications
of these findings for γδ T cell development will be discussed.
Part IV
In order to avoid autoimmunity the T cell compartment has to be tolerant to self. In the thymus T
cell tolerance (central tolerance) is established by deletion (negative selection) while peripheral
T cell tolerance is mediated by the induction of anergy, by suppression through Tregs and by
activation induced cell death. Recently we showed that transgenic mice expressing Influenza
hemagglutinin (HA) under of the kappa light chain (KLC) promoter when crossed with the
mouse expressing a CD4, HA specific TCR (TCR-HA) led to the formation of TCR-HA
regulatory T cells. On the contrary when mice expressing HA under the control of the CD11c
promoter were crossed with TCR-HA mice, these double transgenic mice developed systemic
autoimmunity. Analysis of the T cell compartments in these mice revealed that TCR-HA T cells
escape negative selection in the thymus by the expression of a second endogenous TCR alpha
chain. Thus the systemic autoimmunity seems to be caused by T cells expressing two TCRs. In
order to test whether the development of systemic autoimmunity is restricted to the HA system
or more general we have now generated transgenic mice expressing OVA under control of the
CD11c and KLC promoter. From both transgenic lines founders have been identified that show
strong negative selection in the thymus and the periphery of OT1 (MHCI restricted OVA specific
TCR) and OT2 (MHCII restricted OVA specific TCR) T cells.
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Introduction
In order to face the multiple and various attacks coming from the environment, vertebrates
have throughout evolution developed an immune system with different levels of complexity
involving many different cell types with various degree of specialisation.
Haematopoiesis
Every cell of the immune system originates from a common precursor located in the bone
marrow (BM): the haematopoietic stem cell (HSC). HSCs are defined by their ability to renew
themselves and to give rise to all mature blood cell types. These unique properties of
pluripotency and self-renewal capacity have been used for many years in clinical care through
bone marrow transplantation for reconstituting a life-long complete haematopoietic system in
immunodeficient patients.
Haematopoiesis begins in the mouse embryo as early as embryonic day E7.5 in the yolk sac
(Figure 1) (Dzierzak and Speck, 2008). Around E10, haematopoietic stem cells migrate to the
foetal liver where they undergo further differentiation. They colonise thymus and spleen around
E11 and E12.5, respectively. Finally, starting at E15, the BM becomes the main site for
haematopoiesis and ensures continuous production of 1011 to 1012 blood cells daily throughout
life.
Figure 1: Haematopoiesis:
Arrows above indicate the onset of specific hematopoietic cell generation and/or appearance;
arrows below indicate the earliest time of colonisation of the secondary hematopoietic territories.
Adapted from Dzierzak and Speck, 2008.
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Among the HSC population, a small fraction lacking expression of the cytokine receptor fms-
related tyrosine kinase 3 (FLT3) is able to self-renew, whereas FLT3+ population are non-
renewing cells and are referred to as multipotential progenitors (MPP). Three different lineages
arise from HSCs that are defined as Lineage negative (Lin-) Stem-cell antigen 1 positive
(SCA1+) cKIThi (also called CD117) (LSK). The erythroid cell lineage is represented by red blood
cells and megakaryocytes. These cells arise from megakaryocyte/erythroid progenitors (MEPs),
which themselves originate from MPPs. The common myeloid progenitor (CMP), derived from
MPPs, gives rise to granulocytes, megakaryocytes, and macrophages. Myeloid cells can play a
role in innate, adaptive immunity and coagulation. Finally, the third lineage is comprised of
lymphoid cells such as B and T lymphocytes that are key players in adaptive immunity. These
cells develop from a Common lymphoid Progenitor (CLP) characterised by low expression of
cKIT, high level of interleukin 7 receptor α-chain (IL-7Rα) and FLT3.
Along their differentiation towards committed precursors, HSCs express various key
transcription factors such as Pax5 or Ikaros (Figure 2). These transcription factors are essential,
as mutations or deletions of their genes result in a complete or partial block in cell lineage
development. They have been used to define different developmental stages of haematopoiesis
in that they reflect the commitment of a cell to a discrete cell lineage. In addition, these
developmental stages can be characterized by surface expression of various receptors for
cytokines, such as the receptor for IL-7 or growth factors like colony stimulating factor (CSF).
Receptor expression is tightly regulated since it conditions the responsiveness of a stage-
specific cell to receive a signal that allows it to further differentiate. Many of the ligands for these
receptors, cytokines as well as growth factors, are provided by the microenvironment and more
specifically by stromal cells that support HSC growth and differentiation. Hence, the HSC’s fate
is thought to be determined by the microenvironment, which provides the growth factors
necessary for cell survival.
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Figure 2: The genetic control of B-cell specification and commitment in the bone marrow.
This diagram shows a scheme of the genetic switch that regulates early B-cell specification. For
simplicity, only some of the differentiation stages are shown. The developmental steps that are affected
by the mutation of specific transcription factors are indicated. In some cases, the simultaneous mutation
of two factors is required for a developmental phenotype to be observed. ID2 (inhibitor of DNA binding 2)-
deficient mice have impaired natural killer (NK)-cell development and increased E2A activity, which
correlates with an increased frequency of class switching to IgE. BCR, B-cell receptor; EBF, early B-cell
factor; CLP, common lymphoid progenitor; IRF, interferon-regulatory factor; LEF1, lymphoid-enhancer-
binding factor 1; OBF1, OCT (octamer-binding transcription factor)-binding factor 1; PAX5, paired box
protein 5; PHSC, pluripotent haematopoietic stem cell; SOX4, sex-determining region Y (SRY) box 4
(adapted from Matthias and Rolink).
Different models have been proposed to describe haematopoiesis. Whereas it was originally
thought that HSC differentiation was rather linear, with a progressive loss of lineage potential
corresponding with increasing differentiation, recent studies have shown that committed
progenitors may actually maintain the potential to differentiate into various lineages until late in
development. As an example, pro B cells from Pax5-deficient mice can develop into myeloid,
NK and T cells both in vivo and in vitro (Rolink et al., 2002). Among the different models that
have been suggested, the widely accepted Weissman model is based on cell surface
phenotype (Figure 3) (Kondo et al., 2003) A second model based on analyses of transcription
factor mutant mice has been proposed by Singh et al. (Figure 4) (Medina and Singh, 2005).
Finally, based on studies on in vitro proliferation of murine fetal liver progenitors, Katsura et al.
proposed that all progenitors maintain a myeloid potential early into lymphoid and erythroid
differentiation (Figure 5) (Katsura, 2002). It may be possible that these models are not mutually
exclusive but rather complementary to one another. Indeed, Rolink et al. has proposed a fourth
model integrating these previous models (Rolink et al., 2006). We have chosen to base our
work on the Rolink model of haematopoiesis, which results of the integration of the previous
models and our experiments (Figure 6).
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Figure 3: Weissman Model
Conceptual hematopoietic trees in adult mice: Indicated cell populations can be purified based on the cell
surface phenotype. Not all of the linear relationships in this figure have been proven. Multipotent
progenitors (MPPs), at least at the population level, can differentiate into all types of hematopoietic cells,
but have no detectable self-renewal potential in vivo. Megakaryocyte progenitors have recently been
identified. Pro T cells are present in the thymus (Adapted from Kondo et al., 2003.).
Figure 4: Singh Model
Developmental scheme for the generation of B cell precursors from multipotential hematopoietic
progenitors: Alternate cell fate options (myeloid and T-lineage) are also shown. LTRC and STRC
represent long- and short-term multilineage reconstituting cells. CMP, ELP, and ETP denote common
myeloid progenitor, early lymphoid progenitor and early thymic progenitor, respectively. Regulatory
molecules (signaling receptors and transcription factors) that are genetically demonstrated to be
important for development are indicated. Bold case font is used to indicate changes in activity or
expression state of the relevant transcription factor. Solid (experimentally based) and dotted arrows
(proposed) highlight regulatory connections that can be assembled to form rudimentary networks. Cell
fate specification and commitment are sequential transitions. CD19 is a B cell surface marker and pBCR
refers to the pre-B cell receptor that is assembled after productive rearrangements of the IgH locus
(Adapted from Medina et al., 2005.).
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Figure 5: Katsura Model
Model of lineage commitment in hematopoiesis: A new model of hematopoiesis proposed from findings
with the MLP–MTB and MLP–METB assays. Myeloid potential accompanies early stages of all T, B and
erythroid (E) progenitors. T-cell and B-cell progenitors are produced from the common myelo-lymphoid
progenitor (CMLP; p-MTB) through the intermediate p-MT and p-MB bipotent stages, respectively. It is
still unclear whether a myeloid (M)-specific pathway independent of T, B or erythroid pathways exists. T,
B, M, E and Meg (megakaryocyte) in this figure indicate the progenitor’s name but not the name of
mature cells (Adapted from Katsura et al., 2002.).
Figure 6 Current working model of hematopoietic development.
Figure 6 depicts our current working model of hematopoietic development. HSCs with long-term self-
renewing capacity give rise to ones with only limited self-renewing potential. As proposed by the Katsura
model mentioned above, the short-term self-renewing HSC gives rise to a progenitor with erythroid and
myeloid (PEM) potential. The next cell in the scheme is a progenitor with a developmental potential
restricted to the myeloid and lymphoid lineages (MLP). These cells are the direct precursors of the
common myeloid progenitor (CMP), a cell type with a developmental potential restricted to the myeloid
lineages. MLPs will moreover give rise the common lymphocyte progenitors (CLP), and some of the
MLPs will migrate to the thymus (TSP: thymic seeding progenitor) and will there undergo the T cell
differentiation program. Early stages of T and B cell development will be described in more detail below.
The solid arrows in the model indicate the main developmental pathway. The broken arrows indicate the
lymphocyte precursors in the bone marrow that still possess T cell developmental potential and
thymocyte precursors that possess B cell developmental potential (Adapted from Rolink et al., 2006).
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Innate immunity
As a first line of defence against infection, the innate immune system mediates specific and
direct responses against pathogens but does so with rather limited recognition capability and
short-lived protective immunity. It includes four different levels of protection.
First, physical invasion of pathogens is prevented by an intact anatomical barrier. Thus, the skin
and the mucosal surfaces of the gastrointestinal, respiratory and urogenital tracts are critical for
efficient defence against pathogen attack. Second, regulation of pH and/or temperature
maintains a physiological barrier that ensures further host protection. A third level of defence
involves numerous soluble factors present in the blood or extracellular compartment. These
include hydrolytic or digestive enzymes that degrade proteins of harmful microorganisms. In
addition, antimicrobial substances such as α-defensins, interferon produced after viral infection,
and complement components all play roles in fighting pathogen attacks. Finally, phagocytosis
and endocytosis are used by multiple cell types and constitute the last degree of innate
immune-mediated protection. Every cell can perform pinocytosis, on the other hand endocytosis
is often mediated through a cell surface receptor. Phagocytosis is a property of specialized cell
types such as macrophages, neutrophils, and dendritic cells; these cells can internalize and
digest whole pathogenic microorganisms via specialized protein machinery.
Innate mechanisms are based on the detection of conserved molecular structures shared by a
large group of pathogens, called pathogen-associated molecular patterns (PAMPs), by pattern
recognition receptors. As an example, lipopolysaccharide, a cell-wall component of all gram-
negative bacteria, is recognized by Toll-like receptor 4 on the surface of dendritic and other
cells. In this system, pattern recognition receptors signal the presence of infection and induce
the production of antimicrobial proteins or peptides as well as pro-inflammatory cytokines. They
also trigger the transcription of various gene products that control subsequent adaptive immune
response.
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Figure 7: Ligand specificities of TLRs
Toll-like receptors (TLRs) recognize a variety of pathogen-associated molecular patterns (PAMPs).
Recognition of lipopolysaccharide (LPS) by TLR4 is aided by two accessory proteins: CD14 and MD-2.
TLR2 recognizes a broad range of structurally unrelated ligands and functions in combination with several
(but not all) other TLRs, including TLR1 and TLR6. TLR3 is involved in recognition of double-stranded
(dsRNA). TLR5 is specific for bacterial flagellin, whereas TLR9 is a receptor for unmethylated CpG motifs,
which are abundant in bacterial DNA. G+, Gram-positive; G–, Gram negative; GPI, glycophosphoinositol;
RSV, respiratory syncytial virus. Adapted from Medzhitov, 2001.
Innate immunity offers the advantage of triggering an immediate response before activation of
the adaptive immune system. However, it displays a limited repertoire of recognition molecules
and lacks the properties of memory or long-lasting immunity. The interaction of different cell
types of the innate immune response with the lymphocytes of adaptive immunity allows for a
coordinated response that is both immediate and powerful in the elimination of foreign
pathogens.
Adaptive immunity
In parallel with innate immunity, vertebrates have developed an adaptive immune system to
respond more efficiently to immune challenges. Adaptive immune responses allow the host to
respond in a highly specific manner to a broader range of antigens, to develop memory
responses, and to discriminate between self and non-self.
Key players of adaptive immunity are lymphocytes. There are two major types of lymphocytes,
namely B cells and T cells. These are very specialized cells that display each of the specific
features mentioned above. They are highly specific via cell surface expression of the T cell
receptor (TCR) or B cell receptor (BCR). Moreover, they encompass a highly diverse repertoire
of specificity through gene recombination, and/or somatic hypermutation in the case of B cells.
They are also able to differentiate into long-lived memory cells. Finally, through continual clonal
selection throughout their development, T cells are able to distinguish non-self antigen
presented exclusively by major histocompatibility complexes (MHC).
B lymphocytes
B cells initially develop from a common lymphoid progenitor within the bone marrow and further
differentiate into mature B cells within secondary lymphoid organs.
B cells are specialized in triggering a humoral immune response specifically aimed at
eradicating extracellular pathogens. They respond to antigen stimulation by differentiating into
plasmocytes [plasma cells?], which produce a large quantity of antibodies directed against
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specific antigenic epitopes. One cell is able to produce only one specific type of antibody able
to bind one particular epitope of a given antigen. Their diversity potential is so high that B cells
can together produce up to 1011 different antibodies.
B cell differentiation and germinal center reaction
Progenitor B cells, the first cells of the B lymphocyte lineage, develop within the bone marrow.
They proliferate and differentiate into precursor B cells by influence of stromal cell products like
stem cell factor (SCF) and interleukin 7 (IL-7) (Figure 8).
Figure 8: B cells develop from early haematopoietic progenitors.
The main compartments — bone marrow, thymus and blood — are shown. The various developmental
stages that have been defined are indicated, as well as their relative order. Dashed arrows show
pathways that are not yet firmly established. Pluripotent hematopoietic stem cells (PHSCs), multipotential
progenitors (MPPs), common myeloid progenitors (CMPs), early lymphoid progenitors (ELPs) and
common lymphoid progenitors (CLPs) are known as lineage (Lin)- cells; these cells lack detectable
expression of any of the markers that are associated with cells of the mature blood lineages or their
committed progenitors -- that is, CD3, CD8, B220, CD11b, CD19, GR1 and TER119. Cells that are
defined as LSK are Lin- stem-cell antigen (SCA)hiKIThi, which is a possible precursor stage to early T-cell-
lineage progenitors (ETPs) (Schwarz and Bhandoola, 2004) Using the Hardy classification (Hardy and
Hayakawa, 2001), pro-B cells (also known as fraction B/C) are defined as B220+CD43+, and pre-B cells
(also known as fraction C'/D) are defined as B220+CD43- surface IgM-. BCR, B-cell receptor; DC,
dendritic cell; FLT3, fms-related tyrosine kinase 3; NK, natural killer; IL-7R, -chain of the interleukin-7
receptor (Adapted from Matthias and Rolink, 2005.).
B cell maturation involves immunoglobulin (Ig) gene rearrangement, leading to extraordinary
antibody diversity. This process consists of somatic rearrangement of germline-encoded
immunoglobulin segments, the V(D)J genes, creating a new sequence encoding for a unique
BCR molecule (Figure 9). One single productive rearrangement occurs in an individual
lymphocyte due to the mechanism of allelic exclusion: as soon as a productive rearrangement is
accomplished, any further rearrangement is blocked. Recombination activating gene products
18
RAG-1 and RAG-2 are essential for the gene recombination process to occur. During the
process of recombination, the terminal deoxynucleotidyl transferase (TdT) enzyme provides
further junctional diversity by adding a few nucleotides at the gene segment junctions.
Figure 9: General scheme of V(D)J recombination for assembly of antigen-receptor genes.
Antigen receptors consist of two protein chains that are encoded by independent loci. One locus (the first
receptor-chain locus) is generated by the assembly of individual germline variable (V), diversity (D) and
joining (J) minigene elements from among multiple minigene elements. The other locus (the second
receptor-chain locus) lacks D elements and is assembled by direct V-to-J joining. V, D and J elements are
recombined through the activity of recombination-activating gene 1 (RAG1)–RAG2 protein complexes and
the non-homologous end-joining machinery to generate VDJ or VJ combinations. Upon transcription,
mRNAs that encode the protein chains are generated and spliced as indicated by the red lines. D-
element-encoded regions, and junctions between V, D and J elements, are centrally displayed in the
antigen-receptor antigen-combining site, as depicted in the inset. C, constant (Adapted from (Nemazee,
2006).
Upon completion of the heavy chain rearrangement, a pro B cell becomes a pre B cell. Further
rearrangement of the Ig light chain provides the immature B cell with a given antigenic
specificity. When they leave the bone marrow en route to the spleen, B cells are still immature
and are characterized by membrane-bound immunoglobulin IgM that together with heterodimers
of Ig-α and Ig-β forms the B cell receptor (BCR). They also express on their surface flow-
cytometric markers B220 (CD45R) and CD19. Throughout the maturation process, if an
immature B cell encounters a self-antigen, it becomes anergic or dies by apoptosis. This
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process is known as negative selection. However, there is also evidence that at least some
immature B cells can be rescued from apoptosis by receptor editing. In other words, B cells
are able to express a second light chain to form a novel non-autoreactive BCR (Nemazee,
2000; Tiegs et al., 1993).
Once in the periphery, activation, proliferation and differentiation of a given mature B cell
requires an encounter with its specific antigen (Figure 10). These steps occur in the lymph
nodes or in the spleen, depending on whether the antigen originates in the lymphatic vessels or
blood, respectively. A B cell binds the antigen, internalizes it, and presents it on its MHC II
surface molecules. The initial activation of B cells takes place in the paracortex, where T and B
cells interact, via CD40, the MHC II-Ag complex and cytokines, to form a B-T conjugate. This
interaction leads to proliferation of B cells to form primary foci. B cells then differentiate into
plasma cells that secrete IgM isotypes. Subsequently, a few activated B cells along with some
Thelper cells migrate to primary follicles, which becomes secondary follicles. Subsequently
proliferation of activated B cells forms a germinal center. Activated B cells undergo clonal
expansion and somatic hypermutation; they are then called centroblasts and constitute the so-
called dark zone of the germinal center. The selective survival of high-affinity centroblasts leads
to their differentiation into centrocytes.  Centrocytes move to the light zone where they
encounter antigen presented by follicular dendritic cells. Subsequently, centrocytes will form two
kinds of progeny: small memory B cells and large plasmablasts. The first population of cells will
go back to the bone marrow and recirculate in the periphery. Plasmablasts remain
predominantly in the lymph nodes as short lived memory cells, but may also be found in the
bone marrow as long-lived memory cells.
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Figure 10: Activated B cells form germinal centers in lymphoid follicles
Some B cells activated in the primary focus migrate to form a germinal center within a primary follicle.
Germinal centers are sites of rapid B-cell proliferation and differentiation. Follicles in which germinal
centers have formed are known as secondary follicles. Within the germinal center, B cells commence
their differentiation into either antibody-secreting plasma cells or memory B cells. Plasma cells leave the
germinal center and migrate to the medullary cords or leave the lymph node altogether via the efferent
lymphatics and migrate to the bone marrow. Memory B cells continue to recirculate through the B-cell
zones of secondary lymphoid tissue (not shown) and some may preferentially reside in the splenic
marginal zone (Adapted from Immunobiology, Janeway, Charles A.; Travers, Paul; Walport, Mark;
Shlomchik, Mark New York and London: Garland Science ; 2001.).
T lymphocytes
T lymphocytes are thymus-derived and are specialized in immunity against intracellular
microbes such as viruses or intracellular bacteria and provide help to B cells in the generation of
antibodies.
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The Thymus
The thymus is a bilobed organ located in the upper anterior thorax where T cell development
occurs. Each lobe is comprised of an outer cortex, which contains a dense collection of
thymocytes, and an inner medulla, which contains fewer thymocytes. Three major cell types of
distinct developmental origin are found in the thymus, mesenchymal cells and thymic epithelial
cells constituting the stroma and bone marrow-derived T lymphocytes. Mesenchymal
components of the stroma derive from the neural crest; they are a constituent of the thymic
capsule and septae but can also be found in the cortex. Mesenchymal cells have been shown to
influence thymic development in two different ways. First, they influence the initial stage of
thymic formation by regulating thymic epithelial cell differentiation and proliferation through
various interactions and production of fibroblast growth factor (FGF). Second, mesenchymal
fibroblasts support T cell precursor survival and early maturation by secreting IL-7. Thymic
epithelial cells (TEC) are stromal cells of endodermal origin. They originate from the third
pharyngeal pouch to form a thymic anlage, which attracts cells of haematopoietic origin at day
E11.5. TECs constitute a complex network that provides an optimal microenvironment for the
development of bone marrow-derived cells, namely thymocytes, macrophages and dendritic
cells (DC). During development, there is mutual interaction between thymic epithelial cells and
thymocytes such that the latter influence the development, survival and organization of the
thymic epithelial network, which in return supports thymocyte maturation by providing cytokines
essential for thymocyte proliferation.
The rate of T cell production is not constant throughout lifetime. Production is highest during
younger years and drastically slows down in adults to a level just sufficient for maintaining a
constant peripheral pool of T cells. This age-related thymic involution is responsible for the
absence of new T cell production in older individuals.
In the mature thymus, TECs are subdivided into medullary and cortical (mTEC and cTEC,
respectively).  TECs mediate central tolerance along with BM derived thymic DCs (BMdDCs).
Uncommitted lymphoid precursors coming from the BM enter the thymic cortex via blood
vessels at the cortico-medullary junction. The most immature thymocytes do not express
antigen receptors or T cell markers such as CD4 or CD8, and are hence called double-negative
(DN CD4-CD8-) thymocytes. They represent about 5% of the total thymocyte population. In the
cortex, thymic precursors undergo intense proliferation and differentiation for about one week.
Thymocytes migrate from the cortex, transitioning from DN to double-positive (DP CD4+CD8+),
then through the medulla, where the vast majority of thymocytes become single-positive (SP
CD4-CD8+ or CD4+CD8-). Along the way, they interact with various cell types, namely cTEC and
macrophages in the cortex and mTECs, thymic DCs and macrophages in the medulla (Figure
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11). En route to the medulla, thymocytes rearrange their TCR, first the β chain followed by the
α chain, to become CD4+CD8+ DP cells. A particular population of DN cells do not rearrange
their β and α TCR genes, but rather rearrange their γ and δ genes. These cells acquire only the
CD3 surface marker, do not transition through the CD4+CD8+DP stage, and become γ/δ T cells.
Specifics of the development of this particular population will be discussed in a specific chapter
later. CD4+CD8+DP thymocytes undergo positive selection in the cortex, which allows for the
selection of cells able to recognize self-MHC molecules. This is followed by negative selection,
which eliminates cells recognizing self-antigens. These two processes will be discussed in more
detail later.
Figure 11: Cellular composition of the thymus.
The major cell types and the sequential cell-cell interactions along the migratory route of developing
thymocytes are depicted here. The different APCs are color-coded. mTECs, highlighted in red, play an
essential role in self-tolerance induction toward tissue-restricted self-antigens. Shaded areas depict
functionally distinct stratified microenvironments as recently proposed (Petrie, 2003). (Adapted from
Kyewski, 2006.)
More than 95% of thymocytes will die by apoptosis in the thymus throughout the maturation
process, either because they were not able to produce a functional TCR or failed to receive a
survival signal after positive selection or rearrangement of their TCR genes or because they
received an apoptotic signal during negative selection. The dying cells are ingested by
macrophages present in the cortex as well as in the medulla.
After positive and negative selection, thymocytes downregulate one of their co-receptors, either
CD8 or CD4, and become a SP CD4+CD8- or SP CD4-CD8+. αβTCR CD4+CD8- T cells
represents about 12% of the adult thymocyte population. These are MHCII-restricted and have
a helper activity function. On the other hand, αβTCR CD4-CD8+ T cells display a cytolytic
activity and are MHCI-restricted. Once these two mature populations reach the periphery, they
are called CD4+ helper (Th) and CD8+ cytolytic (CTL) T lymphocytes.
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Early T cell development
As mentioned above, MLP give rise to B cells as well as T cells. Although it has been shown
that other progenitors retain T cell lineage potential – i.e., they are able to initiate T cell
development when artificially injected intravenously - MLP are considered to be the most
probable physiological originator of the early T-cell progenitor. Since there are no HSCs within
the thymus, there is a constant need for BM progenitors to colonize the thymus in order to
maintain a constant rate of T cell development. It is thought that thymus-settling progenitors
(TSPs) characterised by a ckitintCCR9+CD44+CD25-Flt3+ phenotype migrate to the thymus to
undergo T cell differentiation.
One very important determinant for T cell commitment is Notch1 receptor signaling, as the
thymus of Notch1 deficient mice is colonised by B cell precursors (Radtke et al., 1999). Many
studies have been trying to characterise the earliest TSP, which retains B cell potential and
loses it upon Notch signaling as shown by Radtke et al. It is well established that these cells
belong to the DN CD4-CD8- population.
The DN population can be subdivided into four different subsets according to CD25 and CD44
markers, corresponding with four successive developmental stages (Figure 12). T cell
progenitors enter the thymus via the blood as LinlowckithighCD25- cells and then develop into DN1
cells, which are CD25-CD44+. When they acquire CD25 cell surface marker to become DN2,
they start to rearrange the β chain locus. DN3 thymocytes downregulate CD44 and c-kit to
become CD25+CD44-. They are arrested at this stage until they productively rearrange the β
chain locus of the TCR; this checkpoint is called β selection. TCR β chain pairs with a surrogate
pre-Tα chain, and the whole pre-TCR is expressed on the cell surface. This pairing signals
through the cytoplasm and triggers entry into the cell cycle. Surface expression of the pre-TCR
is associated with the DN4 stage: low level of surface CD3, loss of CD25, completion of β
rearrangement, cell proliferation, and finally acquisition of CD4 and CD8. Once proliferation is
over, DP decrease in size and start to rearrange the α locus gene segment, which results in DP
cells expressing low levels of αβTCR on their surface along with the CD3 complex. These cells
are ready to undergo positive and negative selection.
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Figure 12: Immature thymocyte progenitor subsets.
a. Subsets of double-negative (DN) thymocytes, based on their expression of CD25 and CD44 and
their sequential development through the DN1 (CD25-CD44+), DN2 (CD25+CD44+) and DN3
(CD25+CD44-) stages, are shown. CD25-CD44- cells, which are also called DN4 cells, express
Cd4 and Cd8 mRNA and are termed pre-double-positive (pre-DP). Early T-cell progenitors
(ETPs), which are c-kithiCD25-CD44hi, are efficient T-cell progenitors that are transcriptionally
equivalent to DN1 cells.
b. Defining ETPs. C57Bl/6 total thymocytes (25x106 cells) were stained with antibodies specific for
c-kit and CD25, as well as a cocktail of antibodies specific for the following lineage (Lin) markers:
NK1.1, T-cell-receptor -chain (TCR), TCR, macrophage receptor 1 (MAC1), B220, TER119 (also
known as Ly76), CD3, CD8, CD8, CD11c and CD19, but not CD4 because some ETPs express
of CD4 on the cell surface. Gating for lineage markers is adjusted so as not to exclude c-kithi cells
that are expressing low levels of Lin (left panel). ETPs are defined as Linlowc-kithiCD25- (right
panel), (Adapted from Bhandoola and Sambandam, 2006).
TSPs are included in the DN1 population and can be distinguished from B, NK and myeloid
thymic cells by expression of the c-kit marker. In addition, it has been recently shown that the
DN1 population can be further subdivided into DN1.1 and DN1.2. DN1.1 cells are characterised
by Flt3 ligand receptor (CD135) and CC-chemokine receptor 9 expression, whereas DN1.2
cells, which are the direct downstream progeny of DN1.1 cells, do not (Sambandam et al.,
2005). DN1.1 cells are most probably the earliest thymic progenitors since they retain a B cell
potential. It has to be noted that, while these DN1.1 cells are in a very low number in adult
mouse thymi, they are much more numerous and hundred times more potent for B cell
development in newborn mice.
Table 1 shows the main markers used to distinguish between early thymocyte populations.
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Table 1: Cell-surface markers expressed by early thymocytes.
It has been previously shown that DN1 and DN2 require Notch signaling, IL-7 and c-kit, which is
under the control of Notch signaling. These cells are not yet committed to the T cell lineage; but
while TSP can still generate B cells, DN cells have lost B cell potential. On the other hand, DN3
and DN4 lose c-kit expression, DN3 showing intermediate levels and DN4 being negative for c-
kit. They are unable to differentiate into anything other than T cells. DN3 still require Notch
signaling to continue T cell development, but their growth is independent of IL-7 and c-kit.
TCR gene rearrangement in αβ T cells
During development from DN to DP, thymocytes undergo TCR gene rearrangement in a similar
manner as the immunoglobulin gene rearrangement occuring in B cells.
The TCR molecule is a membrane-bound antigen receptor made up of two different
polypeptides, either αβ or γδ. We will mainly talk in this section about αβ TCR; γδ TCR will be
the subject of a separate chapter. The TCR molecule displays high structural and sequence
similarity with Ig from B cells and is indeed encoded by homologous genes. Each chain is
composed of a variable and a constant region, the variable part containing the antigen-binding
cleft.
Germline TCR genes are organised similarly as Ig genes: V and J segments form the α and γ
chains whereas V, D and J segments form the β and δ loci (Rowen et al., 1996). The same
enzymatic machinery as in B cells, RAG1 and RAG2, performs this gene segment
recombination (Shinkai et al., 1992). As a result, a genetic defect affecting the control of V(D)J
recombination will equally affect T and B cells and leads to lack of functional lymphocytes in the
deficient individual. The high diversity of TCR sequences is a result of somatic recombination
within sets of gene segments. It is also a result of junctional variability through the addition of P
26
and N nucleotides at the junctions between V and J segments or V, D and J segments of the
α or β chain (Abbey and O'Neill, 2008; Nemazee, 2006). In contrast to that of the BCR, TCR
gene rearrangement displays lower diversity within the constant regions, which encode for the
transmembrane polypeptides. Since the TCR is not secreted like immunoglobulins, the constant
region does not mediate any particular functions and only the variable region is important in
recognition of Ag presented by MHC molecule. In addition, the variability of the TCR has to be
restricted to some extent in order to ensure binding with the MHC molecule. Although
controversial, it is thought that the highest degree of diversity is focused on the variable part of
the α chain. Indeed, more than 60 J gene segments can be found in the TCRα locus, and the
CDR3s of the α and β chains show a great degree of hypervariability. These two regions take
part in the formation of the centre of the TCR, the portion that binds the Ag. Finally, somatic
hypermutation does not occur during TCR gene recombination unlike during BCR gene
recombination.
T cells, like B cells, have a high degree of allelic exclusion, meaning that one specific cell is
carrying only one specific TCR. However, whereas it is true concerning the β chain, it appears
to be not as stringent for the α chain. It has been reported that one TCR β chain can actually
pair with two different α  chains on the same cell. This phenomenon might allow some
autoreactive T cells to escape negative selection by downregulating the autoreactive α chain
and expressing a new α chain, thereby acquiring a new non-autoreactive TCR (Figure 13).
Indeed it has been reported by Sarukhan et al. that once they reach the periphery, these dual
TCR-expressing T cells carry the two different TCRs on their surface and trigger autoimmune
disorders (McGargill et al., 2000; Sarukhan et al., 1998; Zal et al., 1996).
Figure 13: Editing versus positive selection as mutually exclusive aspects of receptor selection.
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In double-positive (CD4+CD8+) thymocytes, which express T-cell receptors (TCRs), the threshold for
positive selection requires weak signaling after recognition of self-peptide–MHC complexes. Agonists,
by contrast, trigger tolerance by inducing developmental arrest and either apoptosis or, possibly,
receptor editing.
Altogether, the TCR coupled with the CD3 molecule forms the TCR receptor complex. CD3 is in
charge of transmitting the signal sensed by the TCR, which has short cytoplasmic tails (Figure
14). Ag binding of the TCR leads to cellular activation by phosphorylation of ITAM sequences of
the CD3 intracytoplasmic tail. This is followed by release of second messengers such as inositol
tri-phosphate (IP3) and Ca++. This leads to NFκB (Nuclear factor kappa B) as well as NF-AT
(Nuclear Factor of Activated T cells) nuclear translocation. In parallel MAPK (Mitogen Activated
Protein Kinase) cascade is triggered and induce translocation of various transcription factors in
the nucleus, which set off transcription of specific genes. It should be noted that monoclonal
anti-CD3 antibody can actually bypass the TCR Ag sensing requirement and lead to a similar
activation effect (Cantrell, 1996).
CD4 and CD8 function as co-receptor molecules by transducing TCR signals and stabilising
interactions with MHC I or II. Intracellularly, these two molecules interact with leukocyte specific
tyrosine kinase (lck).
Figure 14: A current model for TCR-mediated signal transduction.
Interaction of antigen with TCR/CD3 complex initiates a series of biochemical events, of which the
earliest is phosphorylation of various proteins on tyrosine residues. Stimulation of PTKs is coupled
to the hydrolysis of PLCγ1, which results in a rise in intracellular Ca2+, and activation of PKC
through IP3 and DAG pathways, respectively. Activation of Lck, Fyn, and ZAP-70 induces
localization of adaptor proteins Shc, Grb2, and Sos to the cytoplasmic membrane. Associations of
these adaptor proteins with Ras, allows the rapid conversion of Ras from the inactive form (GDP-
Ras) to the active form (GTP-Ras). Activation of Ras results in sequential phosphorylation and
activation of a series of enzymes involved in MAPK cascade that eventually transmit the
stimulatory signal received from cytoplasmic membrane into the nucleus. Abbreviations: TCR, T
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cell receptor; APC, antigen presenting cell; MHC, major histocompatibility complex; PLCg1,
phosphlipase C-gamma 1; DAG, diacylglycerol; IP2, phosphoinositol biphosphate; IP3, inositol 1,4,5-
triphosphate; SH2, Src-homology-2; PTB; phosphotyrosine binding; PKC, protein kinase C; NFATc,
nuclear factor of activated T cell; CaN, calcineurin; CaMK, calcium calmodulin-dependent protein
kinase; MAPK, mitogen-activated protein kinase; MEK, MAPK kinase; MKP1, MAPK phosphatase-
1 (Adapted from Pahlavani, 1998).
Selection of MHC-restricted αβTCR specific for foreign antigens
As discussed earlier, antigen receptor gene recombination guarantees antigen recognition with
a high degree of diversity and specificity. Nevertheless, the TCR has to be tested for its antigen
recognition properties, in terms of affinity and specificity. The interaction of the TCR with the
thymic environment will condition the fate of the TCR-bearing thymocyte, in other words,
survival or death. Ultimately, thymocytes must be simultaneously MHC-restricted and specific
for foreign Ag but tolerant to self-antigen. Subsequent developmental steps involve peptide-
MHC complex interaction with the TCR of stromal cells.
Developing thymocytes whose receptor interacts weakly with self-peptide-MHC complex will
survive; this process is called positive selection. The lymphocytes that do not receive any signal
die by neglect since they are of useless specificity. This default fate occurs for the majority of
thymocytes. Additionally, negative selection will ensure that lymphocytes whose receptor binds
strongly to self–antigen receive an apoptotic signal. This prevents any auto-reactive T cells from
joining the mature T cell repertoire.
Positive selection
Small DP quiescent thymocytes, which have passed the β selection checkpoint, actively
rearrange the α TCR locus, but unlike for the β chain, productive α chain rearrangement is not
sufficient to downregulate recombination machinery expression and to stop further
rearrangement. Only after MHC restriction of the αβ TCR has been checked does the cell
trigger termination of the recombination process (Brandle et al., 1992). Although the α and β
chains display, as mentioned above, an inherent propensity to bind to MHC molecules, TCR-
MHC matching is actually quite rare due to the high degree of polymorphism of MHC molecules
(Zerrahn et al., 1997). That is why the majority of DP thymocytes maintain an elevated level of
RAG expression and stay undifferentiated. One thymocyte can perform multiple recombinations
at the same allele, which starts at the 5’ end of the J locus to end at the 3’ end. This increases
the probability for a cell to get an MHC- restricted TCR (Petrie et al., 1993). This process is,
however, limited in time by the life span of a DP thymocyte, estimated as no more than 3 to 4
days. RORγ and TCF1 are thought to be the transcription factors regulating the Bcl-XL gene
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expression, allowing the DP cell to survive (Ioannidis et al., 2001; Sun et al., 2000). If a cell
fails to receive a signal induced by weak recognition of the TCR and peptide-MHC within a
time frame of 3 to 4 days, RORγ and TCF1 will not trigger Bcl-XL expression and the cell will
consequently die by neglect.
In addition, due to incomplete allelic exclusion of the α locus, one single developing lymphocyte
has the ability to express two different rearranged α chains during positive selection; this “TCR
editing” process enhances the yield of positive selection (Nemazee, 2006). It is estimated that
about one-third of the mature T cell population will possess two α chains on their surface.
The nature of the specific ligand for positive selection is still unclear. Whereas it was originally
thought that most of the peptides displayed by MHC molecules during positive selection are
self-peptides, the situation regarding this statement seems to be more complex. It is clear that
the TCR affinity for positively selecting ligands is much lower than for negative selection (Liu et
al., 1998). In fact, Naeher et al. identified a constant affinity threshold for negative versus
positive selection in MHCI-restricted thymocytes and demonstrated that there is clear correlation
between selection potential and apparent affinity, defined as the strength of interaction between
MHC ligand and the TCR and its co-receptor (Naeher et al., 2007). Previously, this question has
been addressed mainly through the study of transgenic TCR systems, which represent forced
TCR expression; these models have a different kinetics of TCR expression than WT mice. It has
been shown that it is not mandatory for the positively selecting peptide presented by MHC to
have structural homology to the antigenic peptide ligand (Ignatowicz et al., 1997). In addition,
these peptides have been shown to be non-stimulatory in in vitro assays (Berg et al., 2000). In
conclusion, positive selection seems to be mediated through the presentation of rare, low
affinity self-peptide ligands with more or less structural homology to the antigenic peptide (Starr
et al., 2003).
All of the physical components of the TCR complex (α and β chain, CD3γ and CD3ε) and of its
signaling pathway (src and syk kinases, ZAP 70, LAT or PLCγ for example) are required for
positive selection to occur, but a few other transcription factors are suspected to play a role as
well in this process. Helix-loop-helix family members like E proteins seem to play an important
role of positive selection probably through their capacity to regulate RAG gene expression and
TCR locus accessibility (Quong et al., 2002). In addition, a mouse deficient in Schnurri-2, a zinc
finger transcription factor, has been found to have a block in positive selection (Takagi et al.,
2001).
Importantly, positive selection is carried out within an intact three-dimensional (3D) thymic
microenvironment formed by a network of cTECs, which are the second key cellular component
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in positive selection (Hare et al., 2001). This has been shown by performing bone marrow
chimera experiments from mice with distinct MHC haplotypes. The 3D architecture is of great
importance since a monolayer culture of cTECs is unable to complete positive selection (Sato et
al., 2001). In addition to presenting the positive selection ligand by MHC, cTECs provide the
specialized accessory interaction necessary for positive selection. Advanced microscopy
techniques have allowed visualization of thymocytes migrating through the 3D network of the
thymic cortex, sampling cTEC for recognition of peptide/MHC complex and stopping for a
couple hours when finding the corresponding match (Bousso et al., 2002).
Positive selection coordinates expression of CD4 and CD8 molecules according to the TCR
specificity for MHCI or MHCII and potential effector functions, helper or cytotoxic, respectively. It
is generally admitted that positive selection depends on the engagement of both the TCR and
its co-receptor, but the link between this engagement and the lineage commitment of
thymocytes towards CD8 or CD4 T cell is not quite clear.
Negative selection
In order to eliminate any potential autoreactive T cells from the mature T cell repertoire,
developing thymocytes undergo negative selection. The thymocyte engages its TCR with a high
affinity ligand in the thymus, which leads to apoptosis.
Various models have been used to study clonal deletion, but the differences between these
models have led to very little consensus concerning the mechanisms underlying negative
selection. Classical models in the field are based on TCR transgenic mice that concomitantly
express self-antigen where both TCR and Ag are expressed as transgenes. Transgenic TCR
expression kinetics in these systems are all different, with some being expressed much earlier
than in physiological conditions. The affinity between the TCR and its specific ligand may also
greatly differ between one system and another (Pircher et al., 1989). Finally, the cell type
expressing transgenic self-antigen might also play a significant role in the TCR-ligand
interaction outcome.
Clonal deletion can also be induced by using cross-linking antibodies, which present the
drawback of generating huge T cell activation. This induces the production of inflammatory
cytokines and steroid hormones, and leads to nonspecific death of DP thymocytes (Page et al.,
1998; Xue et al., 1996). In vitro assays in which thymocytes are incubated with cross-linking
antibodies also show a high rate of non-specific apoptosis among thymocytes. Additionally, this
method does not consider the possible requirement for costimulatory factors. Finally, Ab
crosslinking might induce a qualitatively distinct signal through the TCR than the one induced by
peptide-MHC ligand interaction.
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A third technique to study clonal deletion has used direct injection of peptides of interest.
Again, this has led to overwhelming activation in the thymus involving cytokine-mediated
stromal cell activation, recruitment of eosinophils, and finally collapse of thymic architecture
(Martin and Bevan, 1997; Murphy et al., 1990).
In conclusion, the most physiologic model for studying negative selection seems to use TCR
transgenic mice where the TCRαβ molecule is not expressed earlier than normal and where the
frequency of the responder T cell is not artificially high (Starr et al., 2003).
It is thought that about 5% of the total thymocytes undergo negative selection, and a similar
proportion of cells undergo positive selection (Palmer, 2003). Despite the sequential location of
DN to SP cells from the cortex to the medulla, respectively, the two events seems to be rather
independent of each other since negative selection can happen either before or after positive
selection and T cells seem to be able to undergo negative selection at all stages of
development.
Heterogeneous TCR transgenic models have been used to characterise thymocytes undergoing
negative selection. In some cases, clonal deletion appears to occur early during the transition
from DN to DP stage, whereas in other models, it occurs later at the DP stage (Stockinger,
1999). The first situation, however, is believed to be a transgenic artefact; normal mice are
indeed thought to undergo negative selection at the DP stage. Nevertheless, it is possible that
two different molecular mechanisms govern clonal deletion, one mechanism for early clonal
deletion in transgenic mice and another mechanism driving late negative selection in WT mice.
This is further supported by the fact that DP T cells are found in the cortex whereas SP
thymocytes reside in the medulla. Physiologically, clonal deletion is thought to happen more
efficiently at later stages, during the DP→SP transition, since it requires intact and strong
surface expression of TCRαβ  (Sant'Angelo and Janeway, 2002). It has been shown to involve
MHCII-restricted TCR T cells displaying a CD24high phenotype. This subpopulation of SP
thymocytes is called semi-mature and becomes apoptotic in response to antigenic stimulation.
After clonal deletion, SP CD4 T cells down regulate CD24 (Kishimoto and Sprent, 1997).
The location of negative selection has been controversial as some experiments indicate that it
occurs in the cortex (von Boehmer, 1990), while others suggest the medulla (Burkly et al.,
1993). TCR transgenic mice expressing high-affinity self antigen show atrophy of the cortex
along with a high rate of clonal deletion among DP thymocytes, but again, the abnormally high
expression of transgenic TCR on DP cells might introduce a bias in the negative selection in
those mice (Sprent and Kishimoto, 2001). In addition, mice with MHCII expression restricted to
the cortex area show an increase in mature auto-reactive CD4 T cells, proving that indeed some
negative selection occurs outside of the cortex (Laufer et al., 1996). Another observation
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favouring this idea is the lack of expression of the co-stimulatory molecules CD80 and CD86
on the surface of cTEC although they are thought to play a role in clonal deletion (Degermann
et al., 1994). In contrast, in the medulla, two types of antigen presenting cells (APC) are present
and crucial for negative selection -- bone marrow-derived dendritic cells (BMdDCs) and mTECs.
Medullary TECs are central players in negative selection in that they are responsible for
promiscuous gene expression (PGE) (Klein et al., 2000). PGE refers to the ability of these cells
to express and present nearly the entire peripheral self-peptide repertoire of an individual. PGE
is, at least partially, under the control of the autoimmune regulator transcription factor (AIRE);
and AIRE deficiency in patients leads to a multi-organ autoimmune syndrome known as
Autoimmune Polyendocrine Syndrome type 1 (APECED) (Anderson et al., 2002). mTECs have
been shown to be efficient APCs and capable of mediating negative selection of CD4 auto-
reactive T cells (Laufer et al., 1999). DCs present in the thymus are thought to be very important
for central tolerance and are able to acquire self-antigen from mTECs by the mechanism of
cross-presentation and induce clonal deletion of both developing CD4 and CD8 T cells
(Gallegos and Bevan, 2004).
The question of whether the TCR signal is by itself sufficient to induce negative selection or if a
second signal is required is still unresolved. The first insight into this issue has been the
observation that antibodies against the TCR added to thymocytes in vitro is not sufficient to
promote clonal deletion while the use of APCs restores negative selection (Punt et al., 1994).
Two co-stimulatory molecules, namely B7-1 and B7-2, have been proposed to provide a second
signal to DP thymocytes, inducing apoptosis (Page et al., 1993). In fact, anti-CD28 mAbs used
in vitro have been shown to have a similar effect on DP thymocytes. Similarly, the addition of
anti-CD43 and anti-CD5 mAbs in vitro has been reported to provoke an increased death rate
among CD4+CD8-CD24hi (Kishimoto and Sprent, 1999). Surprisingly, gene knock-out (KO) or
mutant mice for these co-stimulatory molecules, such as CD28-/- animals, show normal
thymopoiesis (Walunas et al., 1996). CD40L deficiency in thymocytes results in impaired
negative selection, although this block is incomplete and CD40L deficiency might only delay
negative selection (Foy et al., 1995). LIGHT, a TNF receptor family member which binds to
lymphotoxin β receptor, has likewise been proposed to provide a second signal for negative
selection, but again the corresponding KO mouse model does not show any deficiency in
thymopoiesis (Wang et al., 2001). It could well be that co-stimulatory function is so important for
negative selection that several molecules are responsible for it; this redundancy among co-
stimulatory molecules would explain the lack of an observed phenotype in single KO mice. On
the contrary, high-affinity interactions involved in clonal deletion do not require co-stimulation.
This difference between high-affinity versus low-affinity interactions may underlie the differences
in negative selection between whether an endogenous or an exogenous ligand is used
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Unlike positive selection, it appears that the CD4 and CD8 co-receptors do not participate in
clonal deletion, perhaps due to the high-affinity of the interaction which makes it less
dependent on any co-receptor involvement.
A simplistic view in the field presumes that recognition of low-affinity peptide-MHC complex
ligand mediates positive selection whereas high-affinity interactions lead to clonal deletion.
However, the mechanisms behind these events are not clear. Understanding the mechanisms
of positive versus negative selection is further complicated by the paradox that the same TCR
binding has to result in two different downstream signaling events leading to opposite cell fates.
There are two ways of explaining the outcome of thymic selection. The first one considers the
rate of occupancy of TCR molecules at a given time point, the cell being able to count how
many TCRs are engaged. It is assumed that the higher the affinity, the more TCRs are
interacting with peptide-MHC ligands. A certain threshold number of occupied TCRs could
trigger negative selection. This interpretation, however, has not been verified consistently by
experiments (Sebzda et al., 1994). Another explanation would consider the sensing of
differential durations of the TCR/peptide-MHC interaction. If the length of TCR engagement with
peptide/MHC complex is short, the cell will receive only an early TCR signal; this is the case
with low-affinity-mediated positive selection. If the TCR forms a sustained interaction with its
ligand due to high affinity, both early and late TCR signals would be triggered, followed by
clonal deletion. This version has been supported by surface plasmon resonance studies
showing a slow off rate for high-affinity ligands and fast off rate corresponding to low-affinity
ligands (Alam et al., 1996). This is known as kinetic proofreading. Some of the problems raised
with Surface Plasmon Resonance are that it does not account for the role of co-stimulatory
molecules and does not explain what happens when the TCR binds an intermediate-affinity
ligand.
Along with this kinetic differentiation in thymic selection outcome, a similar kinetics of
extracellular signal regulated kinase (ERK) activation has been observed. In the presence of
positively selecting ligands, a slow and sustained accumulation of ERK has been reported
whereas negatively selecting ligands induce a strong but transient burst of ERK activity (Werlen
et al., 2000).
The signaling pathway and transcription factors involved in negative selection are a vast area of
investigation that will not be extensively discussed herein, but will just be mentioned for
completeness. As in positive selection, all TCR complex components are necessary for negative
selection. The MAPK pathway seems to be involved in a differential kinetics-related manner,
involving the same molecules as positive selection, namely p38, Jun N-terminal Kinase (JNK)
and ERK. Linker for activation of T cells (LAT) acts upstream of the MAPK pathway to activate
it, and the recruitment of the adaptor GRB2 to LAT seems also to be of primary importance.
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Phosphatase and tensin homologue (PTEN), the nuclear orphan steroid receptor (NUR77),
and NFκB are also implicated in negative selection, as in positive selection. On the other
hand, the FAS apoptotic pathway seems to be dispensable for deletion of self-reactive
thymocytes. Rather, pathways mediated by B-cell lymphoma 2 anti-apoptotic protein (BCL-2)
family members have been shown to be more relevant, via involvement of the pro-apoptotic
factor BCL-2 interacting mediator of cell death (BIM) (Werlen et al., 2003).
Figure 15: Kinetics of positive and negative selection signals.
(A) During positive selection, LAT phosphorylation, Ca2+ mobilization, and ERK activation are
slowly induced over a sustained period of time. This contrasts with the induction of p38 and JNK,
which are activated with different kinetics. Low-affinity pMHC ligands, which occupy the TCR for a
relatively short time, could induce the phosphorylation of Tyr175 and Tyr195 on LAT. This might
recruit Gads, SLP-76, and PLC-1 and lead to the slow production of DAG and the slow activation of
RasGRP, Ras, and ERK. (B) During negative selection, LAT phosphorylation, Ca2+ mobilization,
and ERK activation are rapidly and transiently induced. High-affinity ligands occupy the TCR for
longer times and might induce the phosphorylation of Tyr175, Tyr195, and Tyr136. The
phosphorylation of the Tyr136 residue might stabilize PLC-1 within the growing TCR signalosome,
leading to the rapid activation of Ras and ERK. High-affinity ligands could also lead to the
phosphorylation of Tyr113, Tyr132, and Tyr235, which recruit Grb-2 and the guanine nucleotide
exchange factor, Sos. This could increase the speed of ERK activation. Diacylglycerol kinase
(DGK) and RasGAP might terminate ERK activity. Interestingly, the kinetics of p38 and JNK
activation during negative selection are the same as during positive selection (Adapted from
Werlen, 2003).
Agonist selection
As previously mentioned, thymocyte fate is thought to be conditioned by TCR affinity. DP
thymocytes encountering a low-affinity peptide-MHC complex are positively selected,
thymocytes encountering high-affinity ligands undergo clonal deletion, and DP cells unable to
display a functional TCR or with no affinity for MHC peptide die by neglect. A fourth pathway of
differentiation has been described whereby thymocytes can actually be selected following
encounter with a high-affinity TCR agonist ligand (reviewed in Baldwin et al., 2004). Agonist
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selection has been shown to drive the development of three mature T cell populations, namely
NK T cells, CD8αα intraepithelial cells T lymphocytes (IEL) of the gut, and CD4+CD25+
regulatory T cells. These populations are self-reactive and share common phenotypic and
functional properties. They are all involved in the regulation of the immune response.
NK T cells are CD1d-restricted, CD1 molecules being non-classical MHC I molecules. The
majority of NK T cells express invariant rearranged TCR Vα14 chain, which recognises an
unidentified agonist endogenous glycolipid associated with CD1d molecules. Development of
NK T cells requires an encounter with the CD1d-glycolipid complex exclusively on BMdDCs of
the thymus (Kronenberg and Gapin, 2002). They are thought to arise from DP thymocytes as
shown by transfer experiments (Gapin et al., 2001). At the end of their thymic development, they
acquire the marker NK1.1, as well as other activation markers such as CD44. Finally, they are
specialised in regulating immune responses through the secretion of cytokines.
CD8αα intraepithelial lymphocytes also have regulatory functions. They are numerous in the gut
and represent about 50% of all intraepithelial T cells. They are MHC I-restricted and, like NK T
cells, display an activated phenotype. Several studies have suggested that they arise after
agonist selection; in fact, they are increased in TCR transgenic mice expressing agonist ligand
(Leishman et al., 2002). Whether these cells originate within or outside the thymus has been the
subject of controversy. An experiment using fetal thymic organ culture (FTOC) in combination
with high-affinity agonist ligand suggests that the development site of these CD8αα T cells is
within the thymus (Cheroutre and Lambolez, 2008; Hogquist and Bonnevier, 1998). It is
furthermore unclear whether CD8αα are derived from DP or DN T cells. One argument in favour
of the latter hypothesis is the expression of the Fc fragment of IgE, high-affinity I receptor γ
polypeptide (FcεR1γ) signal transducer, within the TCR complex of this lymphocyte population
(Heiken et al., 1996). On the other hand, Eberl and Littman showed that CD8αα IEL express a
reporter gene that is only activated after β selection (Eberl and Littman, 2004).
Finally, naturally thymic-derived CD4+CD25+ regulatory T cells (Tregs), which will be discussed
in further detail in a later chapter, are also selected through agonist selection. Tregs are able to
inhibit T cell proliferation in vitro and to prevent many autoimmune disorders in vivo, such as
colitis or diabetes (Mottet et al., 2003; Salomon et al., 2000). Caton et al have shown that
haemagglutin (HA)-specific TCR transgenic mice expressing the agonist ligand HA under the
control of various promoters display various levels of deletion but a striking increase in the
CD4+CD25+ T cell population (Apostolou et al., 2002; Jordan et al., 2001). This subset carries
particular surface activation markers on their surface, such as CD25, GITR and CD5. They are
generated in the thymus where they are presumed to be selected by radioresistant APCs
presenting high-affinity self-antigen. It is still under debate whether thymic epithelial cells or
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thymic BMdDCs are the physiologic cell type supporting their development (Apostolou et al.,
2002). They have been shown to be self-reactive since they expand rapidly after adoptive
transfer into lymphopenic hosts (Hsieh et al., 2004). Tregs can also arise from CD4+CD25-
peripheral T cells through specific conditions of antigen encounter. Thymic derived regulatory T
cells cannot be distinguished from their peripheral counterparts since they are phenotypically
identical.
All of the above three subsets share common features such as partially activated phenotype,
regulatory function, and a dominant role for agonist interaction during their development.
However, this does not imply that they share a similar development pathway. The discovery of
FoxP3 repressor and its close association with regulatory T cell phenotype and function, as well
as the reporter gene knock-in mouse generated by Rudensky et al., have proven the existence
of a unique regulatory T cell lineage (Fontenot et al., 2003; Fontenot et al., 2005a; Fontenot et
al., 2005b). Nevertheless, it is not yet clear whether the other populations represents a unique
lineage or merely a specific activation state of T cells.
It is also unclear whether agonist selection is a variation of positive or negative selection or if it
represents a particular type of antigen reactivity. These cell subsets might develop at a specific
stage of development through interaction with MHC-peptide complex or react to agonist
stimulation in a different way than clonal selection. It appears that both selection features may
be involved (ref. Baldwin TA). Another question raised is whether their specific phenotype
allows them to survive clonal deletion or if the agonist encounter drives their development. It
seems that although TCR affinity seems to dictate the fate of these cells, upregulation of
costimulation or signaling molecules are necessary for these cells to develop (Baldwin et al.,
2004).
It has been hypothesized that different degrees of avidity would allow agonist-selected T cells to
avoid deletion; however, despite indications that avidity might play a role, direct proof has not
been provided (Jordan et al., 2000). Another possibility is that agonist presentation occurs
through different APC types. For example, it is not quite clear which cell type induces regulatory
T cell development. Laufer et al. have shown that cortical epithelial expression of MHCII could
support the differentiation of Tregs (Bensinger et al., 2001) whereas studies by Aschenbrenner
et al. argue in favour of a role for Aire+mTECs in the selection of Tregs (Aschenbrenner et al.,
2007).
Receptor editing
As discussed previously, quasi-random gene rearrangement ensures a high diversity of TCR
specificities, while the risk of generating autoreactive thymocytes is limited through elimination
of cells carrying unsuitable Ag receptors. According to the Burnett model, this is accomplished
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through the control of lymphocyte survival and proliferation illustrated best as clonal deletion.
Recently, increasing evidence has suggested the existence of alternative regulatory
mechanisms, such as receptor editing. This is defined as a feedback mechanism by which the
antigen receptor could signal either to cease or to continue recombination, thereby controlling
the maintenance or the alteration of Ag receptor specificity (Nemazee, 2006). It basically
decides to turn the recombination machinery on or off depending on the nature of the signal
received. In this manner, receptor editing excises a rearranged Ag receptor gene segment by
producing a secondary rearrangement and results in alteration of the original receptor
specificity. Receptor editing has been shown to play a major role in central tolerance by
replacing auto-reactive receptors of developing thymocytes with innocuous ones, preventing
subsequent autoimmune disease from developing in the periphery (Santori et al., 2002). As
mentioned previously, this phenomenon is well established in B cells and is thought to happen
in an analogous mode in T cells (Nemazee, 2000).
There is essentially no editing at the level of the TCR β chain. After a proliferative burst of pre-T
cells along with the first chain rearrangement, thymocytes modify DNA accessibility for RAG1
and 2 proteins in order to maintain allelic exclusion. This is done by deacetylation of the Vβ
gene during the transition form DN to DP stage (Tripathi et al., 2002). On the other hand, the α
chain locus is more prone to receptor editing. In fact, as mentioned earlier, the recombination of
the α  chain is less stochastic than the β chain recombination due to 5’ to 3’ sequential
recombination attempts at the TCRA locus.
Rearrangement events occur in the thymic cortex. It has been known for a while that TCR cell
surface expression is not sufficient to stop recombination events; rather, only successful positive
selection leads to termination of RAG protein expression (Brandle et al., 1992; Brandle et al.,
1994). In fact, recombination is ongoing at the DP stage. As reported earlier, high-affinity
interaction presumably leads to clonal deletion but negative selection studies have been limited
by the wide use of TCR transgenic models, which in the vast majority present a forced
expression of the TCR and subsequently promote a distinct form of central tolerance. Wang et
al. first showed that negative selection might actually lead to receptor editing (Wang et al.,
1998). At the same time, Mc Gargill et al. showed that receptor editing represents a major
developmental mechanism in OT1 transgenic mice expressing OVA as a self-Ag on the surface
of cTECs, and they proposed that auto-reactive DP thymocytes can undergo receptor editing in
the cortex upon encountering their Ag provided that TCR expression is not abnormally
premature (McGargill et al., 2000). The OT1 transgenic mice demonstrate decreased deletion
and activation of auto-reactive T cells, as well as internalisation of the TCR, with maintained
RAG expression. An increase in endogenous rearrangements at the TCR α locus leads to
higher numbers of cells expressing the endogenous α chain pairing with the transgenic β chain.
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This Ag-induced TCR internalization provides thymocytes with the opportunity to rearrange
other receptors and edit their specificity. Contrary to these findings, another study by Buch et
al. argues that receptor editing might not be a governing principle in thymic development since
their HY-I, a VαJα knock-in combined with a cre-lox system of TCRδ mice, produce a negligible
amount of receptor-edited T cells (Buch et al., 2002). They interpret these results as sequential
gene rearrangement being a direct consequence of positive selection screening.
It is not clear what the factors promoting receptor editing are. The avidity, the stage of deletion
during negative selection, either early or late, or the tissue specificity have been proposed to
influence the occurrence of receptor editing (McGargill and Hogquist, 2000). It seems that the
type of cells presenting the Ag would also be a major determinant since, according to McGargill
and Hogquist, cTECs are not able to provide any costimulation factor to developing T cells nor
are they able to provoke apoptosis in the same cells. It has to be mentioned though that a
double transgenic mouse model developed in our lab co-expressing HA-specific TCR and HA
agonist in DCs displays a high rate of TCR editing despite the presence of costimulation
molecules on the surface of the DCs.
When secondary gene rearrangement of the TCR occurs at a different allele than the primary
gene rearrangement, it does not lead to excision of the first TCR gene rearrangement, such that
one T cell then carries two different receptor specificities. This dual TCR receptor expression
has generally been considered as a potential hazard for the peripheral immune system since T
cells with an auto-reactive TCR can escape negative selection and reach the periphery
(McGargill and Hogquist, 2000). Another group challenged this idea by considering dual TCR T
cells as a way to expand the TCR repertoire for foreign antigens (Gavin and Rudensky, 2002;
He et al., 2002). Nevertheless, autoimmunity due to dual receptor expressing T cells has only
been described in TCR transgenic contexts and are likely overtly exaggerated in these systems
compared to wild-type situation (McGargill and Hogquist, 2000).
In conclusion, the importance of TCR editing in the pathway of central tolerance in physiological
conditions is unknown at present. It may concern only a minority of developing self-reactive T
cells but cannot be overlooked.
T cell tolerance
The immune system faces the dual challenges of mounting an adequate immune response
against an incredibly high range of pathogens while at the same time limiting any reaction
against a large variety of self-antigen. The latter process is called tolerance. A fine-tuned
balance between these two processes prevents the two pathological extreme situations of
immunodeficiency and autoimmunity. Central tolerance refers to the mechanisms preventing the
development of auto-reactive immune cells in primary sites of lymphocyte development.
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Although this is an efficient process, it does not eliminate all self-reactive lymphocytes. Thus,
peripheral tolerance also exists to control the activation and proliferation of self-reactive
mature cells in lymphoid and non-lymphoid organs. Induction of T cell anergy, T cell deletion,
and immunological ignorance are some mechanisms of peripheral tolerance.
Central tolerance
In the thymus, central tolerance is achieved through selection and development of a T cell
repertoire targeting foreign antigens and devoid of any self-reactivity. An immature T cell
encountering its cognate antigen in the thymus becomes self-tolerant through induction of
anergy, a state of non-responsiveness to Ag stimulation, clonal deletion, receptor editing, or the
development of regulatory T cell population as described earlier. This results in the impairment
or elimination of high-affinity self-reactive T cells.
One longstanding question was how developing T cells encounter peripheral antigens in the
thymus. It had been hypothesised for a long time that Ag could access the thymus via blood
vessels, either in a soluble form or carried by recirculating cells such as immature DCs. In fact,
Le Douarin and colleagues were the first to show that tolerance was mediated by the thymus.
They transplanted thymectomised birds with thymic anlage and rendered them tolerant (Ohki et
al., 1987). Almost ten years later, Asano et al showed that neonatal thymectomy of mice up to 3
days after birth resulted in multi-organ autoimmunity (Asano et al., 1996). They were the first to
identify a CD4+CD25+ regulatory T cell population. Finally, when generating a transgenic mouse
model using tissue specific promoter elements, unexpected expression of the transgenic gene
product was reported in the thymus in addition to targeted organ specific expression (reference
rudensky GFP knock in).
This led to the discovery years later of promiscuous expression of tissue-restricted self-antigens
(TSA) specifically by thymic stromal cells (Derbinski et al., 2001). Derbinski et al. identified a
variety of peripheral antigens expressed specifically in mTEC that are often targets of
autoimmune disorders. They also showed that promiscuous gene expression is a property
conserved in the thymus throughout life, even during age-related thymic involution, and that it is
independent of any developmental regulation. Interestingly, TSA genes do not show any
structural or functional commonalities but have been shown to organise in genetic clusters
(Derbinski et al., 2005; Gotter et al., 2004). Other studies have suggested a link between thymic
promiscuous gene expression and tolerance induction (Klein et al., 1998; Klein et al., 2000).
The identification of the autoimmune regulator AIRE, which in humans is associated with the
multiorgan autoimmune disorder known as autoimmune polyendocrinopathy candidiasis
ectodermal dystrophy (APECED) (Bjorses et al., 1998), and the generation of AIRE KO mice
(Anderson et al., 2002) revealed new insights into this field. AIRE is a transcription factor
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displaying a nuclear localisation signal and several DNA binding domains. It is expressed
specifically in MHCIIhigh CD80high mTECS in the thymus (Derbinski et al., 2005) and controls
promiscuous gene expression (PGE) in the thymic medulla (Anderson et al., 2002). Liston et al.
directly demonstrated that AIRE is indeed responsible for negative selection of organ-specific T
cells through regulation of TSA expression (Liston et al., 2003).
Although it acts in a gene-specific manner, how AIRE controls PGE is still unclear. AIRE has
been shown to co-localize and function in cooperation with CREB binding protein (CBP), which
controls expression of a wide range of genes, but there is no experimental evidence yet for
direct binding of AIRE to CIS-acting sequences of target genes (Pitkanen et al., 2000; Pitkanen
et al., 2005). The genetic clustering of PGE suggests that molecular regulation might be
dictated by epigenetic mechanisms to ensure that TSA expression mirrors practically all tissues
in the body irrespective of developmental or spatio-temporal expression patterns.
PGE is not restricted to mTECs, but rather can also occur in cTECs as well as thymic DCs.
Furthermore, TSA expression is not always controlled by AIRE; C-reactive protein (CRP) and
glutamic acid decarboxylase 67kDa (GAD67) are two examples of peripheral antigens whose
expression is not regulated by AIRE (Anderson et al., 2002). In addition, there is phenotypic
heterogeneity upon AIRE loss: APECED can be sporadic and slow to develop; the phenotype of
AIRE KO mouse differs according to genetic background; and finally, disease onset is actually
much accelerated after bone marrow transplantation (BMT) of WT into AIRE-/- hosts (Anderson
et al., 2002). These observations led to the conclusion that some other genes might
compensate for lack of AIRE and sustained PGE may play a role in tolerance independent of
AIRE.
Given the very low concentration of TSA synthesized by mTECs and the rare number of mTECs
displaying a given peripheral antigen (1-3%), T cells have to scan extensively the stromal cell
compartment for expression of self-antigen, necessitating a very high degree of motility during
their time of residence in the medulla (Kyewski and Klein, 2006). In addition, considering the low
efficiency of mTECs in inducing apoptosis, it is quite possible that thymic DCs help mTECs in
inducing clonal deletion through cross-presentation. Thymic DCs can indeed acquire TSA via
the presence of apoptotic mTECs; they have been described to have a high turnover of about 3
weeks. Antigen spreading can also be mediated by secreted exosomes or by gap junction’s
transfers shown by in vitro data (Harshyne et al., 2001; Neijssen et al., 2005; Thery et al., 2002).
This would increase the availability of tolerizing antigen for T cells undergoing negative
selection. In fact, Bevan and Gallegos have reported such a mechanism in the thymus
(Gallegos and Bevan, 2004).
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Figure 16: Presentation of self-proteins by bone marrow_derived APCs versus mTECs (MEC) for
tolerance induction in the thymus.
APCs, as represented by dendritic cells (DCs), efficiently present endogenously synthesized proteins to
both CD4+ and CD8+ T cells and circulate proteins to CD4+ T cells. APCs thus induce tolerance (clonal
deletion) to ubiquitous proteins, whether they are secreted or arise intracellularly. Tolerance to ubiquitous
antigen may also be mediated by MECs (Medullary Epithelial Cells, not illustrated). However, the principal
role of MECs may be to purge T cells that are reactive to tissue-specific antigens (TSAs). Such deletion is
the result of ectopic expression of TSAs by MECs. How MECs are able to synthesis TSAs is still
unknown, but recent work has indicated that AIRE, a putative transcription factor, is centrally involved in
this process. In direct support of this idea, Liston et al show that clonal deletion of T cells reactive to a
neo-TSA is abolished or greatly reduced in the absence of AIRE (Adapted from Sprent 2003).
Regulatory T cells
As mentioned earlier, despite negative selection, some autoreactive T cells reach the periphery
and represent a potential hazard for the individual. Regulatory T cell subsets are supposed to
control the proliferation and effector functions of these harmful autoreactive T cells. There are
numerous subpopulations of regulatory T cells, in addition to CD8αα+ and NK T cells mentioned
earlier. The CD4 T cell subset includes IL-10-producing Tr1 regulatory T cells (Groux et al.,
1997) and transforming growth factor β (TGF-β)-producing T helper type 3 cells (Chen et al.,
1994) that are confined in the periphery. We will mainly focus here on the natural thymus-
derived CD4+CD25+FoxP3+ population and peripheral induced Tregs, which altogether
represent about 10% to 15% of the peripheral CD4 T cell population.
Phenotype and Function
Recent studies have implicated so-called naturally-arising regulatory T cells (Treg) as key
components controlling autoimmunity (Kronenberg and Rudensky, 2005; Sakaguchi et al.,
1995; Shevach, 2004). Tregs were first described as a population of CD5highCD4+ cells that
upon transfer could protect mice from autoimmune disease caused by neonatal thymectomy
(Sakaguchi et al., 1982). Later, it was shown that during mouse ontogeny, Tregs appeared
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shortly after birth and that CD25, the alpha chain of the IL-2R complex, could be used as a
surrogate marker for these cells (Fontenot et al., 2005a; Sakaguchi et al., 1995). More
recently, the transcription factor FoxP3 has been shown to be critically associated with Treg
function (Hori et al., 2003); and indeed a knock-in transgenic mouse line containing a GFP-
FoxP3 construct indicated that FoxP3 may be used as a lineage marker for Tregs (Fontenot et
al., 2005b). Many phenotypic features of Tregs, namely spontaneous CD25 expression,
glucocorticoid-induced tumour necrosis factor receptor (GITR) (Shimizu et al., 2002) and
cytotoxic T lymphocyte antigen 4 (CTLA-4) constitutive expression (Read et al., 2006), as well
as down-regulation of CD4, CD3 and TCRβ transcripts and surface antigen expression are
similar to those of activated T cells (Bosco et al., 2006b; Gavin et al., 2002b; Kasow et al.,
2004). Natural Tregs are anergic:  they respond very poorly to TCR stimulation and do not
produce IL-2 in vitro although their survival is critically dependent on this specific cytokine.
However, this anergy can be overcome by adding anti-CD28 mAb and IL-2 to the culture,
although at the expense of their suppressive capacity. Surprisingly, they proliferate extensively
in vivo and more specifically in lymphopenic conditions (Cozzo et al., 2003). The repertoire of
TCR expressed by Treg is generally thought to be broad; however, it would seem that their TCR
have a relatively high affinity for self antigens (Hsieh et al., 2004). Thus, their CD5high phenotype
may have protected them from negative selection in the thymus (Azzam et al., 2001).
Functionally, Tregs inhibit the proliferation and cytokine production of naïve responder T cells in
vitro (Thornton and Shevach, 1998). Their main functional role in vivo (Asano et al., 1996)
appears to be in preventing the activation and reducing the expansion of activated T cells
(Sakaguchi, 2004). Tregs are part of the natural T cell repertoire and suppress harmful
immunopathological responses to self or foreign antigen. Indeed, several experiments have
shown that regulatory T cells exert dominant extrathymic immune regulation. CD4+CD25+ Tregs
have been shown to inhibit experimental autoimmune encephalomyelitis (EAE) (Olivares-
Villagomez et al., 1998) as well as spontaneous immune diabetes in susceptible mouse strains
(Salomon et al., 2000; Tang et al., 2006). Another model of natural Treg-mediated immune
regulation is the inflammatory bowel disease (IBD) model reported by Powrie et al., whereby the
severe colitis in SCID mice reconstituted with CD4+CD45Rbhi can be inhibited by cotransfer of
CD4+CD45RBlo containing the CD25+ subset. Finally, natural Tregs mediate tolerance to
alloantigen in transplantation experiments, impede anti-tumour immunity, and control
homeostasis (Sakaguchi et al., 2001).
Natural Treg-mediated inhibition of T cell expansion can be seen as advantageous in situations
of autoimmunity, but they may be disadvantageous in situations of lymphopenia-induced
proliferation or anti-tumour immunity (Dolnikov et al., 2003; Nomura and Sakaguchi, 2005).
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Foxp3
Mice carrying the spontaneous X-linked Scurfy mutation and humans affected by the rare
Immunodysregulation, Polyendocrinopathy, Enteropathy, X-linked (IPEX) syndrome share
similar symptoms and suffer from autoimmunity (Wildin et al., 2001). Their disease is
characterised by chronic polyclonal activation and hyperproliferation of CD4+ T cells, which
produce a variety of pro-inflammatory cytokines, display decreased activation threshold, and
show diminished dependence on co-stimulation signals leading to multi-organ lymphocytic
infiltrations. Brunkow et al. in 2001 were the first to clone the gene responsible for the disease,
namely Foxp3 (Brunkow et al., 2001). It belongs to the forkhead/winged helix family of
transcriptional repressors and carries a zinc finger as well as a leucine zipper motif. The
forkhead domain has been recently shown to be required for both DNA binding and nuclear
localization whereas the leucine zipper motif mediates homodimerization. The less
characterized N-term domain has been shown to mediate suppression by binding to NFAT/AP-1
sites of 5’ regulatory sequences of cytokine genes and more specifically the IL-2 promoter,
explaining the anergic phenotype of regulatory T cells (Lopes et al., 2006).
Foxp3 is a critical element for the differentiation and function of mouse regulatory T cells (Hori et
al., 2003; Khattri et al., 2003), and adoptive transfer of natural regulatory T cells is able to
prevent disease in scurfy mice (Fontenot et al., 2003). In addition, ectopic expression of Foxp3
in CD4+T cells endows non-regulatory T cells with regulatory properties such as anergy and
suppressive ability (Khattri et al., 2003; Khattri et al., 2001). Based on these studies, Foxp3 has
been well established as a mediator of genetic mechanisms governing dominant tolerance and
a Treg-lineage specification marker. It has to be noted, however, that Foxp3 seems to behave
differently in humans as activation-mediated Foxp3 induction has been reported in CD4+CD25+
T cells (Walker et al., 2003).
The generation of a knock-in allele encoding a Foxp3-gfp fusion product has provided many
insights into FOXP3 biology (Fontenot et al., 2005a) and Treg function in general. This new tool
allows for tracing much more faithfully regulatory T cell fate in vivo and facilitates sorting of
natural Tregs. It is now clear that FOXP3 is highly restricted to T cells.
Regulatory T cell development
CD4+CD25+ Tregs represent 5% of thymic CD4 SP T cells and are capable of suppressive
activity in vitro. It has been reported that, despite their presence in neonates, they are not
functional before 3 to 4 days after birth (Asano et al., 1996). CD25+ is acquired relatively late
during T cell development, during transition from the DP to SP stage. Moreover, Foxp3-gfp mice
have allowed identification of GFP-positive cells preferentially within the CD4 SP thymocyte
population, although about 11% of FOXP3+ cells are also found within the DP CD24hi subset. It
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has not been clearly demonstrated that the former is the progeny of the latter, but this
demonstrates that commitment to Treg occurs during late stages of development (Fontenot et
al., 2005a).
For years, the origin of regulatory T cells had been a subject of intense debate, some
considering Tregs as products of effector T cell differentiation and others favouring the
existence of an independent thymic-derived Treg lineage. It appears today that both of these
hypotheses are correct:  a unique thymic-derived FOXP3+ CD4+ T cell population is well
established as an independent lineage, but generation of FOXP3-expressing Tregs from
effector T cells also occurs in the periphery. In this section, we will mainly focus on thymic
development of natural Tregs. Multiple studies have reported increased generation of natural
Tregs in double transgenic mice co-expressing a specific TCR and its agonist in the thymus
(Apostolou et al., 2002; Jordan et al., 2001). From these studies, it was concluded that the
choice of Treg lineage is induced upon binding of TCR to its cognate Ag. It was hypothesized
that this interaction, at an avidity just below the threshold required for negative selection, would
promote development of regulatory T cells (Maloy and Powrie, 2001). Indeed, Jordan et al.
showed that the affinity of the TCR for its antigen determines the T cell developmental outcome,
namely regulatory T cell commitment versus negative selection (Jordan et al., 2000). An
alternate view on regulatory T cell development is defended by van Santen et al., who argue
that T cells are stochastically selected towards the Treg lineage (van Santen et al., 2004). They
found no increase in absolute numbers of Tregs in a similar model of double transgenic mice,
but rather only an increase in the percentage of Tregs. They explained this observation by the
fact that Tregs are merely more resistant to induced apoptosis. As a result, preferential survival
of Tregs would inflate their percentage within the total thymic cell population while CD4+CD25-
are eliminated by negative selection. These two models are not mutually exclusive, and further
studies using the KI Foxp3-gfp model have helped reconcile the two hypotheses. Lin et al. have
shown that when Foxp3 is replaced by a non-functional copy of the gene fused with egfp, a true
population of Tregs with classical Treg phenotype develops, although these Treg-like cells do
not show suppressive capacity either in vivo or in vitro (Lin et al., 2007). It seems that the high-
affinity TCR-Ag/MHC interaction initiates the development of a Treg cell-like precursor, which
upon TCR signalling induces FOXP3 expression. In addition to TCR signaling, other
costimulatory molecules influence Treg commitment. For example, CD28-deficient (CD28-/-) as
well as B7-deficient (B7 being a ligand for CD28 expressed by medullary DCs) mice have
decreased numbers of regulatory T cells, and CD28-/- mice do not show an increase in Treg
percentage in the double transgenic condition (Salomon et al., 2000).  TSLP-differentiated DCs,
which are known to upregulate B7 expression, have also been reported as capable of inducing
regulatory T cells (Watanabe et al., 2005). Other molecules, such as CD40 or CTLA-4, have
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been shown to be involved in Treg development. However, although a decrease in Tregs has
been reported in the corresponding deficient animals, the remaining Tregs are functional and
capable of suppression, suggesting that these molecules are not absolutely necessary for Treg
development. On the other hand, TGF-β and IL-2 have been shown to be required for Treg
survival and maintenance in the periphery but not for development (Buhlmann et al., 2003;
Furtado et al., 2002; Kumanogoh et al., 2001; Marie et al., 2005).
The thymic cells responsible for Treg selection have also been a matter of debate. Long ago, it
was shown that radio-resistant thymic elements of the thymus were responsible for T cell-
mediated tolerance (Ohki et al., 1987). It is now widely accepted that radio-resistant elements
can mediate selection of CD4+CD25+ Tregs. According to Jordan and Apostolou, BM-derived
DCs expressing self-Ag induce anergy of CD4+CD25- Tregs whereas TECs mediate
development of regulatory T cells. Again, there is always the possibility of cross-presentation
between the two cell types (Gallegos and Bevan, 2004). In fact, it has been suggested that
thymic DCs can also mediate Treg selection (Graca et al., 2006). Some studies argue for a
major role for cTEC whereas others favour the medullary component of thymic epithelium
(Aschenbrenner et al., 2007; Bensinger et al., 2001). In support of the latter, deficiencies in
genes playing a key role in the mTECs, such as NFκB, show an impaired regulatory T cell
compartment. In addition, green cells of the Foxp3-gfp KI mice generated by Rudensky’s
laboratory are found as a majority in the medulla (Fontenot et al., 2005a). Moreover, mTECs
express all of the costimulatory molecules that may influence Treg development, such as CD80
and CD86, MHCII, and specific cytokines. However, it is not clear if only the medullary
component is required or if Tregs are generated in the cortex with the medulla being necessary
for further development.
What are the peptide ligands presented to Treg precursors? Based on  the increase in Tregs
generated in double transgenic mice, the fact that they proliferate robustly in lymphopenic hosts,
and the lack of protection against a specific organ when the Tregs originate from an animal
lacking this organ (Seddon and Mason, 1999; Taguchi and Nishizuka, 1980), it is natural to
hypothesise that presentation of tissue-restricted self Ag would select for regulatory T cells. It is
also tempting to suggest a role for TSA, promiscuously expressed by mTEC, in the selection of
Tregs. However, the Treg compartment is normal in AIRE-deficient mice, suggesting that AIRE
is not needed for Treg generation. Hsieh et al. have shown that the TCR repertoire of Tregs
partially overlaps with the repertoire of conventional T cells and, in fact, that the same TCR
could be expressed by both self-reactive T cells and Tregs (Hsieh et al., 2004; Hsieh et al.,
2006) A recent study showed selection of Tregs specific for self antigen by AIRE+ mTECs
presenting that Ag, along with the concomitant deletion of self-reactive conventional T cells by
thymic DCs cross-presenting TSA (Aschenbrenner et al., 2007). AIRE+ mTECs seem to be
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sufficient for Treg generation, but it remains uncertain whether they are the only cells capable
of supporting Treg selection. In contrast, the same study showed that Ag presentation by DCs
is dispensable for agonist-specific T cells. It may be that the two cell types cooperate with each
other, perhaps through cross presentation. It remains obscure how thymic DCs and mTEC
manage to elicit negative selection and Treg production at the same time.
Homeostasis of Tregs in the periphery and de novo generation
As mentioned previously, TGFβ and IL-2 have been shown to be necessary for the peripheral
maintenance of natural Tregs (D'Cruz and Klein, 2005; Fontenot et al., 2005a; Li et al., 2006;
Marie et al., 2005), although this has been recently challenged by Liu et al. (Liu et al., 2008).
The partially activated phenotype of Tregs suggests continuous stimulation of these cells. In
addition, their repertoire is thought to tend towards self-reactivity. The source of IL-2 is
presumed to be CD4+CD25- naïve T cells.. The presence of cognate antigen in the periphery is
also thought to be necessary for the maintenance of natural Tregs. Indeed, adoptive transfer of
peripheral Tregs from athyroid rats are unable to inhibit thyroiditis, whereas thymocytes isolated
from the same donor are effective in doing so. This last experiment argues in favour of organ-
specific, antigen-driven peripheral maintenance of Tregs. On the other hand, adoptive transfer
of Ag-specific Tregs generated from double transgenic Ag-specific TCR/ agonist mice can
survive for several weeks in a host lacking this agonist: they are able to proliferate and to
suppress Ag-driven CD4 and CD8 responses in vivo against Ag expressing tumour cells after
priming (Klein et al., 2003). The discrepancy between the two studies may lie in the use of
lymphopenic mice in earlier studies, which do not reflect physiologic homeostatic conditions. It is
also quite possible that the priming of Ag-specific Tregs by immunization enhanced their
suppressive potential in Klein’s studies whereas such priming does not occur in the Le Douarin
model of organ-specific tolerance. It would be interesting to use Foxp3-gfp knock-in Treg cells
and physiologic non-lymphopenia driven autoimmune models, such as diabetes, to better define
the factors driving homeostatic proliferation of Ag-specific Tregs. If not agonist-driven, Treg
homeostatic proliferation may alternatively be driven by MHCII molecules, as suggested by
Gavin et al. (Gavin et al., 2002a). However, it has been quite challenging to prove a direct effect
of MHCII deficiency on Tregs and to distinguish between MHCII-mediated effects on
development versus on homeostasis of Tregs (Bochtler et al., 2006; Shimoda et al., 2006)
Despite the major role of natural thymic-derived regulatory T cells, it is well established now that
other regulatory T cells can be induced from naïve T cells in the periphery, under specific
conditions. Their phenotype and function are indistinguishable from those of thymic-derived
Tregs: they are FOXP3-positive and capable of suppression (Walker et al., 2003). Three
examples support this concept. Apostolou and Von Boehmer reported that the generation of
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CD4+CD25+ suppressor T cells is a normal component of the host response to the introduction
of low concentrations of antigen (Apostolou and von Boehmer, 2004). Furthermore, specific
tolerogenic conditions also promote differentiation of naïve T cells into regulatory T cells, which
is mediated by a specific DC subset called tolerogenic (Mahnke and Enk, 2005). Finally, TGFβ
has been shown to induce a regulatory phenotype in naïve T cells (Chen et al., 2003). However,
it is not clear whether these induction protocols genuinely educate naïve T cell to display a
regulatory phenotype and to acquire regulatory function or if they merely induce proliferation of
a previously undetectable Treg population.
Mechanisms of suppression
The mechanism underlying the suppressive function of regulatory T cells has been the subject
of a substantial number of studies, which have suggested involvement of many alternate
molecules and/or pathways. This might be due to the variety of models used to characterise
Treg-mediated suppression. For one, the in vitro setting might be quite different from the in vivo
setting. Even among in vitro suppression assays, conditions may vary depending on the source
of Tregs used – whether taken directly ex vivo or expanded through IL-2 and anti-CD28 mAb
stimulation, in the presence of APCs or TGFβ in the culture medium. In vivo, the use of different
models of autoimmunity for studying Treg-mediated suppression might further account for the
discrepancies in identification of suppression mechanisms. In addition, before the development
of the FoxP3-gfp mouse tool, the definition of regulatory T cells by the CD25 marker or various
markers shared by other activated Teffs might have led to isolation of heterogeneous or distinct
Treg populations acting by different mechanisms.
In vitro data support a mechanism based on cell-cell contact. Studies have also shown that TCR
activation of regulatory T cells is necessary for suppression, although once activated, Tregs can
inhibit Teff proliferation in a manner independent of TCR specificity. In vitro data have further
shown that this suppression mechanism is insensitive to TGFβ or IL-10 blockade, which does
not seem to be the case for in vivo experimental models. Barthlott et al. have suggested a
mechanism based on competition for IL-2 between Teffs and Tregs since the survival and
proliferation of both of these subpopulations are highly dependent on this cytokine (Barthlott et
al., 2003; Barthlott et al., 2005). Tregs would consume the IL-2 available in the local
environment, which would then inhibit Teff proliferation. This hypothesis has been questioned
by the fact that addition of IL-2 in so-called classical inhibition assays does not overcome
suppression (Duthoit et al., 2005). A role for CTLA-4 as mediator of suppression has also been
suggested as CTLA-4 is well known for its inhibitory effect. However, peripheral Tregs of CTLA-
4-deficient mice display normal suppressive function, albeit reduced numbers (Kataoka et al.,
2005; Read et al., 2006). In humans, Grossman et al. have shown a role for perforin- and
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granzyme-dependent pathways in Treg-mediated suppression, mediating apoptosis of Teffs.
However, no evidence for killing has been found in Teffs undergoing Treg-mediated
suppression in mice (Grossman et al., 2004). In vivo, some cytokines have been shown to play
a role in Treg-mediated suppression. For example, Treg-mediated suppression in IBD involves
IL-10 and TGFβ  (Annacker et al., 2001). Recently, a new molecular target, cyclic adenosine
monophosphate (cAMP), has been proposed as a mediator for suppression. cAMP is a second
messenger, able to inhibit T cell proliferation and IL-2 production when added in vitro. It is
proposed that this molecule is transmitted via gap junctions formed between effector and
regulatory T cells (Bopp et al., 2007). In conclusion, several molecules seem to be involved in
the suppression mediated by Tregs, but none of these mechanisms have been found to be
absolutely essential for this inhibitory function. This suggests that perhaps several mechanisms
are involved and that the cell might be able to adapt its suppression mechanism depending on
its local environment or the conditions of suppression.
In addition, some molecules can regulate the suppressive function of Tregs. These include
cytokines like IL-2 and TNFα, as well as costimulatory factors like CD80 and CD86. For
example, ligation of CD40 or activation of TLRs on DCs appears to abrogate the effect of Tregs
(Pasare and Medzhitov, 2003; Serra et al., 2003).
Therapeutic perspectives in Humans
The enthusiasm raised by Tregs also lies in their great therapeutic potential to control
physiological and pathological immune responses. In cancer patients, depletion of Tregs leads
to an increased T cell response against tumour-associated Ag when stimulated in vitro with
tumour antigen (Danke et al., 2004; Nishikawa et al., 2005). In addition, FoxP3+ Tregs are often
found in tumours and are suspected to impede immunosurveillance by reducing responsiveness
of Teffs towards tumour cells. Promoting the depletion of Tregs specifically in the tumour might
be a promising approach for cancer immunotherapy to enhance the anti-tumour immune
response.
During infection, depletion of natural Tregs enhances the immune response to pathogenic
microbes, as reviewed by Belkaid and Rouse (Belkaid and Rouse, 2005). Tregs have even
been shown to be responsible for long-term persistence of Leishmania major in chronically
infected mice (Belkaid et al., 2002). They serve to control the quality and the magnitude of anti-
microbial immune responses and are thought also to play a role in termination of the immune
response.
Finally, one can use the ability of Tregs to expand in vitro or in vivo and their stable suppressive
property to induce tolerance in autoimmune diseases, to treat allergy, or to suppress graft
rejection (Kang et al., 2007). Moreover, techniques aimed at clonally expanding Ag-specific
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natural Tregs are of great potential since Ag-specific Tregs have been shown to be more
effective in models of autoimmune diabetes, BMT, and organ transplantation. However, the
need for more specific and reliable surface molecular markers is necessary to discriminate
between Tregs and Teffs. CD127, the IL7 receptor α chain, has been found to correlate with
both FoxP3 and regulatory activity and will likely be of great help in isolating true human Tregs.
It is also possible to take advantage of the conversion of adaptive T cells into Tregs under
specific conditions of antigenic stimulation to enhance transplant tolerance since Tregs are
suspected to limit the inflammatory response during organ rejection. Additionally, treatments
that preferentially dampen effector T cell function while preserving and even enhancing Treg
function may prove beneficial. One example is anti-CD3 Mab therapy administered to NOD
mice, which reverses diabetes due to Treg induction (You et al., 2007). Finally, the induction of
pDCs may promote tolerance since pDCs are able to induce Tregs in the periphery (Ochando et
al., 2006).
γ/δ T cells
γ/δ T cells are non-MHC-restricted, nonconventional T cells. They are located in the epithelia of
various tissues constituting the internal and external surfaces of the body, such as the tongue,
skin, reproductive tract, and lung. In addition, other γ/δ T cells can be found in secondary
lymphoid organs, representing 1 to 5% of circulating T cells. They are characterized by a limited
repertoire due to unique invariant γ and δ chain combinations corresponding to each specific
tissue. They are thought to act as a first line of defence in primary immune responses and also
play roles in immunoregulation, tumour surveillance, and wound healing (Hayday and Tigelaar,
2003). γ/δ T cells are the first T cells to develop during ontogeny. Specific subsets of γ/δ T cells
expressing unique TCR chain combinations develop in waves, with increasing TCR complexity,
during the transition from foetal to adult thymus; and they sequentially populate the different
tissues mentioned above. Each wave of γ/δ T cell development corresponds to different
hematopoietic progenitor cohorts with distinct developmental potential (Ikuta et al., 1990). In
addition, foetal or newborn stroma may provide specific properties favouring the development of
specific γ/δ T cell subsets since the adult thymus is unable to support differentiation of those γ/δ
T cell subsets developing during foetal life. These early developing γ/δ T cell subsets are tissue-
specific and are characterized by a very simple TCR composition. For example, dendritic
epidermal T cells (DETCs) present in the skin carry invariant Vγ and Vδ gene segments,
specifically Vγ5Vδ1, without any junctional diversity since thymic TdT activation occurs later in
their development. In contrast, γ/δ T cells developing in the adult thymus present a higher
variability of Vγ, being Vγ2, Vγ1.1 or Vγ1.2, and in addition possess highly diverse junctional
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sequences; these T cells will migrate to secondary lymphoid organs. Lastly, Vγ5 T cells
constitute intestinal intraepithelial lymphocytes. Some γ/δ T cells have also been reported to
develop extrathymically (Lefrancois and Puddington, 1995).
γ/δ T cells develop from a common DN progenitor giving rise to either α/β or γ/δ T cells. The
molecular events leading to lineage bifurcation between the two populations has not been fully
resolved but this lineage decision is thought to be determined at the DN2 stage, despite the fact
that DN2 precursors of γ/δ T cell are indistinguishable from α/β DN2 precursors. γ/δ T cells
never go through a DP stage, and signals through the γ/δ TCR regulate differentiation into
mature γ/δ T cells, characterized by down-regulation of CD24. Following the DN3 stage, γ/δ T
cells do not undergo a β selection checkpoint-induced proliferative burst like α /β  T cell
precursors as they do not express pre-TCR but rather the definitive form of the γ/δ TCR.
Therefore, major clonal expansion of γ/δ T cells occurs after completion of their maturation.
To account for γ/δ development, two models have been proposed. One is a selective model
whereby lineage specification is thought to be mainly determined in thymocyte precursors
before TCR gene rearrangement starts. The adequacy of the subsequent random TCR
rearrangement would allow for survival or death. The other is an instructive model whereby the
signal originating from the TCR influences uncommitted progenitors towards either α/β  or γ/δ
fates. As detailed below, various studies have supported these models, but to date, none can
entirely explain the physiological situation and fully validate one of the models.
The selective model is supported by the observations of Durum et al. that a pro-T cell population
carrying high levels of IL-7Rα is more prone to develop towards the γ/δ T cell lineage whereas
IL-7 Rα low or negative pro-T cells will preferentially differentiate into α/β (Durum et al., 1998;
Kang et al., 2001). Further support for this hypothesis was provided by Maki et al., who showed
that IL-7Rα-deficient mice are devoid of γ/δ T cells (Maki et al., 1996). The theory of TCR-
independent lineage specification is also supported by the fact that some DN2 cells display a
bias in lineage potential before the TCR is expressed on their surface, as shown by the clonal
analysis potential of DN2 in Notch ligand-dependent cell culture (Ciofani et al., 2006). Garcia-
Peydro et al. also suggested a positive role for Notch in the development of γ/δ T cells from very
early precursors (Garcia-Peydro et al., 2003). Surprisingly, a deficiency in Notch specifically at
the transition from DN2 to DN3 stage favours an increase in γ/δ T cell production. These two
seemingly contradictory results have been reconciled by Ciofani et al., who showed that Notch
is essential for early γ/δ T cell development up to the DN2 stage but not beyond the DN3 stage
(Ciofani et al., 2006). This is in contrast to the continuous requirement of Notch throughout α/β
T cell development up to the DP stage.
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The instructive model, on the other hand, proposes that signals from the γ/δ TCR regulate γ/δ
cell development. It is based on the observation that pre-Tα−deficient mice show a great
increase in γ/δ T cell differentiation. In addition, γ/δ TCR transgenic mice show inhibition of α/β T
cell development. Moreover, developing T cells expressing γ/δ TCR are excluded from the α/β
lineage (Kang et al., 1995; Livak et al., 1995). These findings support the conclusion that γ/δ
TCR expression is not neutral, but rather drives T cell progenitors towards the γ/δ T cell
pathway. In addition, it was previously argued that the γ/δ TCR signal is stronger than the signal
delivered by pre-TCR (Hayes et al., 2003). Nevertheless, these experiments do not directly
prove that TCR dictates lineage decision as its expression may simply allow for survival of cells
that are already committed. In addition, this theory is challenged by the fact that γ/δ TCR chain
rearrangement occurs in α/β T cell progenitors and that intracellular β chain rearrangement has
been reported in about 15% of γ/δ T cells. Ultimately, it has been suggested that lineage
decision might be conditioned by the quality or the strength of the TCR signal, and indeed,
despite a high similarity between the two TCR signaling pathways, γ/δ TCR have been shown to
induce a stronger signal than α/β TCR (Haks et al., 2005; Hayes et al., 2005). Through the use
of γ/δ TCR transgenic mice, Hayes et al. were able to alter γ/δ versus α/β T cell numbers by
adjusting the strength of TCR signaling. The stronger the TCR signal, the more γ/δ and the
fewer α/β T cells that developed. More recently, Kreslavsky et al. showed through single cell
analysis that there is no commitment to either the α/β or γ/δ lineage before TCR expression and
that modification of TCR signaling can change lineage commitment (Kreslavsky et al., 2008).
These reports provide new insights in favour of this quantitative model of commitment.
In addition to the two models described above, Pennington et al. have proposed an alternate
possibility. They defined a γ/δ-biased gene expression profile to identify γ/δ precursors and
found them to be absent in pre-Tα mice and RAG-deficient mice. Based on this, they proposed
that failure of γ/δ T cell development was due to the lack of DP T cells by a so called “trans-
acting” feedback via the LTβ receptor.
Thymic ligands for positive selection of γ/δ T cells have been investigated for years before
Boyden et al. identified one of them recently. It was previously thought that γ/δ T cells might be
selected by encountering their cognate antigen in the peripheral tissues where they migrate.
This encounter with self-antigen would induce their survival. Indeed, by mapping and genetic
complementation of a mouse strain devoid of Vγ5Vδ1 epidermal T cells, Boyden et al. showed
that Skint1, expressed in the thymus and skin, positively selects epidermal γ/δ T cells (Boyden
et al., 2007).
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Aim of the study:
We propose to study tolerance and T cell development throughout different models. We first
observed that immunodeficient mice reconstituted with bone marrow from syngeneic host suffer
from autoimmunity whereas immunocompetent mice stayed healthy. We have tried to identify
the radioresistant cell subset responsible for this protection. In a second study we investigated
further on radioresistant thymocytes to identify the origin of the single wave of differentiation of
host derived T cells observed in mice reconstituted with bone marrow. In a third part we propose
to explain the presence of β  chain in the cytoplasm of γ /δ  T cells by reconstituting
immunodeficient mice with Pax5 KO cells transfected with β chain isolated from either α/β or γ/δ
T cells. Finally we have developed a new double transgenic system by crossing mice
expressing OVA antigen under the control of KLC and CD11c promoter and OT1 and OT2 mice.
This will allow us to study T cell tolerance through regulatory T cell development and anergy
induction.
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Results
Part I: Regulatory T cells control auto-immunity following syngeneic
bone marrow transplantation.
Angèle Bénard, Rhodri Ceredig, and Antonius G Rolink.
Introduction
Reconstitution of the lympho-hemopoietic system by bone marrow (BM)
transplantation is a frequently used treatment modality for various haematological abnormalities,
including anaemia, leukaemia and lymphoma (Nakase et al., 2005) and more recently fulminant
auto-immunity (van Bekkum, 2004). Although this is frequently carried out with BM from haplo-
disparate donors, even in situations where the BM graft is haplo-identical, patients can develop
syngeneic graft versus host disease (GVH) (Adams et al., 2004; Latif et al., 2003; Spaner et al.,
1998). Disease can be acute, starting at day 8 (Latif et al., 2003) or more chronic starting at
about 5 weeks (Adams et al., 2004) following BM transplantation, a time when lymphoid
reconstitution has begun, but when the patient is still relatively lymphopenic. Many of the
features of syngeneic chronic GVH, including diarrhoea, weight loss, cutaneous and
lymphocytic infiltrations in multiple organs and the presence of auto-antibodies are also seen in
systemic auto-immune diseases such as inflammatory bowel disease (IBD), rheumatoid
arthritis, systemic lupus erythematosis and systemic sclerosis (Lyons et al., 2005)
Recent studies have implicated so-called naturally-arising regulatory T cells
(Treg) as key components controlling auto-immunity (Kronenberg and Rudensky, 2005;
Sakaguchi et al., 1995; Shevach, 2004). Treg were first described as a population of
CD5highCD4+ cells that upon transfer could protect mice from auto-immune disease caused by
neonatal thymectomy (Sakaguchi et al., 1982). Later it was shown that during mouse ontogeny,
Tregs appeared shortly after birth and that CD25, the alpha chain of the IL-2R complex, could
be used as a surrogate marker for these cells(Fontenot et al., 2005a; Sakaguchi et al., 1995).
More recently, the transcription factor FoxP3 has been shown to be critically associated with
Treg function (Hori et al., 2003) and indeed a knock-in transgenic mouse line containing a GFP-
FoxP3 construct indicated that FoxP3 may be used as a lineage marker for Treg (Fontenot et
al., 2005b). Many phenotypic features of Treg, namely spontaneous CD25 expression, down-
regulation of CD4, CD3 and TCRβ transcripts and surface antigen expression are similar to
those of activated T cells (Bosco et al., 2006b; Gavin et al., 2002b; Kasow et al., 2004). The
repertoire of TCR expressed by Treg is generally thought to be broad; however, it would seem
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that their TCR have a relatively high affinity for self antigens (Hsieh et al., 2004). Thus their
CD5high phenotype may have protected them from negative selection in the thymus (Azzam et
al., 2001). Functionally, Treg inhibit the proliferation of naïve responder T cells in vitro (Thornton
and Shevach, 1998). Their main functional role in vivo (Asano et al., 1996) appears to be in
preventing the activation and reducing the expansion of activated T cells (Sakaguchi, 2004).
This inhibition of T cell expansion can be seen as advantageous in situations of auto-immunity,
but may be disadvantageous in situations of lymphopenia-induced proliferation or anti-tumor
immunity (Dolnikov et al., 2003; Nomura and Sakaguchi, 2005). It is therefore rather paradoxical
that auto-immunity is controlled in a dominant fashion by a population of T cells which is itself
intrinsically auto-reactive (Kronenberg and Rudensky, 2005).
In the mouse, syngeneic BM transplantation of immuno-competent recipients rarely results in
disease. In contrast, in man, syngeneic GVH has been reported to develop with a cumulative
incidence of 18% among syngeneic hematopoeitic cell transplant recipients (Adams et al.,
2004). This difference could be due to the relatively faster kinetics of reconstitution in mice,
which is of the order of weeks compared with months in man. However, in analyzing the
reconstitution potential of sub-lethally irradiated immuno-deficient recipient mice with in vitro-
generated, T cell-restricted, BM-derived progenitor cells, recipient mice frequently died between
four and six weeks after reconstitution (A. Rolink unpublished observations). Mice died despite
evidence indicating that the T cell compartment was being well reconstituted by donor-derived
cells. In this report we describe results of experiments where the outcome of syngeneic BM
transplantation in sublethally-irradiated immuno-deficient C57Bl/6 RAG-2-/- was compared with
that in immuno-competent WT C57Bl/6 recipients. Whereas immuno-competent mice survived,
immuno-deficient mice succumbed to auto-immunity with diarrhea and weight loss beginning at
three weeks following BM transplantation. Disease was associated with IgG anti-nuclear
antibodies. Auto-immunity was initiated by T cells but could be prevented by co-transferring
naturally-arising regulatory T cells with the BM inoculum. Survival of immuno-competent
recipients was shown to be due to the presence of residual, extra-thymically-located, radio-
resistant, functional regulatory T cells in the lethally-irradiated host. Moreover depletion of
regulatory T cell in wild type mice prior to bone marrow transplantation resulted in a phenotype
similar to that of immuno-deficient hosts although with milder clinical symptoms. T h e
implications of these results in the context of BM transplantation will be discussed.
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Results
RAG-2-/- mice show symptoms of autoimmune disease following
transplantation of syngeneic RAG proficient BM.
When sublethally-irradiated Bl/6 Ly5.2 RAG-2-/- mice were reconstituted with C57Bl/6 wild type
(WT) Ly5.1 T-cell depleted BM and despite successful reconstitution of T lymphopoiesis in the
thymus and B lymphopoiesis in the BM, most animals died between four and seven weeks later.
Figure 1.A shows the survival curve of a group of 25 RAG-2-/- mice from 5 individual
experiments reconstituted with T cell-depleted BM from WT syngeneic donors. Until about 33
days, 100% mice survived, but from then on there was a progressive decrease in survival with
only 20% of mice surviving beyond 50 days.
Figure 17: A. Survival curve of C57Bl/6.Ly5.1→C57Bl/6.RAG-2-/-.Ly5.2 BM chimeras.
Sub-lethally irradiated Ly5.2 RAG2-/- mice were transplanted with T cell depleted bone marrow from Ly5.1
C57Bl/6 mice. Shown is the pooled survival curve of 25 mice from four different experiments. Survival did
not differ between individual experiments.
Prior to day 33, mice began having diarrhoea and when groups of five to six mice were
individually weighed following BM transplantation (Figure 1B) there was progressive weight loss
from day 21 with mice loosing approximately 40% of their initial body weight by day 42. Thus,
diarrhoea and weight loss preceded death of the mice.
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Figure 1: B. Weight loss among BM chimeras.
Shown is the kinetic of mean weight loss in one group of six BM chimeras. Mice were weighed every
three days over a six-week observation period.
Inspection of the intestines from mice with diarrhoea showed that the lower third of the colon
was dilated with thickening of the wall. Histological analysis of this region (Figure 1C1) showed
characteristic features of IBD (Maloy et al., 2005), namely epithelial hyperplasia, extensive
lymphocytic infiltration of the lamina propria, crypt abscesses and destruction of the mucous
membrane with prominent ulceration.
Figure 1C1. Widespread lymphocytic infiltration in non-lymphoid organs of immuno-deficient mice after
bone marrow transplantation.
The upper picture is a photograph of H+E stained 3_m paraffin sections of the lower third of the colon
from Bl/6→RAG2-/- BM chimeras (Original magnification x100).
Histological analysis of other organs, for example the liver (Figure 1C2), also showed evidence
of lymphocytic infiltration.
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Figure 1C2. Widespread lymphocytic infiltration in non-lymphoid organs of immuno-deficient mice after
bone marrow transplantation.
The upper picture is a photograph of H+E stained 3_m frozen sections of liver from Bl/6→RAG2-/- BM
chimeras (Original magnification x400).
Moreover the architecture of secondary lymphoid organs was disturbed in that discrete lymphoid
follicles were absent (Figure 1C3).
Figure 1C3. Disorganised cellular architecture in lymphoid organs of immuno-deficient mice after bone
marrow transplantation.
The upper picture is a photograph of immunohistochemical analysis of 5_m frozen sections of spleen
from Bl/6→RAG2-/- BM chimeras (Original magnification x100). Sections were stained for peanut
agglutinin (red) and IgM (green).
Flow cytometric analysis of LN cells from mice with diarrhoea was carried out. Results obtained
(Figure 2) showed that whereas there was clear evidence of B cell (left cytogram) and T cell
(middle cytogram) reconstitution, further analysis of gated CD4+ cells (right cytogram) showed
that many had up-regulated CD69 and CD25 expression. Two color analysis of gated CD4+ T
cells showed that ~19% were CD69+CD25-, 18% CD69+CD25+ and 12% CD69-CD25+. Thus,
CD4+ T cells from affected mice showed an activated phenotype.
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Figure 18: Lymphocyte reconstitution in sub-lethally-irradiated C57Bl/6.Ly5.1_C57Bl/6.RAG-2-/-.Ly5.2 BM
chimeras.
Shown are two-color cytogram displays of LN cells from BM chimeras stained with the indicated mAb. In
each panel, quadrants are placed so that 100% unstained cells were contained in the lower left quadrant.
In the upper right panel, the % positive cells in each quadrant is indicated. The left panel shows B cell
reconstitution, the middle panel that of CD4 and CD8 T cell subpopulations and the right panel expression
of CD69 and CD25 on gated CD4+ T cells. See text for details.
Onset of disease in RAG-2-/- recipient mice is mediated by T cells.
In RAG-2-/- mice reconstituted with syngeneic WT BM, onset of diarrhoea and weight loss
coincided with a state of relative lymphopenia during the initial phase of lymphocyte
reconstitution. In addition, CD4+ T cells from affected mice showed evidence of extensive
activation. Therefore, to see whether T cells were responsible for initiating disease, RAG-2-/-
mice were reconstituted with BM from donors incapable of reconstituting the T cell
compartment, namely Ly5.1 CD3ε-/- mice. In six Ly5.2 RAG-2-/- mice reconstituted with Ly5.1
CD3ε-/- BM and in which the BM B cell compartment was fully reconstituted with Ly5.1 B cells,
none developed signs of diarrhoea or weight loss with all mice surviving until six months
following reconstitution (Figure3). Thus, T cells were responsible for initiating disease in BM-
transplanted mice.
Figure 19: Absence of weight loss among BM chimeras transplanted with CD3ε-/- bone marrow.
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Shown is the kinetic of mean weight loss in two groups of BM chimeras. The first group (n=6) was RAG-
/- mice transplanted with wild type bone marrow and the second group (n=5) were RAG-/- mice
transplanted with CD3ε-/- bone marrow Mice were weighed every three days over a six-week
observation period.
Co-transplantation of regulatory T cells protects RAG-2-/- recipient
mice from disease.
RAG-2-/- mice reconstituted with syngeneic BM manifested signs of IBD and this was initiated by
T cells. Previous experiments have shown that naturally arising regulatory T cells could protect
lymphopenic mice from IBD (Martin et al., 2004). Therefore, to see if naturally arising regulatory
T cells could protect BM transplanted mice from IBD, Ly5.2 RAG-2-/- recipient mice were
reconstituted with a mixture of T cell-depleted Ly5.2 BM together with 1-3x105 sorted Ly5.1
CD4+CD25+ LN cells. In three groups of experimental mice, no diarrhoea or weight loss was
noted. Gross inspection of the intestines showed them to be normal and histological analysis of
the lower third of the colon confirmed this (Figure4) showing a completely normal picture.
Figure 20A
Figure 20B
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Absence of lymphocytic infiltration in non-lymphoid organs of bone marrow transplanted, regulatory T
cells coinjected immuno-deficient mice.
Hematoxylin and eosin staining of the gut in RAG2-/- mice transplanted with bone marrow cells along
with CD4+CD25+ T cells. The luminal epithelial is intact and thin, there is no lymphocytic infiltration
detectable, and the crypt size is limited. (Original magnifications, x100)
Histological analysis of other organs from these mice showed the total absence of lymphocytic
infiltration. Moreover secondary lymphoid organs showed a normal architecture. However,
relatively large numbers of germinal centers were present in the spleen. This finding strongly
suggests that, although not showing signs of disease, an immune response was ongoing in
these mice.
Figure 21: cellular architecture in lymphoid organs of immuno-deficient mice after bone marrow
transplantation and co-injection of Treg.
The upper picture is a photograph of immunohistochemical analysis of 5_m frozen sections of spleen
from Bl/6 + Treg→RAG2-/- BM chimeras (Original magnification x100). Sections were stained for peanut
agglutinin (red) and IgM (green)
The phenotype of the transferred Ly5.1+ CD4+CD25+ T cells as well as that of the cohort of T
cells derived from the BM donor was analyzed by three-color flow cytometry. Figure 6 shows the
results of a typical experiment of spleen cells seven weeks after BM transplantation. Thus, 0.2%
of gated lymphocytes expressed Ly5.1, the Ly5 allotype of the injected CD4+CD25+ LN T cells
(Figure 6.A, histogram). Further analysis of gated Ly5.1+ spleen cells (right cytogram displays)
showed that they were practically all CD4+CD8- cells (right upper cytogram) with the vast
majority (80%, lower right cytogram) retaining the CD25+ phenotype.
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Figure 22A. CD4+CD25+ T cells co-injected into recipient mice survive for up to 9 weeks following BM
reconstitution
Sub-lethally-irradiated (500Rad) Ly5.2.RAG2-/- mice were reconstituted with T cell-depleted Ly5.2.Bl/6
WT BM together with sorted Ly5.1+CD4+CD25+ T cells. The top histogram is of spleen cells from one of
four similar experiments stained with FITC-labeled anti-Ly5.1mAb. and shows the presence of residual
Ly5.1+CD4+CD25+ regulatory T cells at this time. Cytogram displays show the two color staining profiles
of gated donor-derived (left, Ly5.1-) and injected Ly5.1+CD4+CD25+ (right) T cells stained for CD4 and
CD8 (upper cytograms) or CD4 and CD25 (lower cytograms). Figures in the upper right quadrant of each
panel show the % of positive cells in each quadrant. See text for details.
Thus, the transferred Ly5.1+ cells were not contaminated by cells capable of reconstituting the
host thymus and they persisted in recipient mice for up to ten weeks after BM transplantation.
When gated on Ly5.1-negative (namely Ly5.2+) cells, the spleen contained the expected
subpopulations of donor-derived CD4+ and CD8+ T cells, with in this case a high CD4/CD8 T
cell ratio (~4) (left upper cytogram). However, the proportion of CD25+ cells among the CD4+
subpopulation was relatively low (~7%, left lower cytogram).  As is the case for naturally-arising
CD25+ regulatory T cells, donor-derived CD4+CD25+ cells had a slightly decreased CD4
expression (Bosco et al., 2006b). Additional staining of LN cells from such chimeras with CD4,
CD25 and CD69 showed that co-transplantation of Treg prevented, to a large extent, the
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activation of BM donor-derived T cells. Thus only 11.6% of BM donor CD4 cells expressed the
early activation marker CD69 (Figure 6B) compared with 36.6% in the chimera without co-
transferred Tregs (Figure 2). Moreover, most gated CD25+ cells were now CD69-negative
(Figure 3.B), confirming that they were not simply activated CD25+ T cells. Thus, co-transfer of
naturally arising CD25+ regulatory T cells to BM transplanted mice inhibits the activation of BM-
derived T cells and also protected mice from IBD.
Figure 6B. Donor-derived CD4+ T cells retain a naive phenotype.
The two-color cytogram shows the CD69 versus CD25 staining profile of Bl/6 WT-derived CD4 cells in
C57Bl/6.Ly5.2→C57Bl/6.RAG-2-/-.Ly5.2 BM chimeras co-injected with sorted Ly5.1.CD4+CD25+ T cells.
Co-transplantation of regulatory T cells prevents the formation of
auto-antibodies in RAG-2-/- recipients.
Given the fact that BM transplanted mice showed signs of systemic auto-immunity, we decided
to investigate whether the serum from such mice contained auto-antibodies. For this, frozen
sections of kidneys from RAG-2-/- mice were incubated with serum from BM transplanted RAG-
2-/- mice reconstituted with or without Tregs and the presence of autoantibodies determined by
indirect immunofluorescence.
Figure 23A: Immunofluorescent detection of anti-nuclear autoantibodies
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A. Kidney sections of RAG-/- mice were incubated with serum samples of RAG-/- mice transplanted with
bone marrow cells alone (left picture), or co-injected with CD4+CD25+ T cells (middle picture) and goat
anti-mouse IgG FITC labeled antibody was used to detect anti-nuclear autoantibodies The right panel
shows a negative control without the addition of serum. (original magnification, x200)
Figure 7B: Co-injection of regulatory T cells inhibits the formation of antinuclear auto-antibodies in BM
chimeras
Shown are the titers of anti-nuclear auto-antibodies, detected by indirect immunofluorescence as
described, in sera from BM chimeras co-injected (left, BM+Treg) or not (right, BM) with sorted
CD4+CD25+ regulatory T cells.
As shown in Figure 7B, whereas the serum of BM-transplanted mice contained readily-
detectable anti-nuclear antibodies, they were undetectable in BM recipients co-transferred with
Tregs.
Normal Bl/6 mice do not develop symptoms of auto-immunity
following BM transplantation
Auto-immunity was only seen when RAG-2-/- recipients were reconstituted with T cell-depleted
BM. Normal Bl/6 mice reconstituted with T cell depleted BM did not suffer from IBD. To see
whether radio-resistant, host-derived, naturally-arising CD25+ regulatory T cells were
responsible for protecting mice from IBD, a series of chimeras was established in which normal
Ly5.1+ Bl/6 mice were reconstituted with T cell-depleted Ly5.2+ Bl/6 BM alone. As expected, no
diarrhoea or weight loss was seen in normal Bl/6 recipients. Again, histological analysis of
intestines and other organs showed no abnormality (not shown). Flow cytometric analysis of LN
cells at six weeks following BM transplantation showed the presence of a significant (14%)
population of host-derived (Ly5.1+) cells (Figure 8.A, histogram) and further analysis of these
gated host-derived LN cells (right cytograms) showed that most (93.5%) were T cells, being
74% CD4+ and 19.5% CD8+. Further analysis of the CD4+ subpopulation (lower right cytogram)
showed that 18.7% (13.9/74.5) were CD25+ cells, the latter again having a slightly reduced CD4
expression as is characteristic of Treg. Parallel analysis of the donor-derived (Ly5.1-negative)
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population showed that, as expected, the majority (67%, lower left quadrant) expressed
neither CD4 nor CD8 and were mostly CD19+ B cells. Indeed, after six weeks, analysis of the
thymus and BM in such chimeras showed that 98.8% ± 0.7 (n=5) of thymocytes and 100% BM
CD19+ cells were donor-derived. This result showed that with this irradiation dose, the
progenitor T and BM B cell lineage was fully reconstituted with donor-derived cells and that
there was no detectable population of surviving host-derived B cells (not shown). Donor-derived
T cells (23.4% CD4 and 9% CD8) had a normal CD4:CD8 ratio and additional analysis of the
CD4+ cells (lower cytogram) showed a distinct population of 7.5% CD25+ cells.
Figure 8A: Radio-resistant, host-derived CD4+CD25+ regulatory T cells protect WT recipients from
autoimmune disease.
The top histogram is of LN cells from C57Bl/6.Ly5.2→C57Bl/6. Ly5.1 BM chimeras stained with FITC-
labeled anti-Ly5.1 mAb. and shows the presence of 14% residual, host-derived, cells. Below are
cytogram displays of cells stained for CD4 and CD8 (upper cytograms) or CD4 and CD25 (lower
cytograms) and gated for either donor (Ly5.1-, left) or host (Ly5.1+right) derived cells. C57/Bl6 Ly5.1+ mice
were irradiated with 9.5 Gy before being reconstituted with T cell-depleted BM cells from Bl/6 Ly5.2+ mice.
To show that radio-resistant, host CD4+CD25+ T cells possessed regulatory function, we carried
out a classical T cell co-culture assay (Thornton and Shevach, 1998) using naïve
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Ly5.1+CD4+CD25- responder T cells and as potential inhibitory cells host-derived
Ly5.2+CD4+CD25+ T cells from Ly5.1_Ly5.2 BM chimeras six weeks after BM transplantation.
Results obtained (Figure 8B) show clearly that when stimulated with anti-CD3ε mAb in the
presence of irradiated APC, naïve T cells alone proliferated normally (left stippled bar) but that
addition of Ly5.2+CD4+CD25+ host-derived T cells from chimeras inhibited this proliferation (right
filled bars). Thus, the host-derived CD4+CD25+ subpopulation that survived lethal irradiation
possessed classical T regulatory activity.
Figure 8B. Host-derived radio-resistant CD4+CD25+ T cells retain regulatory T cell function.
Shown are the 3H thymidine counts from cultures containing Ly5.1+CD4+CD25- responder naive T cells
cultured either alone (left column) or together with sorted Ly5.2+CD4+CD25+ host-derived cells from
C57Bl/6.Ly5.→C57Bl/6. Ly5.2 BM chimeras at the indicated ratios. Cells were cultured as described in
Methods for 72 hours with anti-CD3 mAb and irradiated spleen cells as APC. Each column represents the
mean of 3H-thymidine incorporation from triplicates wells.
Compared with donor-derived cells, the host-derived Ly5.1+CD4+ subpopulation was relatively
enriched in CD25+ cells (Fig 8A, bottom cytograms). This suggested that CD25+ T cells might
preferentially survive a lethal dose of irradiation. The possibility also existed that host-derived
CD4+CD25+ T cells were the progeny of the transient, host-derived, cohort of thymocytes
generated following irradiation and BM reconstitution (Hori et al., 2003). To determine whether
the thymus was required for the appearance of these peripheral CD4+CD25+ cells, recipient
adult mice were first thymectomized and one week later, irradiated and reconstituted with T-cell-
deficient RAG-2-/- BM. In these thymectomised mice, any surviving T cells must have been in an
extra-thymic location at the time of irradiation. Flow cytometric analysis of LN cells from such a
chimera at 5 weeks following reconstitution showed that about 3% were CD4+ TCRβ+ T cells
and about 38% of these expressed CD25 (Figure 9).
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Figure 24: Preferential survival of CD4+CD25+ host T cells following irradiation.
Shown is a cytogram display of LN cells from a six week-old B/6 mouse that had been thymectomised,
one week later 4.5 Gy body-irradiated, reconstituted with BM from Bl/6.RAG2-/- donors and stained with
the indicated markers. As shown, about 35% (0.84/2.96) of surviving host-derived CD4 cells expressed
CD25.
However, it should be noted that the number of host-derived T cells in thymectomized chimeras
was dramatically lower than in euthymic controls. Thus the majority of host peripheral T cells in
BM chimeras are the progeny of the cohort of thymocytes generated following irradiation and
BM reconstitution.
Regulatory T cell depleted Bl/6 mice suffer from IBD following BM
transplantation
To check whether among radio-resistant cells, regulatory T cells were the ones responsible for
protecting the mice against IBD, we depleted mice of Tregs prior to irradiation and BM
reconstitution. It has been previously shown that injection of anti-CD25 mAb in vivo depletes the
regulatory T cell compartment (Oldenhove et al., 2003), and several groups have used this
approach to boost anti-tumor immune responses (Dannull et al., 2005). Anti-CD25 mediated
depletion might not eliminate all regulatory T cells (Fontenot et al., 2005b; Kohm et al., 2006),
nevertheless so far it is the only method of eliminating the majority of regulatory T cells in vivo.
Therefore, groups of 5 Ly5.2+Bl/6 mice received either a single 0.5mg dose of PC61 anti-CD25
mAb intra-venously or PBS as control. After 5 days, mice were lethally irradiated (8Gy) and
subsequently reconstituted with T cell depleted Ly5.1+Bl/6 wild type BM. Three weeks after
reconstitution, mice started losing weight and by 6 weeks anti-CD25-treated mice had lost 34%
of their initial body weight (Figure10), accompanied by extensive diarrhea. Out of 5 mice, 1 died
after 4 weeks and the other 4 were sacrificed 7 weeks after transplantation according to
Institutional guidelines due to their deteriorating health.
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Figure 25: Mice depleted of regulatory T cells suffer weight loss after BM reconstitution.
Ly5.2+Bl/6 mice were lethally-irradiated with 9.5Gy and then transplanted with T cell depleted bone
marrow cells from Ly5.1+C57Bl/6 mice. Bone marrow transplanted Bl/6 mice were weighted every 7 days
for 6 weeks. The above figure represents the mean weight variation from one group of five mice.
 Flow cytometry analysis with an anti-CD25 mAb recognizing a CD25 epitope distinct from that
recognized by PC61, the CD25 mAb used for in vivo depletion, showed that CD25+ cells had
been reduced by between 92.5% and 99.9%. In addition, in the absence of CD25+ cells,
surviving CD4+CD25- cells were in a more activated state as shown by enrichment for CD69+
cells (Figure 11).
Figure 26: Donor-derived CD4+ T cells show an activated phenotype when mice are depleted from
regulatory T cells prior to bone marrow transplantation.
The two-color cytogram shows the CD69 versus CD4 staining profile of lymph nodes Bl/6 WT-derived
CD4 cells in C57Bl/6.Ly5.1→C57Bl/6.Ly5.2 BM chimeras treated with anti-CD25 MAb prior to bone
marrow transplantation.
However, clinical parameters were not as severe as in RAG2-/- recipients presumably because,
as shown by others, some regulatory T cell activity still remains following anti CD25 mAb
depletion (Fontenot et al., 2005b; Kohm et al., 2006).
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Discussion
Bone marrow transplantation, whether by haplo-identical or non-identical grafts, is a frequently
used clinical procedure for the reconstitution of the immune system following chemotherapeutic
and irradiation treatment (Van Bekkum, 2003). One of the major complications of such a
procedure is the appearance of GVH especially in cases were patients are transplanted with BM
from haplo-disparate donor. However, and thus far for largely unknown reasons, a similar type
of GVH is also seen even when a haplo-identical graft is used. Clinically, this is marked by
cutaneous, hepatic and gastrointestinal infiltrations (Nakase et al., 2005). In this report, we have
investigated this phenomenon in a mouse model of syngeneic BM transplantation. These
studies were initiated because lethally or sub-lethally irradiated immuno-deficient RAG-2-/- mice
reconstituted with either T cell-depleted BM or in vitro-generated T cell-committed lymphoid
progenitors developed diarrhoea and weight loss, frequently dying four to seven weeks after
reconstitution (Balciunaite et al., 2005b). Here, we show that so-called naturally arising
regulatory T cells, either transferred together with the bone marrow graft, or derived from
endogenous radio-resistant T cells of the host, protect recipient mice from developing auto-
immunity. In corollary, depletion of Treg in WT mice prior to BM transplantation resulted in the
appearance a relatively mild, non-lethal, disease.
Reconstituted mice developed diarrhoea and weight lost. Histological analysis of the lower third
of the colon showed the classical signs of inflammatory bowel disease (IBD), namely epithelial
hyperplasia, extensive lymphocytic infiltration of the lamina propria, crypt abscesses and
destruction of the mucous membrane with prominent ulceration (Figure 1). Initiation of this
disease was T cell-dependent as shown by absence of disease in mice reconstituted with CD3e-
/- BM (Figure 2). Transfer of naturally arising regulatory T cells prevented the appearance of IBD
in this model (Figure 2). Auto-immunity was only seen when RAG-2-/- recipients were
reconstituted with T-cell depleted BM and onset of IBD could be prevented by transferred
naturally arising CD25+ regulatory T cells. However, WT Bl/6 mice reconstituted with BM did not
suffer from IBD. One clear difference between RAG-2-/- and Bl/6 mice is the presence of a
mature T cells in the latter prior to irradiation. It is known that some thymocyte progenitors
(Ceredig and MacDonald, 1982) and peripheral T cells (Lowenthal and Harris, 1985) can
survive a lethal dose of irradiation. Indeed, it was shown some time ago that mitogen-activation
of normal mouse peripheral T or B cells rendered them more resistant to irradiation in vitro
(Lowenthal and Harris, 1985). In addition it as been recently reported that recipient CD4+ T cells
surviving irradiation can regulate chronic graft-versus-host disease in a B10.D2 (H-2d)→BALB/c
(H-2d) MHC-compatible, multiple minor histocompatibility antigen-incompatible BM
transplantation model(Anderson et al., 2004).
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Functional tests indicated that host-derived CD4+CD25+ cells inhibited the proliferation of anti-
CD3e-activated naïve responder T cells in vitro, thereby satisfying the criterion that they were
genuine regulatory T cells (Thornton and Shevach, 1998). Moreover, depletion of CD25+ cells in
lethally-irradiated Bl/6 WT mice prior to reconstitution led to development of IBD as observed
when using immuno-deficient hosts, although to a milder extent. Interestingly, naturally arising
CD25+ regulatory T cells (Treg) share many features with activated T cells, namely down-
regulation of CD4, CD3 and TCRb as well as expression of CD25(Bosco et al., 2006a; Kasow et
al., 2004). In addition, transcriptome analysis has shown that Treg contain abundant transcripts
of pro-survival genes, for example GITR (Nocentini et al., 1997) and more recently Bcl-xL has
been suggested to be up-regulated in Tregs(Minamimura et al., 2006). They are thought to be
constantly encountering their cognate self-antigen in the periphery and therefore to be in a
semi-activated state (Hsieh et al., 2004). However by comparing thymectomized mice
transferred with RAG-/- BM with WT recipients transplanted with WT BM, we could show that
most of the host radio-resistant regulatory T cells were probably derived from the thymus.
Anderson et al. recently reported that radio-resistant Tregs could prevent chronic GVH in a
mouse model of BM transplantation across multiple minor histocompatibility loci (B10.D2 (H-
2d)→BALB/c (H-2d)) (Anderson et al., 2004). Thus BALB/c RAG2-/- mice transplanted with BM
from B10.D2 develop a severe GVH whereas the same recipients transplanted with BM from
WT BALB/c, used as controls, stayed healthy. Unlike what we report here, the authors did not
describe any signs of syngeneic GVH. However, it should be noted that the mice in their
experiments were treated with antibiotics throughout the time course of the experiment. When
we treated our RAG2-/- BM recipients with antibiotics, we observed milder disease with more
animals surviving. These findings strongly suggest that the antigenic load, and more specifically
the gut flora, seem to play important roles in determining disease onset and evolution in this
experiment setting. In this context, it is worthwhile noting that mice prone to IBD do not develop
this disease when kept under germ-free conditions (Contractor et al., 1998; Madsen et al., 2000;
Mahler and Leiter, 2002; Panwala et al., 1998). We conclude that the syngeneic GVH described
in the present paper might be strongly influenced by antigen-driven T cell responses. This is
substantiated by the activated phenotype of T cells in RAG2-/- recipients. The fact that Tregs can
prevent both the activated phenotype and disease onset might suggest that they are controlling
the strength of this immune response.
Another parameter worthy of consideration is the age of the recipient mice. No sign of disease
was observed in sub-lethally irradiated neonatal RAG2-/-Bl/6 mice transplanted with WT
syngeneic BM. At least two mutually non-exclusive explanations could explain this. Firstly, the
antigenic load in neonatal mice may be dramatically lower than in adults and secondly the
neonatal thymus might be more efficient at generating Tregs.
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The T cell-induced auto-immune disease seen in immuno-deficient mice reconstituted with
syngeneic BM resembles, in many ways, the so-called syngeneic GvH disease seen in a
clinical setting. In our mouse model, Treg of either host or donor origin play a key role in
controlling both the severity of IBD and the appearance of auto-antibodies. Using reconstitution
of the lympho-hemopoietic system, after BM transplantation, development of autoimmunity is
clearly dependant upon the number of regulatory T cells. This leads us to propose that infusion
of such cells into BM transplant recipients should be considered as a treatment modality for the
prevention of syngeneic GVH.
Material and methods
Mice.
Ly5.1 and Ly5.2 C57BL/6 (Bl/6), Ly5.1 Bl/6 CD3ε gene deleted (CD3ε-/-) (Malissen et al., 1995)
and Ly5.2 Bl/6 RAG-2-/- (Shinkai et al., 1992) mice were maintained in our own animal SPF
facilities. Male and female mice were used at 8 weeks of age and all experiments carried out
according to Institutional guidelines. Adult thymectomy (ATx) was performed on six week-old
C57Bl/6 mice and mice were used 7 weeks later and absence of residual thymus tissue verified
at the time of autopsy.
Reagents and antibodies.
The following mAb were purchased from PharMingen (San Diego, USA): anti-CD25FITC (7D4),
anti-CD62LFITC (MEL-14), FITC or biotin-conjugated anti-CD8α (53-6.7), anti-CD69PE (H1.2F3),
anti-TCRβPE (H57-597). Anti-CD4PE (RM4-5) antibody was purchased from eBioscience (San
Diego, USA). The anti-Ly5.1FITC (A20) and anti-Ly5.2FITC (104) antibodies were produced and
labeled in our laboratory according to standard techniques. To reveal biotin-labeled antibody,
Streptavidin-APC (Becton Dickinson, San Diego, USA) was used. Anti-CD25 mAb PC61 was
purified from hybridoma culture supernatant by standard procedures.
Flow cytometric analysis and sorting.
Single-cell suspensions of thymus, spleen and lymph nodes were prepared in PBS
supplemented with 2% FBS and 0.2% sodium azide as described previously (Balciunaite et al.,
2005b). Cells were adjusted to 20–10 _ 106 cells/ml and 0.5–1 _ 106 cells incubated for 30 min
at 4°C with the indicated reagents at saturating concentrations as previously described. Stained
cells resuspended in PBS 2% FBS 0.2% azide containing propidium iodide (PI) were analyzed
using a FACSCalibur (Becton Dickinson) and data analyzed using CellQuest (Becton
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Dickinson). Viable lymphoid cells were defined by a combination of FSC, SSC and PI
fluorescence. Stained cells were sorted on a on a FACSAria (Becton Dickinson).
Bone marrow transplantation and adoptive transfer of regulatory T
cells:
Bone marrow cell suspensions from 3 to 5 Bl/6 donor mice were prepared by flushing femurs
and tibias with PBS using a 23g needle. After red blood cell lysis, T cells were depleted by re-
suspending cells in a mixture of rat IgM anti-CD90 (AT83) anti-CD4 (RL172) and anti-CD8α
(31M) monoclonal antibody (mAb) hybridoma supernatants and incubated for 20 min at 4°C
(Ceredig and Rolink, 2002). Following a washing step, antibody-coated cells were lysed by
adding rabbit complement (Low-Tox, Cedarlane, Canada) dissolved in serum-free Dulbecco’s
Modified Eagle’s Medium (DMEM). After incubation for 45 min at 37°C, cells were washed and
resuspended in DMEM prior to injection. To obtain naturally-arising regulatory T cells, spleen
cell suspensions from Ly5.2+ Bl/6 mice were stained with anti-CD4PE (RM4-5) and anti-CD25FITC
(7D4) antibodies and CD4+CD25+ cells sorted on a FACSAria. The purity of sorted cells was
always > 98%.
For in vivo regulatory T cell depletion, mice received one injection of anti-CD25 mAb (PC61;
0.5mg/injection i.v.) 5 days prior to irradiation and BM transplantation.
Viable BM and sorted cells were counted and resuspended in DMEM. Mice were reconstituted
with 200µl containing 3 x 106 T cell-depleted BM cells alone or together with 1-3x105 sorted
CD4+CD25+ cells. Recipient mice were γ-irradiated using a Cobalt source (Gammacell 40,
Atomic Energy of Canada, Ltd) four hours prior to reconstitution.  RAG-2-/- mice were irradiated
with 4Gy and Bl/6 mice with 9.5Gy. Chimeric mice were weighed once a week for up to 12
weeks and analyzed between 4 and 12 weeks. The origin and composition of lymphoid cells
was determined by means of the Ly5.1 and Ly5.2 markers.
Functional regulatory T cell assay:
The ability of CD4+CD25+ T cells from chimeras to inhibit the in vitro proliferation of naïve T cells
was carried out as previously described (Thornton and Shevach, 1998). Briefly, CD4+CD25-
naïve T cells and CD4+CD25+ isolated from chimeras were purified by sorting. Antigen-
presenting cells (APC) were T cell-depleted, irradiated syngeneic spleen cells from Bl/6 mice.
Control cultures contained 2.5x104 CD4+CD25- naïve responder T cells, 5x104 APC and 0.1µg
anti-CD3ε mAb. To test for inhibition, 2.5x104 CD4+CD25+, obtained from the indicated chimeric
mice were added. Cells were cultured in round-bottomed 96-well plates for 72 hours and
1µCi/well of 3H-thymidine was added for the last 8 hours prior to harvesting.
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Immunohistochemistry and histological staining:
Organs were snap frozen in Tissue-Tek OCT compound (Sakura Finetechnical, Tokyo, Japan)
and 5 _m sections cut on a cryostat. Sections were then fixed for 10 min in acetone and stored
at _20 °C. For staining, sections were covered with antibody solution at saturating
concentrations and incubated for 30 min at RT. For the second step, sections were washed in
PBS and incubated with a Neutralite Avidin-TXRD/PBS (Southern Biotech) solution for 15 min at
RT. Primary antibodies used included anti-CD90FITC, anti-IgMCy5 (M41) and biotinylated peanut
agglutinin (Vector laboratories). Slides were washed; one to two drops of a 1:1 mixture of PBS
and glycerin were placed onto the slide and covered with a coverslip (Harfst et al., 2005). A 10_
or 5_ objective was used for magnification. Intestines were fixed in 4% par formaldehyde,
embedded in paraffin, cut in 3 µm sections and stained with haematoxylin/eosin.
For detection of serum anti-nuclear antibodies, snap-frozen sections of kidneys from RAG-2-/-
mice were incubated with sera diluted 1:10 to 1:10,240 and bound antibodies revealed with a
1:50 dilution of FITC-labeled, mouse IgG subclass-specific secondary antibodies (Jackson
ImmunoResearch Laboratories). The pattern and titer of anti-nuclear antibodies were assessed
using an incident-light fluorescence microscope (Zeiss axioskope) and serum titer defined as
the highest dilution showing specific nuclear staining.
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Part II: Auto-reconstitution of the T cell compartment by radio-
resistant hematopoietic cells following lethal irradiation and bone
marrow transplantation
Nabil Bosco, Lee Kim Swee, Angèle Bénard, Rhodri Ceredig and Antonius Rolink
Introduction
In man, syngeneic or allogeneic bone marrow (BM) transplantation (BMT) with
BM donors is a frequently used treatment modality, which has curative results for a variety of
haematological disorders such as malignant or genetic-based immune deficiencies.
Nevertheless, the restoration of an adaptive immune system (with both B and T cells) in
transplanted patients is a very slow process and during the initial reconstitution phase, patients
are lymphopenic.  T cell recovery plays a key role in the clinical recuperation of patients post-
BMT as they lack adequate T cell-mediated immunity: they often succumb to one of several life-
threatening infections, especially cytomegalovirus (CMV) infections (reviewed in Gress et al.,
2007; Hakim and Gress, 2005). Roosnek and colleagues recently showed that the presence of
residual host- (surviving the conditioning regimen) or donor-derived (persisting and expanding
from the BM inoculum) CMV-specific CD8+ memory T cells could provide efficient anti-viral
immunity and help patients combat CMV infections in the lymphopenic period following BMT
(Chalandon et al., 2006). Therefore, in man, it seems that donor and recipient immune infection
history should be taken into account in designing the best BMT protocol strategy including
whether the donor BM should be T cell depleted and how recipients should be conditioned. The
ability of patients, especially adults, to regenerate T lymphocytes after BMT or conditioning
therapy-related depletion of the host mature T lymphocyte compartment has emerged as a
critical problem in clinical medicine. However, studies in man are difficult to control
experimentally and animal models are required to dissect and improve BMT outcomes.
We and others have shown that host-derived T cells are present in lethally
irradiated mouse BM chimeras (Anderson et al., 2004; Benard et al., 2006; Komatsu and Hori,
2007). However, the origin and function of these cells were not fully-characterized. This
prompted us to examine more carefully the host-derived T cell pool in chimeric mice. We
recently showed that host-derived T cells were enriched in extra-thymically located, radio-
resistant, functional CD4+CD25+ regulatory T cells which could prevent a syngeneic graft-
versus-host (GvH) disease following BMT (Benard et al., 2006).
The object of the current study was to characterize further host-derived T cell
development and function in chimeric mice. To this end, we generated chimeras by
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reconstituting lethally-irradiated C57BL/6 mice with either syngeneic RAG2-/- or CD3ε-/- BM. In
such chimeras, donor-derived BM progenitors are not able to generate T cells and surviving T
cells will be exclusively host-derived. We showed that host T cells contain a mixture of de novo-
generated naïve T cells and surviving peripheral memory-like cells. We found that host-derived
thymopoiesis was initiated by DN1-2 prothymocytes having a conventional (CD44high, CD117high,
CD25-/+) phenotype and we further demonstrate that T lymphopoiesis recapitulates normal
thymic ontogeny after BMT. Additionally, by comparing host-derived T cell numbers in non-
thymectomized (NTX) versus thymectomized (TX) hosts, we observed that the differentiation of
host-derived thymocytes provided an important cohort of naïve, functional, mature T cells
having a large TCR repertoire and accounting for up to 35% of the total T cell number found in a
control chimeric or unmanipulated mice. Moreover, by using TX hosts, we could show that there
was a second population of extra-thymically located, CD44highCD62L- memory-phenotype,
functional T cells having an oligoclonal TCR repertoire. These host-derived T cells might provide
a first line of defence against infections during recovery from lymphopenia after BMT.
Results
Host-derived T cells following BMT in lethally-irradiated mice.
More than 30 years ago, it was already recognised that in lethally irradiated BM chimeras, part
of the T cell compartment was of host origin (Ceredig and MacDonald, 1982; Hirokawa et al.,
1985; Kadish and Basch, 1975; Lesley et al., 1990; Sharrow et al., 1983). However, the precise
origin and functional activity of these host-derived T cells has not been thoroughly analysed. In
order to study host-derived lymphocytes, we reconstituted lethally-irradiated C57Bl/6 CD45.2
mice with T-cell depleted (TCD) BM from C57Bl/6 CD45.1 donors. After six months, to
characterise the host- and donor-derived lymphoid compartments of chimeric mice, we stained
splenocyte suspensions with combinations of CD45 allotype-specific antibodies, CD3 for T cells,
and CD19 for B cells and analysed them by FACS. As expected, in these syngeneic bone
marrow transplantation (BMT) experiments, all recipient mice survived (10/10) indicating a good
BM engraftment and there was no evidence of Graft-vs-Host disease (GvHD). However, a
sizeable host-derived CD45.2+ lymphocyte population survived even as long as 6 months after
BMT. Host-derived lymphocytes in chimeric mice were exclusively CD3+ and represented about
5% total splenic T cells (Figure 1A).
Figure 1: Host-derived T cells are present in lymphoid and peripheral organs of mouse BM chimeras.
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Figure 1A
Experimental design. Lethally-irradiated C57Bl/6 CD45.2 mice were reconstituted with T-cell depleted
(TCD) BM from C57Bl/6 CD45.1 donors.
After six months, splenocyte suspensions were stained for CD3, CD19 and CD45 allotype. A typical result
of FACS analysis is shown. CD3+ T cells and CD19+ B cells were gated as shown in left dot-plot and the
proportion of CD45.2+ (host-derived cells) was quantified as shown in the right histograms (N.D., not
detected).
Importantly, the absence of host-derived CD19+ B cells ruled out the possibility that host-derived
multi-potent cells had survived in our chimeras; this was further confirmed by analysis of the BM
where all progenitor compartment were donor-derived (data not shown). Additional phenotypic
analysis of host-derived T cells showed that both CD4+ and CD8+ cells were present and that
they were enriched in CD44high CD62L+/- cells compared with their donor-derived partners
(Figure 1B).
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Figure 1B
In the upper dot-plots, shown are CD4 and CD8 distribution in splenocytes. In the middle and lower dot-
plots data shown are CD44 and CD62L expression on gated CD4+ (middle dot-plots) or CD8+ (lower dot-
plots). Cells were either CD45.1+ donor-derived (left dot-plots) or CD45.2+ host-derived (right dot-plots).
Shown in B-C are representative results of 5-10 mice analyzed. Numbers in the quadrants indicate
percentages of cells.
Thus, host-derived T cells are still present in chimeric mice and are mostly composed of
CD44high memory-like cells (Tough and Sprent, 1994). To evaluate whether host-derived T cells
could be found in other locations, we studied lymphocytes isolated from the blood, gut, liver,
lung, lymph nodes and skin of chimeric mice 6 months after reconstitution. Again, none of these
organs contained host-derived B cells (data not shown) but did contain host-derived T cells in
different proportions. As shown in figure 1C, about 3-5% of blood, LN and spleen, and 10-20%
of gut, liver, lung and skin CD3+ T cells were host-derived. Together, these data revealed the
presence of a substantial pool of host-derived mature T cells in chimeric mice despite lethal
irradiation preceding BMT.
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Figure 1C
T cells chimerism in blood (Bl.), gut, liver (Liv.), lung (Lu.), lymph nodes (LN), spleen (Spl.) and skin (Sk.)
was analysed. Bar histogram represents the mean ± SD of host-derived T cells (CD3+CD45.2+) from 3-5
mice.
Following BMT most host-derived T cells are derived from a single
wave of thymic T cell differentiation.
Multiple origins could explain the persistence of host-derived mature T cells in chimeric mice.
Firstly, host-derived T cell progenitors could survive and generate T cells. These progenitors
could reside either within the thymus or elsewhere and generate either thymus-derived T cells
or extrathymic-derived T cells respectively. Secondly, some host-derived mature T cells could
represent radio-resistant, resident T cells. These hypotheses are not mutually exclusive and to
discriminate between them, we generated several chimeric mouse combinations as described
below.
To demonstrate that the host thymus is still able to produce T cells following lethal irradiation
and BMT, chimeras were generated by reconstituting lethally irradiated C57Bl/6 mice with
C57Bl/6.RAG2-/- BM. In such chimeras, donor-derived BM progenitors are not able to generate
T cells and surviving T cells will be exclusively host-derived. We tracked host-derived T cells in
the thymus and spleen from 1 to 6 weeks following BMT. The total number of thymocytes
rapidly decreased and reached about 2 x 106 cells one week post-BMT. Reduction of cell
number occurred in each CD4 and CD8-defined thymocyte subset, but the degree of reduction
varied among the subsets, possibly reflecting their relative radio-sensitivity (CD4+CD8+ double
positive (DP) > CD4+CD8- or CD4-CD8+ single positive (SP)). Figure 2A shows the changes in
proportion of each T cell subsets in thymus and spleen.
Figure 2: Host-derived T cells in lethally irradiated chimeras are mainly coming from a transient wave of T
cell differentiation within the thymus.
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Figure 2A
Shown in the upper part is the experimental design. Lethally-irradiated C57Bl/6 mice were reconstituted
with total BM from C57Bl/6.RAG2-/- donors. Thymus and spleen were analyzed at week 1, 2 and 6 post-
BMT. Shown are CD4 versus CD8 staining on viable lymphocyte gate. Numbers on the top of the
quadrants and in the quadrants indicate mean organ cell numbers ± SD and percentages of cells
respectively.
As reported by others (Penit and Ezine, 1989), DP thymocytes are highly susceptible to
irradiation and, in the first week following BMT, decreased rapidly from 89.6% in control non-
irradiated mice to 3.3%. In contrast, at one week post-BMT, we observed a relative enrichment
of CD4+ SP cells, representing 73.2% of total thymocytes whereas they represented only about
10% of thymocytes in control mice. At two weeks post-BMT, thymocyte number had increased
to reach a maximum of 45 x 106 cells, representing about 50% of control thymus cellularity. At
that time, the CD4 and CD8 distribution was very similar to controls.  Additionally, phenotypic
analysis revealed that SP thymocytes in chimeric mice were indistinguishable from controls,
expressing high level of CD3 and TCRβ, and about 5% of CD4+ SP cells were FoxP-3+ (data not
shown). At six weeks, thymus cellularity had decreased to less than 1 x 106 cells. At this time,
the thymic rudiment contained exclusively host-derived SP cells.
In the spleen of these chimeras, results reflected what we observed in the thymus. Thus, as
early as one week post-BMT, there was a dramatic loss of cellularity and spleens contained a
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mean of only 10.8 x 106 cells. CD4+ T cells represented almost all radio-resistant T cells. At 2
weeks post-BMT, splenocyte number peaked at 17.1 x 106 cells, finally decreasing to ~8-10 x
106 cells at 6 weeks. Throughout this time, the numbers of CD4+ T cells exceeded that of CD8+
T cells. The percent CD4+ T cells at 1, 2 and 6 weeks post-BMT were 8.5, 2.9 and 39.8 whereas
those of CD8+ cells were 1.1, 1.4 and 6.7 respectively. Interestingly and as already documented
by others, host splenocytes contained about 0.4 % DP cells; this could reflect some degree of
so-called extra-thymic T cell differentiation (Allman et al., 2001; Antica and Scollay, 1999;
Garcia-Ojeda et al., 1998; Terra et al., 2005). Thus, as we (Ceredig and MacDonald, 1982) and
others (Kadish and Basch, 1975; Penit and Ezine, 1989; Sharrow et al., 1983) have previously
shown, following lethal irradiation and BMT, a single wave of host-derived reconstitution
occurred (herein referred as auto-reconstitution), but the nature of the radio-resistant T cell
precursors responsible for this remained undefined. Additionally, we observed a significant
number of mature T cells in the periphery as long as 6 weeks post-BMT. It should be noted that
this pool of host T cells could comprise a mixture of (i) radio-resistant mature peripheral T cells
that had survived and expanded (ii) T cells derived de novo from the host thymus and (iii) some
not well-characterized T cells generated via extra-thymic differentiation.
Next, to clarify the relative contribution of these processes to the host-derived T cell pool, we
generated chimeras where C57Bl/6.CD3ε-/-.CD45.1 BM was transferred into lethally irradiated
C57Bl/6.CD45.2 hosts which were either thymectomized (referred herein as TX) or not
thymectomized (referred herein as NTX). In these chimeras, all mature T cells would be host-
derived with those in TX recipients being of only extra-thymic origin and those in NTX recipients
a mixture of extra-thymically and thymus-derived cells. Thus, the difference in T cell numbers
between these two groups of chimeras would reveal the contribution of thymic-derived T cells to
the overall pool. As shown in figure 2B, the donor-derived B cells in the spleen of NTX and TX
were very similar to controls and represented 50-60 x106 cells or 70-87% splenocytes
respectively 2-3 months post-BMT. In contrast, the mean number of host-derived T cells was
about 20 x106 in control chimeras, decreasing to ~7 x106 cells in NTX and to only about 2 x106
cells in TX chimeras.
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Figure 2B
Shown in the upper part is the experimental design. Lethally-irradiated C57Bl/6.CD45.2 mice were
thymectomized (TX) or not (NTX) and reconstituted with BM from C57Bl/6.CD3ε-/-.CD45.1 donors.
Chimeras were analyzed 8-12 weeks post-BMT. Bar histograms represent total B (black bars) and T
(white bars) lymphocyte numbers ± SD (n=10) in controls and chimeras. , P <0.01.
Thus, in the spleen, 5 x106 host-derived T cells were thymus-derived whereas only 2 x106 were
from an extra-thymic origin. In TX chimeras, histological analysis of spleen sections revealed
abnormal follicular architecture with small, scattered, T cell areas reflecting their severe
lymphopenia. In contrast, spleen sections from NTX animals displayed normal features (figure
2C).
Figure 2C
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Frozen spleen sections from chimeras described in figure 2B were prepared and stained as described
in materials and methods. B cells appear in red and T cells in green. Scale bar, 100 µm.
Our results show that (i) in chimeras where all T cells are host-derived, about 35% [(7/20)
x100] of the normal T cell pool could be formed and maintained and (ii) more importantly, at
least 71% [100 – (2/7 x100)] of host-derived T cells are derived from the thymus. This value
may be an underestimate because it assumes that the extra-thymically derived T cell pool
remained constant in TX versus NTX recipients.
Thymus-derived host T cells originate from radio-resistant DN1-2 like
thymocytes.
The above results demonstrated that most (>70%) host-derived mature T cells were derived
from a single wave of thymocyte differentiation. The presence of a host-derived thymocyte
precursor has been proposed (Ceredig and MacDonald, 1982; Kadish and Basch, 1975; Penit
and Ezine, 1989; Sharrow et al., 1983), however, whether it is an intra-thymic “classical”
progenitor or an “atypical” cell was not resolved. Indeed, it had been proposed recently (Maillard
et al., 2006) that reconstitution of the thymus in the BM chimeras was derived directly from an
“atypical” CD25+CD44-CD117- DN3-like precursor. Therefore, complementary approaches were
undertaken to further characterise host-derived thymocyte precursors.
As host-derived mature lymphocytes were almost exclusively T cells, we concluded that this
radio-resistant precursor should reside within the thymus where T cell precursor commitment is
thought to take place. In order to demonstrate that a pool of intra-thymic T cell precursors
survive lethal irradiation and can differentiate into mature thymocytes, we carried out foetal
thymus organ culture (FTOC) experiments with foetal thymus lobes from lethally irradiated
pregnant mice. As shown in figure 3A (and data not shown), one week after FTOC, irradiated
thymi contained TCRβ+ DP and SP cells in a proportion similar to that of controls. The same
experiments were carried out with pieces of adult thymus in organ culture (ATOC). Again, we
observed typical signs of thymocyte differentiation and despite lethal irradiation, organ-cultured
adult thymi contained TCRβ+ DP and SP cells one week after ATOC (data not shown).
Figure 3:  Radio-resistant DN1-2 thymocyte precursors reside in the thymus following lethal irradiation.
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Figure 3A
Shown are the CD4 versus CD8 profiles of day-7 FTOC with (right) or without (left) lethal irradiation (950
cGy) at day 0. Numbers in the quadrants indicate percentages. Shown is one representative experiment
out of 5 conducted independently.
Next, C57Bl/6 mice were reconstituted with RAG2-/- BM and treated with anti-IL-7Rα mAb
immediately after BMT (figure 3B, right graph). At two weeks post-BMT, following anti-IL-7Rα
treatment, the number of host-derived T cells was greatly diminished with thymocyte cellularity
reduced from ~50 to 1 x 106 cells. This reduction in cellularity was associated with a block of DN
to DP stage transition (figure 3B, left panels). We conclude that some T cell precursors survive
lethal irradiation, reside within the thymus and that their differentiation is IL-7 dependent.
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Figure 3A
The same chimeras as in figure 2A were done and following BMT either injected i.p. with 300 µg of anti-
IL-7R blocking antibody (A7R34) in 200 µl of PBS once a week (treated) or with PBS only (sham). Two
weeks post-BMT, mice were killed and their thymus analysed by FACS. Shown are CD4 versus CD8
profiles (left dot-plots) and mean thymocyte numbers ± SD (n=3) in a logarithmic scale (right histogram
bars). , P <0.05.
The properties of these thymocyte progenitors were reminiscent of those of typical DN1-2
thymocyte precursors (Balciunaite et al., 2005a; Balciunaite et al., 2005c; Ceredig and Rolink,
2002). We therefore enriched DN cells from C57Bl/6.CD45.1  C57Bl/6. CD45.2 chimeric mice
from 1 to 3 weeks post-BMT and by CD44 and CD117 staining, we were able to reveal the
presence of CD44+CD117high cells corresponding to ~0.3 to 0.6% of DN preparations (Figure
4A, left dot plots). As shown in figure 4A, this population contained CD117high DN1
(CD44+CD25-) and DN2 (CD44+CD25+) T cell precursors.
Figure 4: Radio-resistant DN1-2 thymocytes recapitulate normal thymic ontogeny in vitro.
Figure 4A
Shown in the left is the experimental design. Lethally-irradiated C57Bl/6.CD45.2 mice were reconstituted
with TCD BM from C57Bl/6.CD45.1 donors. Thymi were analyzed at week 1, 2 and 3 post-BMT. Shown in
the right are CD44 versus CD117 on DN preparation and CD44 versus CD25 staining on gated
CD44+CD117High cells from an unmanipulated control or a chimeric mouse. CD44+CD25- and
CD44+CD25+ represent DN1 and DN2 respectively. Numbers in the quadrants indicate representative
percentages.
We then quantified the host- and donor-origins of DN1 and DN2 cells from chimeras 1 to 3
weeks post-BMT (Figure 4B, bar graphs). At 1 week post-BMT, DN1-2 cells were detected
which were ~99% host-derived and this proportion decreased to ~90% at 2 weeks and finally to
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less than 1-5% at 3 weeks post-BMT. Thus, early “classical” T cell progenitors exist in the
thymus of chimeric mice even though they are rare cells. Initially, the CD117high progenitor
compartment is almost exclusively host-derived but later gets diluted by donor-derived cells.
Figure 4B
Bar histograms display the kinetics and mean numbers (n= 3-5 mice for each time point) of host- and
donor-derived DN1 and DN2 cells in black and white respectively from 1 to 3 weeks post-BMT.
We next addressed the T-cell development potential in vitro of host-derived thymic
CD44+CD117high cells found in chimeric mice at week 1 post-BMT. About 2x103 cells were
sorted and differentiation potential was assessed by plating them on OP9-DL1 stromal cells
(supporting T-lineage development) in the presence of IL-7. Cells expanded rapidly, reaching
about 105 cells one week after culture when they were harvested and analyzed by FACS. They
underwent typical T-lineage development features by up-regulation of CD25 and down
regulation of CD44 expression (figure 4C left dot-plot). One week post-BMT, 95% of the cells
were CD45.2+
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Figure 4C
The same chimeras as described in figure 4A were done, 5 mice were killed pooled and used to sort
CD44+CD117High DN1 and DN2 cells one week after BMT. About 2000 cells were plated on OP9-DL1
stroma with IL-7 and analysed by FACS 7-10 days later to assess their in vitro T-cell development
potential. Shown are CD44 versus CD25 profiles and CD45.1 (donor-derived) or CD45.2 (host-derived)
proportion of recovered thymocytes.
Taken together, our results characterize for the first time the nature of genuine radio-resistant T
cell precursors. These cells are (i) intra-thymic in location, (ii) grow in an IL-7-dependent
fashion, (iii) display a normal CD117high phenotype and (iv) are functional bona-fide DN1-DN2
cells with canonical T cell developmental potential.
Host-derived T cells are functional, but presence of the thymus is
required to ensure an unbiased TCR repertoire
A series of chimeras comparing NTX and TX hosts were generated and analysed further to
evaluate the functional importance of the thymus in auto-reconstitution. Phenotypically, the most
notable difference between the two subpopulations was the increased proportion of naïve
(CD44lowCD62L+) T cells in NTX hosts (17% and 11.8% for CD4+ and CD8+ T cells respectively)
compared with TX hosts (1.8% and 2.3% for CD4+ and CD8+ T cells respectively) (Figure 5A).
In controls (un-manipulated or Bl/6Bl/6 chimeras), most T cells displayed a naïve phenotype
with 66.8% and 46.2% of CD4+ and CD8+ T cells respectively (Figure 5A left panels) having the
CD44lowCD62L+ phenotype. Thus, NTX chimeras contained a higher proportion of memory
phenotype (CD44HighCD62L-) T cells whereas in TX chimeras almost all T cells were of this
phenotype.
Figure 5: Phenotype, repertoire and functionality of host-derived T cells in lethally-irradiated BM chimeras.
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Figure 5A
Shown are CD44 and CD62L expression on gated CD4+ TCRβ+ (upper dot-plots) or CD8+TCRβ+ (lower
dot-plots). Numbers in the quadrants indicate mean percentages ± SD from at least 5 mice analysed per
group.
The reduced T cell number in TX hosts, where T cells are only extra-thymically derived
combined with their severe T cell lymphopenia might result in a repertoire bias and a
consequent functional defect. To investigate the repertoire question further, we stained T cells
from 10 mice from each group of chimeras with a panel of anti-TCR Vβ-specific mAbs. As
shown in Figure 5B, the TCR Vβ repertoire of CD4+ and CD8+ T cells in NTX chimeras
consistently resembled that found in controls. This was in clear contrast to that of TX chimeras
where in many mice the TCR Vβ repertoire was frequently biased.
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Figure 5B
Vβ repertoire analysis among CD4+ and CD8+ T cells by FACS in chimeras. Each symbol represents a
single mouse from control (), NTX () or TX () group. Black bars represent mean value in control
group. Ten mice per group were analysed.
Next, to determine if TX hosts had functional defects, we measured their ability to mount a T-
dependent (TD) antibody response. As shown in figure 5C, 14 days following NIP-OVA
immunisation, NTX chimeras were able to mount a TD antibody response as efficiently as
controls. This was in striking contrast to TX chimeras, where only 4 out of 10 mice were able to
mount a TD immune response.
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Figure 5C
Depicted is T cell-dependent antibody responses in different group of chimeras day 14 after NIP-OVA
immunization. Shown are relative titers of IgG anti-NIP specific antibodies. Each bar represents a single
mouse and 5-10 mice were analyzed. When the ratio [anti-NIP IgG titers after immunization / anti-NIP IgG
titers before immunization] was below 10 (horizontal line) we considered that the mouse did not mount a
T-dependent response. In control and NTX group, 5/5 mice made a specific response with ratio >100.
Among TX group, only 4/10 mice made a specific response (hatched bars). Control, NTX or TX chimeras
were the same as described in figure 2B.
Taken together, our results show that host-derived T cells in chimeras are functional but in TX
hosts, their oligoclonal nature frequently resulted in an inability to mount an efficient antigen-
specific TD antibody response.
Discussion
By carefully studying the kinetics of development, distribution, phenotype and function of the
host-derived T cells in BM chimeras, we have clarified their previously unappreciated, but
important, contribution to the restoration of the immune system. We called this process “auto-
reconstitution”. We revealed that following lethal irradiation, host-derived haematopoietic cells in
secondary lymphoid organs were almost exclusively composed of T cells and totally devoid of B
cells. In addition, host-derived T cells represented a considerable proportion of total T cells
(~5% of all T cells six months post-BMT). Kinetic analysis showed that the proportion of host-
derived T cells decayed as donor-derived T cell development slowly took place in Bl/6Bl/6
chimeras. In these competitive settings, where the donor BM generated T cells, it was not
possible to study host-derived T cells exclusively. Thus, we generated non-competitive BM
chimeras in which BM donor cells (either RAG2-/- or CD3ε-/-) were incapable of generating T
cells. Then, we were able for the first time to quantify precisely host-derived T cells in these
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non-competitive chimeric settings. Surprisingly, auto-reconstitution could generate a pool of T
cells equivalent to 35% that in normal mice. We could also show that T cell auto-reconstitution
had two origins: (i) a major, thymic-dependent pathway (TD) and (ii) a minor, thymic-
independent pathway (TI). Indeed, in CD3ε-/-Bl/6 chimeras, by comparing host-derived T cell
numbers in euthymic (NTX) versus athymic (TX) hosts, we could quantify TD and TI pathways.
Thus, the TD pathway accounted for 70% of host-derived T cells, thereby representing the main
source of host T cells in an auto-reconstituted T cell compartment. This estimate is based on the
assumption that the size of the TI compartment is not drastically altered by the TD cohort of T
cells and vice versa.
The TD T cells were composed of the progeny of a single wave of T-cell differentiation which
reached a maximum 2 weeks following BMT. As host-derived thymocyte differentiation is only
transient and ceases around 3-4 weeks, the thymus does not contain any DP cells later on and
its cellularity decreases dramatically. This has been previously characterized by others (Ceredig
and MacDonald, 1982). The TD cohort of T cells provides a large number of naïve T cells with a
diverse TCR Vβ repertoire. Logically, this observation led us to investigate the nature of radio-
resistant thymocyte progenitors.
Recently, when addressing the cellular origin of the host-derived cohort of thymocytes
regenerating in BM chimeras, Maillard et al. (Maillard et al., 2006) suggested that they arose
from an abnormal sequence of differentiation starting from a donor-derived CD25+ CD44-
CD117- “DN3-like” stage and therefore might involve an atypical thymocyte progenitor. In
contrast, we could detect the presence of genuine, or “conventional” CD25-/+ CD44+ CD117high
DN1-2 cells. Such conventional DN1-2 cells were few in number, representing around 2000
cells per mouse one week post-BMT. Further analysis indicated that these T cell progenitors
were mainly (~95-99%) host-derived initially and were then replaced by donor derived
progenitors around 3 weeks post-BMT.
The toxicity of ionizing radiation to cells is associated with massive apoptosis which is
particularly acute in hematopoietic organs, well-known to be highly radiosensitive. Lethal γ-
irradiation triggers DNA breaks which in turn activate DNA repair mechanisms and/or p53-
dependent apoptosis, unless DNA repair has been carried out correctly (Jeggo and Lobrich,
2006a; O'Driscoll and Jeggo, 2006). There is a body of literature addressing the radio-sensitivity
of lymphoid cells, but so far, there are no clear mechanisms demonstrating why only some
subpopulations of cells can survive lethal irradiation damage. From in vitro experiments with cell
lines, it has been proposed that the cell cycle status at the time of irradiation might determine
their radio-sensitivity (Jeggo and Lobrich, 2006b; Lobrich and Jeggo, 2007; Pawlik and
Keyomarsi, 2004). Thus, cycling cells harbour much more DNA alterations than their quiescent
counterparts and are more prone to die. This dogma by itself would hardly explain what is going
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on in vivo in lethally irradiated mice. Indeed, it would seem that memory T cells, which are
known to be more rapidly cycling than their naïve counterparts, survive whereas B cells, some
of which are known to be more cycling than others, are totally deleted. Thus, we believe that
certain niches throughout the body might provide lymphocytes with a particular environment
with specific radio-protective signals. In our study, the gut contained a higher proportion of
radio-resistant T cells and could be an interesting candidate for such a radio-protective niche
even though we cannot exclude a preferential relocalisation of surviving T cells following total
body irradiation (TBI). Interestingly, a role for the gut in radioprotection was recently proposed
because a polypeptide-drug derived from commensal salmonella flagellin, which binds to Toll-
like receptor 5 and which activates nuclear factor-κB signalling, was able to prevent mice from
gastrointestinal and hematopoietic disorders following lethal TBI (Burdelya et al., 2008).
Furthermore, in recipient mice where the anti-apoptotic gene Bcl-2 was constitutively over-
expressed (H2K-BCL-2 transgenic mouse), even host-derived B cells survived following TBI and
BMT (data not shown and (Domen et al., 1998)). Thus, the clear contrast in survival properties
of B versus T cells might (at least partly) be due to intrinsic differences in their expression of
pro- versus anti-apoptotic genes. By intracellular staining, we have already observed a higher
baseline level of Bcl-2 expression in T cells versus B cells. Clearly, the issue of the differential
survival of T versus B cells following lethal irradiation is warranted and might shed light on
important pathways for radioprotection at the cellular level.
As shown in TX recipients, the minor, TI-derived, T cell component of auto-reconstitution was
composed of the progeny of mature, radio-resistant peripheral CD4+ and CD8+ T cells.
Following their survival and expansion post-irradiation, they expressed a biased TCR Vβ
repertoire. Phenotypically, these TI cells had a CD44High CD62L+/- memory-like phenotype which
could correspond to their initial phenotype or to a phenotype acquired upon lymphopenia-
induced expansion (Bosco et al., 2005; Bosco et al., 2006a). Additionally, as we and others
have previously shown, these cells were enriched in FoxP-3+ regulatory T cells (Anderson et al.,
2004; Benard et al., 2006; Komatsu and Hori, 2007; Roord et al., 2008). Following BMT in mice,
these TI Treg cells protected the host from GvHD complications in syngeneic conditions
(Benard et al., 2006). Others studies have shown that Treg, as well as memory T cells, are
more resistant to γ-irradiation, chemotherapy or antibody-mediated depletion in vitro and in vivo
(Anderson et al., 2004; Benard et al., 2006; Bourgeois and Stockinger, 2006; Gladstone et al.,
2007; Walzer et al., 2002). The molecular mechanisms behind these interesting observations
are still unknown and require further experiments.
Functionally, in NTX CD3ε-/-Bl/6 thymus-bearing chimeras, host-derived CD4+ T cells alone
were sufficient to mount a TD immune response whereas in TX recipients, the immune
response was frequently impaired. Clinically, it is recommended that patients be re-vaccinated
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following BMT in order to restore a high level of protection against many vaccine-preventable
diseases such as measles, tetanus, hepatitis or polio (Avigan et al., 2001; Gangappa et al.,
2008; Ljungman et al., 2005; Parkman, 2008; Patel et al., 2007). In this context, mouse BM
chimeras might provide a relevant experimental system to study immune response or diseases
associated with lymphopenia subsequent to conditioning regimens and BMT in humans.
Published observations suggested that host-derived cytomegalovirus-specific (CMV) CD8+
memory T cells could provide efficient anti-viral immunity and help patients survive the severe
lymphopenic period following BMT (Chalandon et al., 2006). However, studies in man are
difficult to control experimentally and animal models are required to dissect and improve the
outcome of BMT.
In conclusion, our results demonstrate a so-far unappreciated, but important, residual host-
derived thymic activity following conditioning and BMT. These thymus-derived T cells constitute
a significant population of T cells with a polyclonal TCR Vβ repertoire and normal functional
properties. By analysing thymectomised recipients, we could demonstrate that in their absence,
lymphopenia was more severe, the T cell repertoire was frequently oligoclonal and immune
responses were compromised. Therefore, strategies should be developed to improve and
expand the TD and/or the TI cohort of T cells which together could serve as a first line of
defence in lymphopenic hosts until donor-derived T cell reconstitution takes place. In this
regards, improving thymic reconstitution and peripheral T cell survival by, for example, infusing
IL-7/anti-IL-7 complexes (Boyman et al., 2006; Boyman et al., 2008) during thymus regeneration
would appear to be a promising approach.
Materials and methods
Mice.
Female C57Bl/6, C57Bl/6.RAG2-/-, and C57Bl/6.CD3ε-/- mice of either CD45.1 or CD45.2
genotype were maintained in our SPF animal facility. As BM donors, mice were used at 4-8
weeks of age and recipients were killed by CO2 inhalation prior to analysis. These studies were
approved by the institute animal care and user committee.
Thymectomies.
At 4 to 6 weeks of age, mice were anesthetized and thymus was removed by suction through a
small upper sternal incision. That thymectomy had been complete was verified in each animal
by anatomical inspection at the time of sacrifice.
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Cell preparation, immunofluorescence staining and FACS analysis.
Lymphoid organs (thymus, spleen or lymph nodes) were removed from adult unmanipulated or
chimeric mice at the indicated times. Single-cell suspensions were generated by disruption of
organs through a 40 µm nylon mesh via a syringe plunger and were washed once with 2% FCS-
supplemented DMEM. Spleen cell suspensions were depleted of red cells by NH4Cl treatment
prior to staining. Lymphocyte suspensions from liver, lung and skin were prepared by standard
procedures and Percoll density gradient centrifugation performed as previously described
(Schleussner and Ceredig, 1993) prior to cell recovery. Biotin-, FITC-, PE-, PE.Cy7-, or APC-
conjugated mAbs were either home made or purchased from BD Biosciences or eBioscience
(San Diego, CA). Cell staining was performed as previously described (Bosco et al., 2005;
Bosco et al., 2006a) prior to FACS analysis with a FACScalibur and CELLQuest Pro software
(BD Bioscience). The data presented are of live-gated cells based on a combination of forward-
and side-scatter signals and when possible propidium iodide exclusion.
Bone marrow transplantation.
Bone marrow cell suspensions from CD45 allogenic donor mice were prepared by flushing
femurs and tibias with PBS using a 23g needle. After a red blood cell lysis step, T cells were
depleted when necessary by resuspending cells in a mixture of rat IgM anti-CD4 (RL172) and
anti-CD8α (31M) mAb hybridoma supernatants and incubated for 20 min at 4°C. Following a
washing step, antibody-coated cells were lysed by adding a 1:10 dilution of screened rabbit
serum as source of complement in serum free Dulbecco’s modified Eagle’s medium (DMEM) for
45 min at 37°C. Then, cells were washed, resuspended in serum-free DMEM and counted prior
to injection. Host mice were lethally γ-irradiated with a single dose of 950 cGy at a dose of 80 to
90 cGy/min using a Cobalt-source (Gammacell 40, Atomic energy of Canada, Ltd) 4h prior to
receiving 5x106 bone marrow cells intravenously. Chimeric mice were analysed at the indicated
time points and the host and donor origin of lymphoid cells determined by means of labelled
CD45.1- or CD45.2-specific mAbs.
Fetal thymic organ cultures
Fifteen-day pregnant C57Bl/6 mice were lethally irradiated (950 cGy) prior to embryo removal.
Thymus lobes from irradiated or control un-irradiated embryos were then used for FTOC. For
staining, lobes were dissociated by passing through needles of decreasing size as previously
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described (Balciunaite et al., 2005c), washed in DMEM medium and then stained and
analyzed by flow cytometry.
Thymus DN preparation, cell sorting and culture on OP9-DL1 stroma.
From total thymocytes, CD4-CD8- double negative (DN) cells from control or chimeric mice were
prepared by complement-mediated lysis of CD4 and CD8 expressing thymocytes as described
above. DN thymocytes were then stained with combinations of fluorescently-labelled CD25,
CD44 and CD117 (c-kit) mAbs and pooled CD25- DN1 and CD25+ DN2 cells sorted as
CD117highCD44+ cells using a FACSAria sorter (BD Biosciences). Reanalysis of sorted cells
indicated that their purity was routinely ≥ 98%.
OP9 stromal cells expressing the Notch ligand delta-like-1 (OP9-DL1) were kindly provided by
Professor Juan-Carlos Zúñiga-Pflücker (University of Toronto, ON, Canada) and maintained in
IMDM supplemented with 5 x 10–5 M β-mercaptoethanol, 1 mM glutamine, 0.03% (wt/vol)
Primatone (Quest, Naarden, The Netherlands), 100 U/mL penicillin, 100 µg/mL streptomycin,
and 2% heat-inactivated fetal bovine serum (FBS). Two days prior to coculture, 104 stromal cells
were seeded per well of a 24-well plate. At day 0, stromal cells had grown to semi-confluency
and were then -irradiated with 3000 cGy, culture medium removed and replaced by
supplemented DMEM plus IL-7 (~10ng/mL). To these cultures were added ~5x103 sorted DN1
and DN2 thymocytes. At day 10-14 of culture, cells were either analysed by FCM or kept in
culture after transfer to fresh OP9-DL1 stromal cells.
T cell-dependent antibody responses.
To induce a T cell-dependent antibody response, reconstituted chimeric mice were injected
subcutanously with 200µl complete Freund’s adjuvant emulsion containing 50 µg total NIP-
ovalbumin. Sera were obtained after bleeding prior to and 14 days after immunization and
stored at –20°C. Hapten-specific IgG antibody titres were determined by enzyme-linked
immunosorbent assay (ELISA) as previously described (Ceredig et al., 2006).
Immunofluoresecent staining of spleen sections.
Spleens were snap frozen with dry ice in Tissue-Tek OCT compound and then 5 to 7-µm
sections cut on a cryostat. Sections were then fixed for 10 min in acetone and stored at -80°C.
For staining, sections were covered with an antibody solution at saturating concentration diluted
in PBS-1% FBS for 1h at room temperature. Anti-B220Biotin and anti-CD90FITC were used to
discriminate B and T cell areas respectively, and PNABiotin (Peanut Agglutinin, Vector
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Laboratories) and anti-IgMFITC (M41) used to reveal germinal centres (GC). For the second
step, sections were washed in PBS (three times 10 min) and incubated 30 min at room
temperature with a Neutralite Avidin-Texas-Red reagent (Southern Biotech) diluted in PBS.
Then, sections were washed, coverslipped and analyzed under a fluorescence microscope
(Zeiss axioskope) with a 10 to 20x objective.
Statistical analyses.
Data are presented as the mean and SEM. Comparisons between groups were done using a
Student’s two-tailed t test for independent events. P values of less than 0.05 were considered
significant (, p value <0.05 and , p value <0.01).
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Part III: TCRβ chains derived from peripheral γδ T cells can take part
in αβ Τ cell development
by Nabil Bosco, Corinne Engdahl, Angèle Bénard, Johanna Rolink, Rhodri Ceredig and
Antonius G. Rolink
Introduction
T cell development takes place in the thymus from progenitors of bone marrow
origin. By now it is generally believed that a cell called a thymus settling progenitor (TSP),
characterized by the expression of CD44, CD117, CD135 and the chemokine receptor CCR9
(Benz and Bleul, 2005; Bhandoola et al., 2007; Schwarz et al., 2007; Zediak et al., 2005) is the
bone marrow cell that enters the thymus. However, transplantation experiments in T cell
deficient mice have indicated that other progenitors can enter the thymus and may take part in T
cell development (Balciunaite et al., 2005b; Bhandoola et al., 2007; Martin et al., 2003).
Early T cell progenitors in the thymus lack CD4 and CD8 expression and are
therefore called double negative (DN) cells. Based on the differential expression of CD44, CD25
and CD117, DN cells can be subdivided into DN1-4 subpopulations. Thus DN1 cells are CD44+,
CD25- and CD117High and within this population, TSPs are included as a CD135+ subpopulation
(Bhandoola et al., 2007; Ceredig et al., 2007; Ceredig and Rolink, 2002; Zediak et al., 2005).
DN1 cells differentiate through a CD44+, CD25+, CD117high DN2 stage to become CD44-,
CD25+, CD117-/low DN3 cells (Ceredig and Rolink, 2002). Both DN1 and 2 cells still possess
multi-lineage developmental potential, including that for NK, dendritic and myeloid cells
(Balciunaite et al., 2005c; Bell and Bhandoola, 2008; Wada et al., 2008). However, B cell
lineage potential seems to be restricted to the TSP population within the DN1 subset (Benz and
Bleul, 2005; Bhandoola et al., 2007; Ceredig et al., 2007; Zediak et al., 2005). By largely
unknown mechanisms, commitment to the T cell lineage is acquired at the DN2 to DN3 cell
transition (Balciunaite et al., 2005a; Balciunaite et al., 2005c). However, cells at the DN3 stage
still have the option to develop into either αβ or γδ T cell lineage cells (Hayday and Pennington,
2007; Kreslavsky et al., 2008; von Boehmer et al., 1998). A relatively large number of studies
have indicated that the expression of the pre-TCR plays a crucial role in the development of αβ
T cells (Fehling et al., 1995; Kreslavsky et al., 2008; von Boehmer et al., 1998). Recent,
elegant, single cell studies have indicated that γδ TCR expressing cells still have the option to
develop into either γδ  or αβ TCR expressing T cells (Haks et al., 2005; Hayes et al., 2005;
Kreslavsky et al., 2008). The strength of the TCR-mediated signal that a γδ T cell receives
seems to determine the outcome of this option. Thus, a strong signal (positive selection) drives
these cells into the γδ T cell lineage whereas no, or a weak, signal leads to the differentiation
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into αβ T cell lineage cells (Haks et al., 2005; Hayes et al., 2005; Kreslavsky et al., 2008). The
finding that at least some peripheral γδ T cells are positively selected in the thymus strongly
supports this model (Hayday and Pennington, 2007; Lewis et al., 2006).
It is well known that 10-20% of the peripheral γδ T cells express a
TCRβ protein in their cytoplasm (Wilson and MacDonald, 1998). However, it still unknown why
these cells became γδ and not αβ T cells and why they maintain TCRβ gene transcription and
protein expression. Here we tested whether TCRβ chains isolated from peripheral γδ T cells
could take part in the development αβ T cells. To this end, cDNAs encoding expressed TCRβ 
genes were cloned from sorted lymph node γδ T cells and retrovirally introduced into in vitro-
propagated Pax-5/TCRβ double deficient pro-B cells. The potential of these transduced cells to
give rise to αβ T cells was analyzed in vivo in sublethally-irradiated CD3ε-deficient recipient
mice. Results obtained unambiguously demonstrated that with respect to the reconstitution of
the thymus and the peripheral αβ T cell compartment in this experimental system, TCRβ chains
from γδ T cells were as efficient as those derived from αβ T cells at reconstituting the αβ T cell
compartment. Thus the TCRβ chains found in γδ T cells can potentially mediate αβ T cell
development. The potential implications of these findings for γδ – αβ T cell development will be
discussed.
Results
Thymus reconstitution by Pax5/TCRβ double deficient proB cells
Previously, we have shown that upon transplantation into immune-deficient hosts, in vitro-
propagated Pax5 deficient pro-B cells could readily reconstitute all thymocyte subpopulations as
well as peripheral lymphoid organs with mature αβ T cells (Rolink et al., 1999). Now, we have
generated a Pax5 x TCRβ  double-deficient pro-B cell line in order to test the ability of TCRβ  
chains of different origins to take part in αβ  T cell development. As a first control,
Pax5/TCRβ  double  deficient pro-B cells were transduced with an empty pMIG retroviral vector
and 5 – 7 days later sorted for GFP expression. After a further two weeks of in vitro propagation,
cells were injected intra-venously into sub-lethally irradiated CD3ε-deficient recipient mice.
Three weeks after transfer, the thymi of these mice contained 10 – 15 x 106 cells, 85 – 95% of
which were GFP positive (Figure 1A). Of the GFP+ cells, 15 – 20% were DN, 65 – 75 % DP and
5 – 10% single CD4+ (Figure 1B). Analysis of TCR expression on these various subpopulations
revealed that 15 – 25% DN cells were γδ TCR+ whereas the other subpopulations of CD4/8-
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defined cells were not (Figure1 C-E). Obviously, none of the cells expressed αβ TCR (Figure
1 C-E).  Thus, Pax5/TCRβ  double  deficient pro-B cells can modestly reconstitute the thymus
of CD3ε-deficient mice and some of the resulting DN cells express a γδ TCR.
Figure1: Phenotype of thymocytes in CD3ε-deficient mice three weeks after the injection of PAX5/TCRβ
double deficient proB cells transduced with empty pMIG vector.
(A) Shown is the GFP expression. (B) Shown are the CD4 and CD8 expression on the GFP positive cells.
(C-E) gd TCR (dotted histograms), ab TCR (bold histograms) and controls (thin line histograms) on gated
DN (C), DP (D) and CD4 single positive (E) GFP positive thymocytes. Numbers represent the percentage
of cells in one representative mouse, more than 10 were analyzed.
Thymus reconstitution by Pax5/TCRβ double deficient pro-B cells
using TCRβ  chains from γδ or  αβ T cells
Previously it was shown that about 10-15% of the peripheral γδ T cells are cytoplasmically
TCRβ+ (Wilson and MacDonald, 1998), results confirmed in Figure 2.
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Figure 2: Cytoplasmic TCRβ expression by γδ T cells from WT Bl/6 lymph nodes.
Lymph node cells were stained for γδ TCR cell surface expression and subsequently for intracellular
TCRβ. Histograms represent γδ TCR positive gated cells. Thin line histogram represents the control and
the bold line histogram represents the TCRβ stained sample. The number indicates the percentage of
positive cells in one representative mouse.
To test whether TCRβ chains derived from γδ T cells could take part in αβ T cell development,
we firstly amplified by RT-PCR cDNA from sorted LN γδ T cells (as shown in supplementary Fig.
1) using oligonucleotides specific for Vβ4, Vβ6 or a Vβ8 family members. Amplicons were
sequenced prior to cloning into a pMIG retroviral vector and expressed in the
Pax5/TCRβ double  deficient pro-B cells. (The TCR Vβ sequences used in this study are shown
in Supplementary Table I). Subsequently, TCRβ-expressing, GFP+ cells were injected i.v. into
sublethally-irradiated CD3ε deficient mice. Pax5/TCRβ double  deficient pro-B cells transduced
with vectors containing TCRβ chains amplified from sorted LN αβ  T cells (as shown
supplementary Fig. 1) were used as controls. Three weeks later, the thymus of mice that had
received Pax5/TCRβ   double  deficient pro-B cells transduced with γδ T cell-derived TCRβ
chains contained between 80 and 130 x 106 cells (Figure 3A). Similar thymocyte numbers were
found in recipients of Pax5/TCRβ double  deficient pro-B cells transduced with TCRβ chains
derived from sorted LN αβ T cells (Figure 3A). Thus, thymus cellularity in both groups were
close to those of wild type mice and moreover, were 5 -10 fold greater than in mice that had
received cells transduced with the empty vector (Figure 3A).
Figure 3: Numbers and phenotype of thymocytes derived from CD3ε deficient mice at 3 weeks after the
injection of Pax5/TCRβ double deficient pro B cells transduced with TCRβ derived from lymph node αβ or
γδ T cells.
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Figure 3A
Numbers of thymocytes recovered are shown. Each symbol represents the mean ± SD of 5 mice. Groups
A, B and C were mice injected with different γδ T cell derived TCRβ chain transduced cells. Groups D, E
and F were mice injected with different αβ T cell derived TCRβ  chain transduced cells. Group G
represents the mice that were injected with empty vector transduced cells.
With respect to CD4, CD8 and TCR expression, thymocytes from recipient mice reconstituted
with cells expressing TCRβ chains from either TCRγδ or TCRαβ-derived cells were very similar
to those of wild type mice. Figure 3B and 3C show a typical example of thymocytes from mice
reconstituted with either γδ or αβ-derived TCRβ chains. For comparative purposes, both of
these transduced TCRβ ’s used a Vβ8 family member. In both recipients, over 95% of
thymocytes were GFP+ with 2-5% DN, 75-85% DP, 5-10% CD8 single positive and 10-20% CD4
single positive cells. Moreover, as in wild type mice, αβ TCR expression was low on DP cells
and relatively high on single positive cells. Surprisingly, and in marked contrast to the mice that
had received the Pax5/TCRβ double deficient pro B cells transduced with the empty vector (see
Figure 1), no γδ T cells were detected in the thymus of these mice (see supplementary Fig. 2).
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Figure 3B
GFP, CD4, CD8, αβ TCR and Vβ8 expression by thymocytes derived from a mouse injected with cells
transduced with a Vβ8 using TCRβ chain derived αβ T cells. Three lower histograms represent αβ TCR
(bold line histogram) and Vβ8 (dotted line histogram) expression by double positive (DP) and single
positive CD8 and CD4 cells. Thin line histograms represent the negative controls. Numbers in quadrants
represent the percentage of one representative mouse among 5 analyzed.
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Figure 3C
GFP, CD4, CD8, αβ TCR and Vβ8 expression by thymocytes derived from a mouse injected with cells
transduced with a Vβ8 using TCRβ chain derived γδT cells. Three lower histograms represent αβ TCR
(bold line histogram) and Vβ8 (dotted line histogram) expression by double positive (DP) and single
positive CD8 and CD4 cells. Thin line histograms represent the negative controls. Numbers indicate the
percentage of cells. (>5 mice were analyzed independently).
Taken together, these results indicate that TCRβ chains from γδ cells can guide αβ T cell
development as efficiently as those from αβ T cells. This conclusion is based on the combined
results obtained with 6 TCRβ chains derived from γδ T cells and 6 from αβ Τ cells.
Reconstituted mice develop lethal autoimmune disease
In a next set of experiments, we wanted to test the functional capacity of αβ T cells generated
from TCRβ transduced Pax5/TCRβ  double deficient pro-B cells. However, these studies were
hampered by the fact that independently of the origin of the transduced TCRβ chains, from four
weeks after injection, all recipient mice showed weight loss and had diarrhea and practically all
died within 5 to 15 weeks after transplantation (Figure 4A).
Figure 4: CD3ε mice injected with TCRβ transduced Pax5/TCRβ double deficient pro B cells develop a
fatal autoimmune disease.
Figure 4A
Survival curve of CD3ε mice injected with empty vector transduced cells (, 12 mice), γδ T cell derived
TCRβ transduced cells ( , 15 mice) and αβ T cell derived TCRβ transduced cells ( , 15 mice) are
shown.
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Moreover, all mice had relatively high titers of IgG anti-nuclear autoantibodies in their serum
(Figure 4B).
Figure 4B
IgG anti-nuclear autoantibody titer in CD3ε mice injected with γδ T cell derived TCRβ transduced cells
(groups A-C,,,_) and αβ T cell derived TCRβ transduced cells (groups D-F,, ,) are depicted.
Histological analysis revealed pathological signs resembling inflammatory bowel disease of the
large intestines (Figure 4C) and marked leukocyte infiltrations in the lungs (Figure 4D).
Figure 4 C-D
C and D. Shown are representative pictures of widespread lymphocytic infiltration in non-lymphoid organs
of CD3ε mice injected with TCRβ transduced Pax5/TCRβ double deficient pro B cells. Picture in C is a
photograph of a H+E stained section of the lower colon (magnification x240). Picture D is a photograph of
a H+E stained section of the lung (magnification x240).
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No such signs of disease were observed among mice that had received Pax5/TCRβ double
deficient pro-B cells transduced with the empty vector. Thus, the presence of αβ T cells
developing from the TCRβ-transduced Pax5/TCRβ  double deficient pro-B cells seemed to be
the cause of this disease. This was despite the fact that T cells in mice reconstituted with pro-B
cells expressing TCRβ chains from either γδ or αβ cells contained FoxP3+ cells (not shown).
Recently, we showed that sublethally-irradiated C57Bl/6 RAG-2 deficient mice reconstituted with
T cell-depleted wild type syngeneic bone marrow developed a similar type of disease (Benard et
al., 2006). In that study, we also demonstrated that the disease induction could be prevented by
the co-transplantation of naturally-arising regulatory T (Treg) cells (Benard et al., 2006). To test
whether naturally-arising regulatory T cells could also prevent the development of the disease in
CD3ε-deficient recipients, mice were injected with a mixture of 2 x105 sorted GFP+ Treg cells
from FoxP3 knock-in mice and 5 x 106 TCRβ-transduced Pax5/TCRβ  double deficient pro-B
cells. As in the previous experimental system, co-injection of Treg cells protected the mice from
developing lethal autoimmune disease. Thus, mice containing co-injected Treg did not show
weight loss, had no diarrhea and did not have elevated IgG anti nuclear autoantibody titers in
their serum. At 8 weeks after injection, these mice were analyzed for the presence of T cells in
the periphery. In the spleen of all injected mice, 10 – 20 % cells were GFP positive and
expressed TCRVβ, in this case Vβ8, introduced into injected proB cells and the vast majority
expressed an αβ TCR. In corollary, GFP+ Vβ8-, i. e. cells derived from the injected Treg, were
undetectable (not shown). The lymph nodes contained 50-60% GFP+, αβ TCR+ T cells. An
example of such CD3ε-deficient mice injected with Pax5/TCRβ  double deficient pro-B cells
expressing a Vβ8 TCR chain from either a αβ  or γδ T cell are shown in Figures 5A and 5B
respectively. In the first mouse (Figure 5A) 53% of lymph node cells were GFP positive and
67.5% GFP+ cells expressed CD4 and 12% CD8. In all recipients, a low, but significant, number
of GFP+, CD4- CD8- cells were found, none of which expressed a TCR. Phenotypically, these
cells resembled the injected Pax5/TCRβ  double deficient pro-B cells and thus most likely were
cells that had not homed to the thymus and did not differentiate into T cells. Both GFP+ CD4 and
CD8 cells expressed an αβ TCR that used in this case the Vβ8 TCR chain (Figure 5A).
Therefore, these peripheral GFP+ T cells were derived from the transduced cells and not from a
contamination in the co-injected Treg population.
Figure 5. Phenotype and function of peripheral T cells derived from TCRβ transduced PAX5/TCRβ double
deficient proB cells when mice were co-injected with 2x105 polyclonal Treg cells.
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Figure 5A
GFP, CD4, CD8 and TCR expression by lymph-node cells of a CD3ε-deficient mouse at 8 weeks after
injection of PAX5/TCRβ double deficient pro B cells transduced with a Vβ8 using TCRβ chains derived
from αβT cells. The CD4-CD8 dot plot represents GFP positive cells. The histograms show αβ TCR (bold
line) and Vβ8 (dotted line) expression on gated CD8 and CD4 cells. Thin line histograms represent the
negative controls. Numbers represent the percentage of one representative mouse among 5-10 analyzed.
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Figure 5B
GFP, CD4, CD8 and TCR expression by lymph node cells of a CD3ε-deficient mouse at 8 weeks after
injection of PAX5/TCRβ double deficient proB cells transduced with a Vβ8 using TCRβ chains derived
from γδ T cells. The CD4-CD8 dot plot represents GFP positive cells. The histograms show αβ TCR (bold
line) and Vβ8 (dotted line) expression on gated CD8 and CD4 cells. Thin line histograms represent the
negative controls. Numbers in quadrants represent the percentage of one representative mouse among
5-10 analyzed.
Figure 5B shows the equivalent staining from a CD3ε-deficient mouse reconstituted with cells
transduced with a γδ T cell-derived Vβ8 TCR chain. In this mouse, 54% of cells were GFP+ with
53.8% GFP+ cells expressing CD4 and 40.9% expressing CD8. Again, all CD4 and CD8 cells
expressed a Vβ8 αβTCR (Figure 5B).
αβ T cells in reconstituted mice are functional
To address the functionality of these αβ T cells, their responsiveness to anti-CD3ε antibody
activation was measured. Figure 5C shows the results of such an experiment. Thus T cells
obtained from mice reconstituted with cells transduced with αβ or γδ-derived TCRβ chains
responded equally well and similar to T cells derived from wild type Bl/6 mice, thereby indicating
that these T cells were fully functional.
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Figure 5C
3H-thymidine incorporation upon anti-CD3 stimulation. Groups A-C are MACS purified T cells from CD3ε-
deficient mice injected with PAX5/TCRβ double deficient proB cells transduced with different TCRβ
chains derived from γδ T cells. Groups D-F are MACS purified T cells from CD3ε-deficient mice injected
with PAX5/TCRβ double deficient proB cells transduced with different TCRβ chains derived from αβ T
cells. Group G represents T cells derived from wild type B6 mice. White columns show the amount of 3H-
thymidine incorporated in absence anti-CD3 stimulation.
In vitro activation of ex vivo isolated T cells derived from P5TB cells transduced with different TCRβ’s
In order to test whether these T cells were also able to induce T cell dependent humoral
immune response, various groups of mice were injected with NIP-Ova in alum and 14 days
later, the specific IgG anti-NIP titers determined. Serum taken at day 7 before immunization was
used as a negative control and serum from identically immunized Bl/6 mice as a positive control.
CD3ε deficient mice in which the T cell compartment was reconstituted with cells expressing
TCRβ chains from either γδ or αβ T cells had IgG anti-NIP titers 3 -10 fold above control levels
(Figure 5D). In fact, in every individual mouse, the titer was higher after immunization, indicating
that these T cells could provide help for a humoral response. However, the anti-NIP titers in the
reconstituted mice were 5-10-fold lower than in wild type Bl/6 mice (Figure 5D). This latter result
most likely reflects the oligoclonality of the T cell repertoire generated in these reconstituted
mice restricted as it is by the expression of a single TCRβ chain. Importantly, the anti-NIP titers
of CD3ε-deficient mice reconstituted with Treg alone were not significantly different from non-
reconstituted CD3ε-deficient mice (data not shown).
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Figure 5D
Depicted are IgG anti-NIP titers at 7 days before (filled symbols) and 14 days after NIP-Ova immunization
(non-filled symbols). A ( ,  ) shows wild type B6 mice (n=4), B ( ,  ) shows titers found in mice
injected with PAX5/TCRβ double deficient proB cells transduced with different TCRβ chains derived from
γδ T cells (n=12) and C (, ) shows titers found in mice injected with PAX5/TCRβ double deficient proB
cells transduced with different TCRβ chains derived from αβ T cells (n=13).
Discussion
Although it has been known for many years that γδ T cells can express a TCRβ chain (Wilson
and MacDonald, 1998), the reason why these cells did not end up in the αβ T cell lineage is still
obscure. Using a novel strategy for reconstituting the T cell compartment of recipient mice with
cells expressing individual TCRβ chains, the data presented here clearly and formally
demonstrate that TCRβ chains isolated from γδ T cells can take part in αβ T cell lineage
development and that the resulting mature T cells are fully functional.
Previously, we have shown that for developing B cells, not all expressed IgH chains could pair
with the surrogate light chain molecules λ5 and VpreB to form a pre BCR (ten Boekel et al.,
1997). In an analogous fashion, one could have imagined that for T cell development, not all the
TCRβ chains would be able to pair with preTα and be able to form a pre TCR. This might have
been particularly the case for TCRβ chains expressed by γδ T cells.  However, the data
presented herein strongly argue against this. All the TCRβ chains derived from γδ T cells used
in this study were as efficient in the generation of αβ T cells as those derived from αβ T cells.
The fact that thymus cellularity in reconstituted mice was close to that of normal wild type mice
and much higher than that in preTα deficient mice (Fehling et al., 1995) strongly indicates that T
cell development in these mice went via a preTCR-driven proliferation stage. Previously it has
been shown that allelic exclusion of the TCRβ locus is mediated by the preTCR (Aifantis et al.,
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1997; Krotkova et al., 1997). Recently, using αβ T cell-derived transgenic TCRβ chains,
Ferrero et al (Ferrero et al., 2007) have analyzed TCRβ allelic exclusion specifically in γδ T
cells of both wild type and preTα deficient mice. They clearly demonstrated that in wild type γδ T
cells, expression of a TCRβ transgene resulted in allelic exclusion of the endogenous TCRβ
locus, whereas on a preTα deficient genetic background, they did not. This result also indicates
indirectly that TCRβ chains expressed by γδ T cells can form a preTCR.
At least 3 different scenarios could be imagined to explain why TCRβ-expressing γδ T cells can
nevertheless develop. First, γδ T cells that have been generated and selected and therefore
committed to the γδ lineage could still rearrange and express a TCRβ chain, which in this case
might be inert. Whether such a scenario is feasible is rather questionable since these cells
would have to still express the various enzymes required for the rearrangement after selection
and commitment. That the TCRβ chains isolated from γδ cells seem to be fully functional also
makes this scenario unlikely.
Second, γδ T cells expressing a TCRβ chain might have developed from a precursor that did not
express preTα and thus, despite expressing TCRβ protein, were unable to form a pre TCR. The
preTα “knock-in” Cre-reporter mouse recently described by the Fehling group (Luche et al.,
2007) would be an ideal tool with which to test whether γδ T cells are derived from precursors in
which the preTα gene was never expressed. Third, and to us the most appealing scenario,
TCRβ expressing γδ T cells are derived from cells that co-express the γδ TCR and the pre TCR.
The strength of TCR signal that these cells would receive via their γδ TCR would determine their
fate. Thus, and as recently shown (Haks et al., 2005; Hayes et al., 2005; Kreslavsky et al.,
2008), a strong signal would drive these cells into γδ T cell lineage in these cells would TCRβ+
while a weak or no signal would drive these cells into the αβ T cell lineage. When true, the
expression of a pre TCR would not automatically be an absolute sign for αβ T cell commitment
as previously has been suggested (Kreslavsky et al., 2008).
Expression of and signaling via the TCRβ/preTCR complex at the DN3 stage leads to a very
strong proliferative expansion and differentiation of cells to the next stage of development,
namely DN4 cells. This proliferation accounts for the fact that about 75% of the VDJ TCR
β rearrangements found in DN4 cells are in frame (Dudley et al., 1994; Kisielow and von
Boehmer, 1995; von Boehmer, 2005). This process is also referred to as preTCR mediated β
selection (Dudley et al., 1994; Kisielow and von Boehmer, 1995; von Boehmer, 2005).
Mertsching et al. (Mertsching et al., 1997) determined the in frame/out of frame ratios of VDJ
TCRβ rearrangements in fetal thymic γδ T cells and found 42% of them to be in frame. Since
this is about the double of the percentage one would expect from a non-selected repertoire (i.e.
22.2% in frame) these authors concluded that some γδ T cells in the thymus were β selected.  A
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similar conclusion was reached by Wilson et al. (Wilson and MacDonald, 1998) by showing
that about twice as many thymic γδ T expressing a TCRβ were in cell cycle compared to those
that did not. However, it should be noted that pre TCR expression is not a requirement for γδ T
cell generation since TCRβ (Mombaerts et al., 1992) as well as preTa (Fehling et al., 1995)
deficient mice have normal, or even elevated, numbers of γδ T cells.
Another point worth mentioning is the finding that CD3ε-deficient mice transplanted with the
Pax5/TCRβ double deficient pro-B cells transduced with the empty vector generated decent
numbers of γδ T cells in the thymus whereas those injected with TCRβ chains derived from
either γδ or αβ T cells did not. These findings suggest that early expression of TCRβ chains
prevents γδ T cell development or makes it very inefficient (Gerber et al., 2004; von Boehmer et
al., 1988).
Recently, we showed that sublethally-irradiated RAG-2 and CD3ε deficient mice reconstituted
with wild type syngeneic bone marrow cells develop a fatal autoimmune disease whose
induction could be prevented by the co-transplantation of Treg cells (Benard et al., 2006). The
development of a similar type of disease is also observed here in mice injected with TCRβ
transduced cells and not with those transduced with the empty vector. Thus, the presence of αβ
T cells expressing the rather limited (only 1 TCRβ chain) T cell repertoire derived from these
transduced cells might not be responsible for causing this disease.  Also in this experimental
system the disease could be prevented by the co-injection of Treg cells. Despite reconstituted
mice containing FoxP3+ cells in both thymus and periphery, by themselves, they were incapable
of preventing the onset of autoimmunity. The crucial questions arising from these observations
are why in these chimeric settings are insufficient endogenous TReg generated and why should
there be a requirement for co-transfer of TReg to prevent autoimmunity? Thus far, we have not
been able to answer these questions. Nevertheless, by preventing the onset of autoimmune
disease, we have been able to address the functional activity of the T cells derived from the
TCRβ transduced cells. With respect to anti-CD3 stimulation, our findings demonstrate that they
are practically identical to T cells from wild type mice. Moreover, the T cells derived from TCRβ
transduced cells were also able to provide help for a T cell-dependent B cell response.
However, in these mice, antibody titers were 5 -10 fold lower than those observed in wild type
mice. This latter is most likely due to the fact that in the chimeric mice, TCR receptor diversity is
limited by the expression of a single TCRβ chain.
Previously the Pax5 deficient pro B cell system has successfully been used to analyze mutant
forms of the LAT adaptor in vivo (Ardouin et al., 2005). Herein, we have demonstrated that
TCRβ chains isolated from γδ T cells can very efficiently participate in αβ T cell development
and can give rise to functional T cells. Thus the reconstitution of mice with Pax5 deficient pro B
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cells expressing various genes is an easy, rapid and very powerful way to analyze the function
of such genes in T cell development in vivo.
Materials and Methods
Mice
C57Bl/6, CD3ε deficient (Malissen et al., 1995) and Foxp3/EGFP reporter (Wang et al., 2008)
mice were maintained in our own animal SPF facilities. Female mice were used at 6 to 12
weeks of age and all experiments were carried out according to Institutional guidelines. PAX5+/-
(Urbanek et al., 1994) and TCRβ-/- (Mombaerts et al., 1992) mice were bred at the former Basel
Institute for Immunology to generate PAX5-/- TCRb-/- double deficient mice.
TCRβ  chain cloning and vector construction
Full-length Vβ4, Vβ6 and Vβ8 using TCRβ cDNA’s were amplified from cDNA of sorted
lympnode γδ or αβ T cells using the following primers:
TCRβ-Vβ4-Fwd: Atagctgcagcctgtgtgacactgctatg
TCRβ-Vβ6-Fwd: atagctgcaggaaactccctccaaactatg
TCRβ-Vβ8-Fwd: Atcaagcttcatatcctagaggaagcatg
TCRβ-Cβ1-Rev: ataggatccatcttcacatctgacttcatga
TCRβ-Cβ2-Rev: Ataggatccataaaagtttgtctcaggaattt
Products were cloned into the pGem Teasy vector (Promega) after specific digestion with
restriction enzymes (bold characters above are introduced restriction sites digested with PstI for
Vβ4 and Vβ6 or HindIII for Vβ8 and BamHI for Cβ1 or Cβ2) and sequenced. In frame products
were subsequently cloned into the pMIG plasmid (Addgene plasmid 9044), allowing the bi-
cistronic expression of TCRβ together with green fluorescent protein (GFP). The retroviral
vectors were transfected into the Phoenix retroviral packaging line (ATCC Number: SD 3443).
Cell culture and retroviral infection
Pro B cells were derived from PAX5-/- TCRβ-/- double deficient mice and were grown on a
monolayer of γ-irradiated ST-2 stromal cells in IMDM supplemented with 5x10-5M β -
mercaptoethanol, 1mM glutamine, 0.03‰ (w/v) Primatone (Quest, Naarden, NL), 100U/ml
penicillin, 100 µg/ml streptomycin and 2% FCS and in the presence of recombinant IL-7. Cells
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were transferred every 3 days on a new layer of irradiated stromal cells. Pro-B cells were
retroviral transduced by spin-infection using standard procedures. Infections resulted in 10-
20% GFP positive cells. High GFP expressing cells were sorted using a FACS ARIA (BD
Biosciences) and expanded.
For anti-CD3 stimulation 96-well plates were coated with 50 µl PBS containing 5µg/ml anti-
CD3ε (clone: 2C11) overnight at 4 degree. After extensive washing 105 purified T cells were
added per well. T cells were purified by MACS according to the manufacturer’s instruction. After
3 days 1 µCi/well 3H-thymidine was added for the last 18 h prior to harvesting.
Reconstitution of CD3ε-/- mice
CD3ε-/- mice at 6-12 weeks of age were γ-irradiated (450 Gray) and 3-5 h thereafter i.v. injected
with 5x106 pro B cells and in some experiments with 2x105 Treg cells. Treg cells were obtained
from Foxp3/EGFP reporter mice by sorting.
Antibodies and flow cytometry
The following mAb’s labeled with various fluorochromes were purchased from BD Biosciences:
anti-CD4 (RM4-5), anti-CD8α (53-6.7), anti-TCRβ (H57-597), anti-γδTCR (GL3) and anti-Vβ8
(F23.1). Cell staining was performed as previously described (Rolink et al., 1996). Samples
were analyzed using a FACSCalibur (Becton Dickinson). For cell sorting a FACSAria was used
(Becton Dickinson).
Immune responses
Mice were immunized i.p. with 100µg NIP-Ova (Biosearch Technologies Inc., Novato, CA) in
alum. At day 14 after immunization the mice were bled and the serum IgG anti-NIP titer was
determined by ELISA as previously described (Schubart et al., 1996).
Histology
Organs were fixed in 4% paraformaldehyde and embedded in parafin. Sections of 3µm were
prepared and stained with hematoxylin/eosin.
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Supplementary data
Supplementary Figure 1. Gating strategy and post-sort analysis of LN derived αβ and γδ T cells.
Inguinal, axillary and brachial LN from 4-week old C57Bl/6 mice were pooled and cell suspensions
stained with APC-labeled anti-TCRαβ (H57) and PE-labeled anti-TCRγδ (GL3) prior to being sorted with a
FACS Aria (BD Biosciences). The upper panel shows a cytogram display of stained cells and the gates
used for sorting. Figures in % show the proportion of gated cells. Below are shown post-sort cytograms
indicating that the purity of sorted TCRαβ cells was 99.9% (left cytogram) and of TCRγδ cells 99.6% (right
cytogram) in both cases, contaminating cells were not of the opposite TCR specificity.
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Supplementary Figure 2. Expression of TCRβ chains by PAX5/TCRβ double deficient proB cells
abolishes TCRγδ expression.
Shown are cytogram displays of gated GFP+ thymocytes stained with the indicated markers from mice
reconstituted with PAX5/TCRβ double deficient proB cells transduced with either TCRβ-expressing (upper
panels), or empty-vector (lower panels). As shown in the middle panel, expression of a TCRβ chain
abolished TCRγδ expression. Results are from a representative mouse. Numbers in quadrants represent
the percent positive cells.
Supplementary Table I. Shown are the sequences and Vβ family names of six TCRβ chains
from either αβ or γδ sorted LN T cells used in this study for transduction of PAX5/TCRβ double
deficient proB cells. Above each sequence, is from the left to the right, the name of the given
clone, its αβ or γδ origin and Vβ family.
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12.3 alpha-beta V beta 4
ATGGGCTCCATTTTCCTCAGTTGCCTGGCCGTTTGTCTCCTGGTGGCAGGTCCAGTCGACCCGAAAATTATCCAGAAACC
AAAATATCTGGTGGCAGTCACAGGGAGCGAAAAAATCCTGATATGCGAACAGTATCTAGGCCACAATGCTATGTATTGGT
ATAGACAAAGTGCTAAGAAGCCTCTAGAGTTCATGTTTTCCTACAGCTATCAAAAACTTATGGACAATCAGACTGCCTCAA
GTCGCTTCCAACCTCAAAGTTCAAAGAAAAACCATTTAGACCTTCAGATCACAGCTCTAAAGCCTGATGACTCGGCCACAT
ACTTCTGTGCCAGCAGCCAGGAGGGGGGGGCCGGTGCAGAAACGCTGTATTTTGGCTCAGGAACCAGACTGACTGTTC
TTGAGGATCTGAGAAATGTGACTCCACCCAAGGTCTCCTTGTTTGAGCCATCAAAAGCAGAGATTGCAAACAAACAAAAG
GCTACCCTCGTGTGCTTGGCCAGGGGCTTCTTCCCTGACCACGTGGAGCTGAGCTGGTGGGTGAATGGCAAGGAGGTC
CACAGTGGGGTCAGCACGGACCCTCAGGCCTACAAGGAGAGCAATTATAGCTACTGCCTGAGCAGCCGCCTGAGGGTC
TCTGCTACCTTCTGGCACAATCCTCGAAACCACTTCCGCTGCCAAGTGCAGTTCCATGGGCTTTCAGAGGAGGACAAGTG
GCCAGAGGGCTCACCCAAACCTGTCACACAGAACATCAGTGCAGAGGCCTGGGGCCGAGCAGACTGTGGAATCACTTC
AGCATCCTATCATCAGGGGGTTCTGTCTGCAACCATCCTCTATGAGATCCTACTGGGGAAGGCCACCCTATATGCTGTGC
TGGTCAGTGGCCTGGTGCTGATGGCCATGGTCAAGAAAAAAAATTCCTGA
137.6 gamma-delta V beta 6
ATGAACAAGTGGGTTTTCTGCTGGGTAACCCTTTGTCTCCTTACTGTAGAGACCACACATGGTGATGGTGGCATCATTACT
CAGACACCCAAATTCCTGATTGGTCAGGAAGGGCAAAAACTGACCTTGAAATGTCAACAGAATTTCAATCATGATACAATG
TACTGGTACCGACAGGATTCAGGGAAAGGATTGAGACTGATCTACTATTCAATAACTGAAAACGATCTTCAAAAAGGCGAT
CTATCTGAAGGCTATGATGCGTCTCGAGAGAAGAAGTCATCTTTTTCTCTCACTGTGACATCTGCCCAGAAGAACGAGAT
GGCCGTTTTTCTCTGTGCCAGCAGGACTGGGGGGCAAGACACCCAGTACTTTGGGCCAGGCACTCGGCTCCTCGTGTTA
GAGGATCTGAGAAATGTGACTCCACCCAAGGTCTCCTTGTTTGAGCCATCAAAAGCAGAGATTGCAAACAAACAAAAGGC
TACCCTCGTGTGCTTGGCCAGGGGCTTCTTCCCTGACCACGTGGAGCTGAGCTGGTGGGTGAATGGCAAGGAGGTCCA
CAGTGGGGTCAGCACGGACCCTCAGGCCTACAAGGAGAGCAATTATAGCTACTGCCTGAGCAGCCGCCTGAGGGTCTC
TGCTACCTTCTGGCACAATCCTCGAAACCACTTCCGCTGCCAAGTGCAGTTCCATGGGCTTTCAGAGGAGGACAAGTGG
CCAGAGGGCTCACCCAAACCTGTCACACAGAACATCAGTGCAGAGGCCTGGGGCCGAGCAGACTGTGGAATCACTTCA
GCATCCTATCATCAGGGGGTTCTGTCTGCAACCATCCTCTATGAGATCCTACTGGGGAAGGCCACCCTATATGCTGTGCT
GGTCAGTGGCCTGGTGCTGATGGCCATGGTCAAGAAAAAAAATTCCTGA
31.1 alpha-beta V beta 6
ATGAACAAGTGGGTTTTCTGCTGGGTAACCCTTTGTCTCCTTACTGTAGAGACCACACGTGGTGATGGTGGCATCATTAC
TCAGACACCCAAATTCCTGATTGGTCAGGAAGGGCAAAAACTGACCTTGAAATGTCAACAGAATTTCAATCATGATACAAT
GTACTGGTACCGACAGGATTCAGGGAAAGGATTGAGACTGATCTACTATTCAATAACTGAAAACGATCTTCAAAAAGGCG
ATCTATCTGAAGGCTATGATGCGTCTCGAGAGAAGAAGTCATCTTTTTCTCTCACTGTGACATCTGCCCAGAAGAACGAG
ATGGCCGTTTTTCTCTGTGCCAGCAGTGGGGACACCTTGTACTTTGGTGCGGGCACCCGACTATCGGTGCTAGAGGATC
TGAGAAATGTGACTCCACCCAAGGTCTCCTTGTTTGAGCCATCAAAAGCAGAGATTGCAAACAAACAAAAGGCTACCCTC
GTGTGCTTGGCCAGGGGCTTCTTCCCTGACCACGTGGAGCTGAGCTGGTGGGTGAATGGCAAGGAGGTCCACAGTGGG
GTCAGCACGGACCCTCAGGCCTACAAGGAGAGCAATTATAGCTACTGCCTGAGCAGCCGCCTGAGGGTCTCTGCTACCT
TCTGGCACAATCCTCGAAACCACTTCCGCTGCCAAGTGCAGTTCCATGGGCTTTCAGAGGAGGACAAGTGGCCAGAGGG
CTCACCCAAACCTGTCACACAGAACATCAGTGCAGAGGCCTGGGGCCGAGCAGACTGTGGAATCACTTCAGCATCCTAT
CATCAGGGGGTTCTGTCTGCAACCATCCTCTATGAGATCCTACTGGGGAAGGCCACCCTATATGCTGTGCTGGTCAGTG
GCCTGGTGCTGATGGCCATGGTCAAGAAAAAAAATTCCTGA
146.1 gamma-delta V beta 8
ATGTCTAACACTGCCTTCCCTGACCCCGCCTGGAACACCACCCTGCTATCTTGGGTTGCTCTCTTTCTCCTGGGAACAAA
ACACATGGAGGCTGCAGTCACCCAAAGCCCAAGAAACAAGGTGGCAGTAACAGGAGGAAAGGTGACATTGAGCTGTAAC
CAGACTAATAACCACAACAACATGTACTGGTATCGGCAGGACACGGGGCATGGGCTGAGGCTGATCCATTATTCATATGG
TGCTGGCAGCACTGAGAAAGGAGATATCCCTGATGGATACAAGGCCTCCAGACCAAGCCAAGAGAACTTCTCCCTCATT
CTGGAGTTGGCTACCCCCTCTCAGACATCAGTGTACTTCTGTGCCAGCGGTGATGGGACAAACACAGAAGTCTTCTTTGG
TAAAGGAACCAGACTCACAGTTGTAGAGGATCTGAGAAATGTGACTCCACCCAAGGTCTCCTTGTTTGAGCCATCAAAAG
CAGAGATTGCAAACAAACAAAAGGCTACCCTCGTGTGCTTGGCCAGGGGCTTCTTCCCTGACCACGTGGAGCTGAGCTG
GTGGGTGAATGGCAAGGAGGTCCACAGTGGGGTCAGCACGGACCCTCAGGCCTACAAGGAAAGCAATTATAGCTACTG
CCTGAGCAGCCGCCTGAGGGTCTCTGCTACCTTCTGGCACAATCCTCGCAACCACTTCCGCTGCCAAGTGCAGTTCCAT
GGGCTTTCAGAGGAGGACAAGTGGCCAGAGGGCTCACCCAAACCTGTCACACAGAACATCAGTGCAGAGGCCTGGGGC
CGAGCAGACTGTGGGATTACCTCAGCATCCTATCAACAAGGGGTCTTGTCTGCCACCATCCTCTATGAGATCCTGCTAGG
GAAAGCCACCCTGTATGCTGTGCTTGTCAGTACACTGGTGGTGATGGCTATGGTCAAAAGAAAGAATTCATGA
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174.10 gamma-delta V beta 8
ATGTCTAACACTGCCTTCCCTGACCCCGCCTGGAACACCACCCTGCTATCTTGGGTTGCTCTCTTTCTCCTGGGAACAAG
TTCAGCAAATTCTGGGGTTGTCCAGTCTCCAAGATACATAATCAAAGGAAAGGGAGAAAGGTCCATTCTAAAATGTATTCC
CATCTCTGGACATCTCTCTGTGGCCTGGTATCAACAGACTCAGGGGCAGGAACTAAAGTTCTTCATTCAGCATTATGATAA
AATGGAGAGAGATAAAGGAAACCTGCCCAGCAGATTCTCAGTCCAACAGTTTGATGACTATCACTCTGAGATGAACATGA
GTGCCTTGGAGCTAGAGGACTCTGCCGTGTACTTCTGTGCCAGCTCTCTCTTAAGCTCCTATGAACAGTACTTCGGTCCC
GGCACCAGGCTCACGGTTTTAGAGGATCTGAGAAATGTGACTCCACCCAAGGTCTCCTTGTTTGAGCCATCAAAAGCAGA
GATTGCAAACAAACAAAAGGCTACCCTCGTGTGCTTGGCCAGGGGCTTCTTCCCTGACCACGTGGAGCTGAGCTGGTGG
GTGAATGGCAAGGAGGTCCACAGTGGGGTCAGCACGGACCCTCAGGCCTACAAGGAGAGCAATTATAGCTACTGCCTG
AGCAGCCGCCTGAGGGTCTCTGCTACCTTCTGGCACAATCCTCGAAACCACTTCCGCTGCCAAGTGCAGTTCCATGGGC
TTTCAGAGGAGGACAAGTGGCCAGAGGGCTCACCCAAACCTGTCACACAGAACATCAGTGCAGAGGCCTGGGGCCGAG
CAGACTGTGGAATCACTTCAGCATCCTATCATCAGGGGGTTCTGTCTGCAACCATCCTCTATGAGATCCTACTGGGGAAG
GCCACCCTATATGCTGTGCTGGTCAGTGGCCTGGTGCTGATGGCCATGGTCAAGAAAAAAAATTCCTGA
38.7 alpha-beta V beta 6
ATGAACAAGTGGGTTTTCTGCTGGGTAACCCTTTGTCTCCTTACTGTAGAGACCACACATGGTGATGGTGGCATCATTACT
CAGACACCCAAATTCCTGATTGGTCAGGAAGGGCAAAAACTGACCTTGAAATGTCAACAGAATTTCAATCATGATACAATG
TACTGGTACCGACAGGATTCAGGGAAAGGATTGAGACTGATCTACTATTCAATAACTGAAAACGATCTTCAAAAAGGCGAT
CTATCTGAAGGCTATGATGCGTCTCGAGAGAAGAAGTCATCTTTTTCTCTCACTGTGACATCTGCCCAGAAGAACGAGAT
GGCCGTTTTTCTCTGTGCCAGCAGTCGGGACTGGGGGGGCCCAGACACCCAGTACTTTGGGCCAGGCACTCGGCTCCT
CGTGTTAGAGGATCTGAGAAATGTGACTCCACCCAAGGTCTCCTTGTTTGAGCCATCAAAAGCAGAGATTGCAAACAAAC
AAAAGGCTACCCTCGTGTGCTTGGCCAGGGGCTTCTTCCCTGACCACGTGGAGCTGAGCTGGTGGGTGAATGGCAAGG
AGGTCCACAGTGGGGTCAGCACGGACCCTCAGGCCTACAAGGAGAGCAATTATAGCTACTGCCTGAGCAGCCGCCTGA
GGGTCTCTGCTACCTTCTGGCACAATCCTCGAAACCACTTCCGCTGCCAAGTGCAGTTCCATGGGCTTTCAGAGGAGGA
CAAGTGGCCAGAGGGCTCACCCAAACCTGTCACACAGAACATCAGTGCAGAGGCCTGGGGCCGAGCAGACTGTGGAAT
CATTTCAGCATCCTATCATCAGGGGGTTCTGTCTGCAACCATCCTCTATGAGATCCTACTGGGGAAGGCCACCCTATATG
CTGTGCTGGTCAGTGGCCTGGTGCTGATGGCCATGGTCAAGAAAAAAAATTCCTGA
22.2 alpha-beta V beta 6
ATGAACAAGTGGGTTTTCTGCTGGGTAACCCTTTGTCTCCTTACTGTAGAGACCACACATGGTGATGGTGGCATCATTACT
CAGACACCCAAATTCCTGACTGGTCAGGAAGGGCAAAAACTGACCTTGAAATGTCAACAGAATTTCAATCATGATACAATG
TACTGGTACCGACAGGATTCAGGGAAAGGATTGAGACTGATCTACTATTCAATAACTGAAAACGATCTTCAAAAAGGCGAT
CTATCTGAAGGCTATGATGCGTCTCGAGAGAAGAAGTCATCTTTTTCTCTCACTGTGACATCTGCCCAGAAGAACGAGAT
GGCCGTTTTTCTCTGTGCCAGCAGTATGGGGACAGGGGAGAATTCGCCCCTCTACTTTGCGGCAGGCACCCGGCTCACT
GTGACAGAGGATCTGAGAAATGTGACTCCACCCAAGGTCCCCTTGTTTGAGCCATCAAAAGCAGAGATTGCAAACAAACA
AAAGGCTACCCTCGTGTGCTTGGCCAGGGGCTTCTTCCCTGACCACGTGGAGCTGAGCTGGTGGGTGAATGGCAAGGA
GGTCCACAGTGGGGTCAGCACGGACCCTCAGGCCTACAAGGAGAGCAATTATAGCTACTGCCTGAGCAGCCGCCTGAG
GGTCTCTGCTACCTTCTGGCACAATCCTCGCAACCACTTCCGCTGCCAAGTGCAGTTCCATGGGCTTTCAGAGGAGGAC
AAGTGGCCAGAGGGCTCACCCAAACCTGTCACACAGAACATCAGTGCAGAGGCCTGGGGCCGAGCAGACTGTGGGATT
ACCTCAGCATCCTATCAACAAGGGGTCTTGTCTGCCACCATCCTCTATGAGATCCTGCTAGGGAAAGCCACCCTGTATGC
TGTGCTTGTCAGTACACTGGTGGTGATGGCTATGGTCAAAAGAAAGAATTCATGA
46.4 gamma-delta V beta 4
ATGGGCTCCATTTTCCTCAGTTGCCTGGCCGTTTGTCTCCTGGTGGCAGGTCCAGTCGACCCGAAAATTATCCAGAAACC
AAAATATCTGGTGGCAGTCACAGGGAGCGAAAAAATCCTGATATGCGAACAGTATCTAGGCCACAATGCTATGTATTGGT
ATAGACAAAGTGCTAAGAAGCCTCTAGAGTTCATGTTTTCCTACAGCTATCAAAAACTTATGGACAATCAGACTGCCTCAA
GTCGCTTCCAACCTCAAAGTTCAAAGAAAAACCATTTAGACCTTCAGATCACAGCTCTAAAGCCTGATGACTCGGCCACAT
ACTTCTGTGCCAGCAGCCAAGAACCAGCAGAAGTCTTCTTTGGTAAAGGAACCAGACTCACAGTTGTAGGATTGCGGCTT
TCCTATGCAAGCCACCACAGCTCTCTTACATCTCAGTGTAGGAGTGAATGTGGAACATCAGAGGATCTGAGAAATGTGAC
TCCACCCAAGGTCTCCTTGTTTGAGCCATCAAAAGCAGAGATTGCAAACAAACAAAAGGCTACCCTCGTGTGCTTGGCCA
GGGGCTTCTTCCCTGACCACGTGGAGCTGAGCTGGTGGGTGAATGGCAAGGAGGTCCACAGTGGGGTCAGCACGGACC
CTCAGGCCTACAAGGAGAGCAATTATAGCTACTGCCTGAGCAGCCGCCTGAGGGTCTCTGCTACCTTCTGGCACAATCC
TCGCAACCACTTCCGCTGCCAAGTGCAGTTCCATGGGCTTTCAGAGGAGGACAAGTGGCCAGAGGGCTCACCCAAACCT
GTCACACAGAACATCAGTGCAGAGGCCTGGGGCCGAGCAGACTGTGGGATTACCTCAGCATCCTATCAACAAGGGGTCT
TGTCTGCCACCATCCTCTATGAGATCCTGCTAGGGAAAGCCACCCTGTATGCTGTGCTTGTCAGTACACTGGTGGTGATG
GCTATGGTCAAAAGAAAGAATTCATGA
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68.5 gamma-delta V beta 6
ATGAACAAGTGGGTTTTCTGCTGGGTAACCCTTTGTCTCCTTACTGTAGAGACCACACATGGTGATGGTGGCATCATTACT
CAGACACCCAAATTCCTGATTGGTCAGGAAGGGCAAAAACTGACCTTGAAATGTCAACAGAATTTCAATCATGATACAATG
TACTGGTACCGACAGGATTCAGGGAAAGGATTGAGACTGATCTACTATTCAATAACTGAAAACGATCTTCAAAAAGGCGAT
CTATCTGAAGGCTATGATGCGTCTCGAGAGAAGAAGTCATCTTTTTCTCTCACTGTGACATCTGCCCAGAAGAACGAGAT
GGCCGTTTTTCTCTGTGCCAGCAGTATATGGACAGGGGGCGACTCCGACTACACCTTCGGCTCAGGGACCAGGCTTTTG
GTAATAGAGGATCTGAGAAATGTGACTCCACCCAAGGTCTCCTTGTTTGAGCCATCAAAAGCAGAGATTGCAAACAAACA
AAAGGCTACCCTCGTGTGCTTGGCCAGGGGCTTCTTCCCTGACCACGTGGAGCTGAGCTGGTGGGTGAATGGCAAGGA
GGTCCACAGTGGGGTCAGCACGGACCCTCAGGCCTACAAGGAGAGCAATTATAGCTACTGCCTGAGCAGCCGCCTGAG
GGTCTCTGCTACCTTCTGGCACAATCCTCGCAACCACTTCCGCTGCCAAGTGCAGTTCCATGGGCTTTCAGAGGAGGAC
AAGTGGCCAGAGGGCTCACCCAAACCTGTCACACAGAACATCAGTGCAGAGGCCTGGGGCCGAGCAGACTGTGGGATT
ACCTCAGCATCCTATCAACAAGGGGTCTTGTCTGCCACCATCCTCTATGAGATCCTGCTAGGGAAAGCCACCCTGTATGC
TGTGCTTGTCAGTACACTGGTGGTGATGGCTATGGTCAAAAGAAAGAATTCATGA
80.2 gamma-delta V beta 6
ATGAACAAGTGGGTTTTCTGCTGGGTAACCCTTTGTCTCCTTACTGTAGAGACCACACATGGTGATGGTGGCATCATTACT
CAGACACCCAAATTCCTGATTGGTCAGGAAGGGCAAAAACTGACCTTGAAATGTCAACAGAATTTCAATCATGATACAGTG
TACTGGTACCGACAGGATTCAGGGAAAGGATTGAGACTGATCTACTATTCAATAACTGAAAACGATCTTCAAAAAGGCGAT
CTATCTGAAGGCTATGATGCGTCTCGAGAGAAGAAGTCATCTTTTTCTCTCACTGTGACATCTGCCCAGAAGAACGAGAT
GGCCGTTTTTCTCTGTGCCAGCAGGCGACTGGGGGGGACGGATTATGAACAGTACTTCGGTCCCGGCGCCAGGCTCAC
GGTTTTAGAGGATCTGAGAAATGTGACTCCACCCAAGGTCTCCTTGTTTGAGCCATCAAAAGCAGAGATTGCAAACAAAC
AAAAGGCTACCCTCGTGTGCTTGGCCAGGGGCTTCTTCCCTGACCACGTGGAGCTGAGCTGGTGGGTGAATGGCAAGG
AGGTCCACAGTGGGGTCAGCACGGACCCTCAGGCCTACAAGGAGAGCAATTATAGCTACTGCCTGAGCAGCCGCCTGA
GGGTCTCTGCTACCTTCTGGCACAATCCTCGAAACCACTTCCGCTGCCAAGTGCAGTTCCATGGGCTTTCAGAGGAGGA
CAAGTGGCCAGAGGGCTCACCCAAACCTGTCACACAGAACATCAGTGCAGAGGCCTGGGGCCGAGCAGACTGTGGAAT
CACTTCAGCATCCTATCATCAGGGGGTTCTGTCTGCAACCATCCTCTATGAGATCCTACTGGGGAAGGCCACCCTATATG
CTGTGCTGGTCAGTGGCCTGGTGCTGATGGCCATGGTCAAGAAAAAAAATTCCTGA
86.4 alpha-beta V beta 8
ATGTCTAACACTGCCTTCCCTGACCCCGCCTGGAACACCACCCTGCTATCTTGGGTTGCTCTCTTTCTCCTGGGAACAAA
ACACATGGAGGCTGCAGTCACCCAAAGCCCAAGAAACAAGGTGGCAGTAACAGGAGGAAAGGTGACATTGAGCTGTAAT
CAGACTAATAACCACAACAACATGTACTGGTATCGGCAGGACACGGGGCATGGGCTGAGGCTGATCCATTATTCATATGG
TGCTGGCAGCACTGAGAAAGGAGATATCCCTGATGGATACAAGGCCTCCAGACCAAGCCAAGAGAACTCCTCCCTCATT
CTGGAGTTGGCTACCCCCTCTCAGACATCAGTGTACTTCTGTGCCAGCGGTGATAACAATCAAAACACCTTGTACTTTGG
TGCGGGCACCCGACTATCGGTGCTAGAGGATCTGAGAAATGTGACTCCACCCAAGGTCTCCTTGTTTGAGCCATCAAAA
GCAGAGACTGCAAACAAACAAAAGGCTACCCTCGTGTGCTTGGCCAGGGGCTTCTTCCCTGACCACGTGGAGCTGAGCT
GGTGGGTGAATGGCAAGGAGGTCCACAGTGGGGTCAGCACGGACCCTCAGGCCTACAAGGAGAGCAATTATAGCTACT
GCCTGAGCAGCCGCCTGAGGGTCTCTGCTACCTTCTGGCACAATCCTCGAAACCACTTCCGCTGCCAAGTGCAGTTCCA
TGGGCTTTCAGAGGAGGACAAGTGGCCAGAGGGCTCACCCAAACCTGTCACACAGAACATCAGTGCAGAGGCCTGGGG
CCGAGCAGACTGTGGAATCACTTCAGCATCCTATCATCAGGGGGTTCTGTCTGCAACCATCCTCTATGAGATCCTACTGG
GGAAGGCCACCCTATATGCTGTGCTGGTCAGTGGCCTGGTGCTGATGGCCATGGTCAAGAAAAAAAATTCCTGA
99.1 alpha-beta V beta 8
ATGTCTAACACTGCCTTCCCTGACCCCGCCTGGAACACCACCCTGCTATCTTGGGTTGCTCTCTTTCTCCTGGGAACAAA
ACACATGGAGGCTGCAGTCACCCAAAGCCCAAGAAACAAGGTGGCAGTAACAGGAGGAAAGGTGACATTGAGCTGTAAT
CAGACTAATAACCACAACAACATGTACTGGTATCGGCAGGACACGGGGCATGGGCTGAGGCTGATCCATTATTCATATGG
TGCTGGCAGCACTGAGAAAGGAGATATCCCTGATGGATACAAGGCCTCCAGACCAAGCCAAGAGAACTTCTCCCTCATT
CTGGAGTTGGCTACCCCCTCTCAGACATCAGTGTACTTCTGTGCCAGCGGTGATGCTTATTCTGGAAATACGCTCTATTTT
GGAGAAGGAAGCCGGCTCATTGTTGTAGAGGATCTGAGAAATGTGACTCCACCCAAGGTCTCCTTGTTTGAGCCATCAAA
AGCAGAGATTGCAAACAAACAAAAGGCTACCCTCGTGTGCTTGGCCAGGGGCTTCTTCCCTGACCACGTGGAGCTGAGC
TGGTGGGTGAATGGCAAGGAGGTCCACAGTGGGGTCAGCACGGACCCTCAGGCCTACAAGGAGAGCAATTATAGCTAC
TGCCTGAGCAGCCGCCTGAGGGTCTCTGCTACCTTCTGGCACAATCCTCGCAACCACTTCCGCTGCCAAGTGCAGTTCC
ATGGGCTTTCAGAGGAGGACAAGTGGCCAGAGGGCTCACCCAAACCTGTCACACAGAACATCAGTGCAGAGGCCTGGG
GCCGAGCAGACTGTGGGATTACCTCAGCATCCTATCAACAAGGGGTCTTGTCTGCCACCATCCTCTATGAGATCCTGCTA
GGGAAAGCCACCCTGTATGCTGTGCTTGTCAGTACACTGGTGGTGATGGCTATGGTCAAAAGAAAGAATTCATGA
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Part IV: T cell mediated tolerance in double transgenic mice co-
expressing OVA specific TCR and OVA as agonistic antigen.
Introduction
As reported earlier, T cell tolerance is mediated through diverse mechanisms at different levels.
In the thymus, central tolerance is achieved through negative selection and regulatory T cell
development. In the periphery it is the result of a combination of effects, namely induction of
apoptosis, activation induced cell death, regulatory T cell mediated suppression and anergy.
Models of choice for studying T tolerance are double transgenic mice expressing a given
antigen and a TCR specific for this same antigen. The choice of the promoter used in transgenic
constructs allows for the restriction of antigen expression in specific cell subsets and therefore
for the study of different mechanisms of tolerance. These models enable to follow Ag specific T
cells fate, tolerance or autoimmunity in the periphery being the direct read out in these double
transgenic mice.
Despite strong negative selection, CD11c-HA x TCR-HA mice suffer severe systemic auto-
immunity and hyper-inflammation symptoms start at 3 weeks of age (Figure 1A). Most of them
consequently died about 5 weeks after birth (Figure 1B). On the opposite KLC-HAxTCR-HA
double transgenic mice display no detectable antinuclear auto-antibodies (ANA).
Figure 27: CD11c-HAxTCR-HA mice suffer from systemic autoimmunity.
A. IgG ANA titers in serum of TCR-HA and HA double transgenic mice. When comparing different
groups of double transgenic mice expressing specifically HA in various cell types, only the mice
expressing HA in the DCs population and expressing HA specific TCR, suffer from autoimmune
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disease. They display very high titer of ANA. In contrast the level of ANA in KLC-HAxHA-TCR
mice is in the normal range of a wild type mouse. Those mice are protected from autoimmunity.
B. CD11c-HAxTCR-HA mice succumb to systemic autoimmunity starting at 5 weeks of age. The
presence of antinuclear auto-antiodies, extensive lymphocytic infiltration and arthritis leads to
rapid death of these double transgenic mice.
When CD11c-HA mice were crossed with TCR-HA mice, DCs express HA in the thymus and
induce negative selection of the T cells expressing HA specific TCR.
However a specific population of T cells was able to escape negative selection thanks to TCR
editing, by expressing on their surface a second TCR α  chain while down regulating
autoreactive alpha chain.
After being positively selected, these dual TCR expressing T cells reach the periphery where
they express on their surface two different TCRs, one of the two being autoreactive.
The encounter with self-antigen, namely HA presented by DCs in the periphery, leads to their
proliferation and triggers effector functions. As a consequence, mice die of systemic
autoimmunity (Figure 2).
Figure 2: Theoretical model of T cell mediated autoimmunity development in CD11c-HAxTCR-HA mice.
When HA is presented by thymic DCs, the majority of HA specific T cells are eliminated by negative
selection. However the few T cells undergoing receptor editing, down regulate transgenic α chain. Hence
they are able to escape negative selection and are responsible for autoimmunity in the periphery.
On the contrary, double transgenic mouse models, where agonist antigen is presented by
TECs, have been reported to have an increase in Treg population (Jordan et al., 2001). This led
to the conclusion that interaction of a T cell with its agonist antigen presented by radio-resistant
TECs leads to Treg development. As an example, KLC-HA x TCR-HA showed sharp increase of
regulatory T cells, mice stayed healthy and did not show any sign of autoimmunity (Figure 3).
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Figure 3: Theoretical model of Regulatroy T cell development in KLC-HAxTCR-HA mice.
In the alternative model where HA is expressed under the control of KLC promoter, thymic epithelial cells
present the neo self-antigen to developing T cells thanks to promiscuous gene expression. This is
supposed to drive HA specific TCR cells towards regulatory T cells development as reported in several
other similar studies. In fact HA specific T cells can be found in higher proportion in the periphery where
they have been shown to exert their suppressive function on effector HA specific T cells as shown on the
graph. Autoimmunity in these mice is thought to be prevented by the higher proportion of regulatory T
cells.
Following these observations two working hypotheses were proposed, the first one being that
expression of HA by DCs promotes development of dual TCR expressing T cells responsible for
autoimmunity, whereas when HA is presented by TECs, Tregs development is favoured and
autoimmunity is prevented.
However the question still remains whether this phenomenon is specific to the HA system or if it
can be generalized to any other neo-self antigen expression system. To resolve this issue, we
generated double transgenic mice according to the same principle but using a different antigen
namely chicken ovalbumin (OVA) as an intracellular protein antigen.
We generated for this purpose two different transgenic mouse strains expressing chicken OVA
cDNA under the control of CD11c and KLC promoter, restricting expression to DCs and B cells
respectively. We crossed these mice with OT1 and OT2 mice, carrying a transgenic TCR
specific for OVA, respectively MHC-I and MHC-II restricted.
The generation of transgenic mice CD11c-OVA and KLC-OVA
We proposed to study tolerance under different conditions where OVA antigen expression is
restricted to particular cell types. For this purpose we used two different DNA plasmid constructs
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generated to direct Ova cDNA transcription by cell specific promoters, namely CD11c
promoter to target expression of antigen to DCs and KLC promoter to target OVA expression
to B cells.
Cloning of chicken ovalbumin cDNA
The chicken ovalbumin cDNA used for all constructs is a 1.8Kb digested out with EcoRI
restriction enzyme from the pAc-Neo-Ova vector, a gift from Dr. M.J. Bevan (Moore et al.,
1988). The cDNA encode for a soluble cytosolic protein of 385 amino acids (AA) with a
molecular weight of 43kDa, OVA protein contains one disulfide bond and carries two major T
cell epitopes encoded by AA258-265 recognised by MHC-I restricted CD8+ T cells of OT1 mice and
AA323-339 recognised by MHC-II restricted T cells of OT2 mice (Figure 2).
Figure 28: Restriction map of pAc-neo-Ova.
The complete Ova cDNA was subcloned into the mammalian expression vector pHI3APr-l-neo at the
BamHI and Hindlll sites, under control of the human 6-actin promoter. This plasmid also contains the
neomycin resistance gene, under control of the SV40 promoter, to provide a selectable marker for
transfection. (Adapted from (Moore et al., 1988).
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Figure 29: Ova sequence
In red is shown the open reading frame amino acid (AA) sequence corresponding to the OVA protein.
Two cysteins engaged in a disulfide bond are shown in brown and OT1 and OT2 epitope AA sequence is
displayed respectively in blue and green.
Cloning of the CD11c promoter-Ova DNA construct
Detection of the CD11c β2 integrin by mAb N418 has pointed out that its expression was
restricted to mouse dendritic cells (Agger et al., 1990; Metlay et al., 1990). It is thought to be the
most faithful molecule for dendritic cells and its corresponding promoter is considered to drive
expression with a high specificity to dendritic cells of various tissues including spleen and
thymus.
We used the pBSK(-)-CD11c promoter-HA construct  originally obtained from Dr T. Brocker
from which we cloned out HA sequence by using EcoRI sites. Ova cDNA was removed from the
pAC-Neo-Ova vector from Michael Bevan by EcoRI mediated restriction digest and then
inserted into pBSK(-)-CD11c promoter vector.
The pBSK(-)-CD11c promoter vector contains a long sequence containing 5900bp located
upstream the CD11c start codon providing all the promoter elements (Brocker et al., 1997). It
includes also a rabbit β -globin cDNA expression cassette containing splicing sites and
polyadenylation signal generally used to stabilize and prevent the degradation of the cDNA of
interest (Cavener and Ray, 1991). The Ova cDNA sequence was inserted into this cassette at
the EcoRI site as it was reported to support productive DNA expression (Kouskoff et al., 1993).
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Figure 30: pBSK(-)-CD11c promoter-OVA
In green is shown OVA cDNA sequence surrounded by β-globin cassette in red. Enzyme restriction sites
are indicated in black.
The linear DNA fragment used to generate transgenic mice was obtained by XhoI/NotI
restriction digest and used to transform ES cells injected into blastocyst of Bl/6 mice.
Cloning of the KLC promoter-Ova DNA construct
The β-globin cassette was cloned out of the CD11c promoter construct, a pBSK(-) backbone by
PstI/ClaI restriction digest. This 1.2kb fragment was inserted into a PstI/ClaI digested pBSK(+)
backbone vector resulting in pBSK-β-globin cassette vector. This vector was digested with
EcoRI and into that site the OVA fragment, isolated also by EcoRI from pAC-Neo-Ova, was
inserted.
The KLC promoter and H.C enhancer representing a fragment of 2kb was cloned out of the
vector pCD4-Hg1 CE1, kindly provided by Klaus Karjalainen, by a EcoRI/XbaI restriction digest.
This fragment was inserted into a pBSK(+) copy digested by the same enzymes, EcoRI and
XbaI. This insertion provided the pBSK(+)-KLC-HC vector with new restriction enzyme sites for
EcoR5 and NotI, which were used to clone out the KLC promoter and H.C. enhancer fragment.
This fragment was then inserted into the pBSK-β-globin-Ova beforehand digested with NotI and
SmaI. EcoRV and SmaI are restriction enzymes generating blunt end DNA that allowed the
ligation of KLC promoter and H.C. enhancer fragment to pBSK-β-globin-OVA.
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Once again the linear DNA fragment used to generate transgenic mice was obtained by
XhoI/NotI restriction digest. Transgenic constructs were transfected into packaging cells and
tested for OVA expression in vitro.
Screening for the presence of Ova transgene in transgenic mice
Offsprings of foster mothers were analyzed for the presence of the OVA transgene. Hence, Ova
specific PCR on tail DNA revealed the mice that had integrated the transgenic construct into
their genome. The following primers specific for Ova were used: Ova upstream primer: 5’-
C A A T C C T G C C A G A A T A C T T G C - 3 ’  a n d  O v a  dowstream primer: 5’-
TCCATCTTCATGCGAGGTAA-3’ resulting in a PCR product of 554bp. As positive controls,
primers specific for β-actin were used. After 39 cycles (20s 94°C, 30s 55°C, 80s 72°C) amplified
DNA was detected on a 1.5% agarose gel containing ethidium bromide.
OT1 mice
OT1 mice were a kind gift of Ed Palmer. These mice were originally developed by Hogquist et Al
(Barnden et al., 1998; Hogquist et al., 1994). OT1 mice express a Vα2/Vβ5 TCR derived from
the Kb-restricted OVA257-264 specific T cell clone 149.2. This TCR recognizes the OT1 peptide
SIINFEKL in the context of H-2Kb.
OT1 mice display normal numbers of lymphocytes in the thymus and in the periphery. FACS
analysis in the thymus showed a bigger CD8 SP T cell population than WT mice; with a parallel
increase in CD4 SP T cell population (Figure 8). The expression of the specific Vα2/Vβ5 TCR
starts early at the DN stage for 95% of the DN cells and stays high throughout all stages of
thymic development. Surprisingly CD4 SP T cell subpopulation show also high expression of
both transgenic TCR chains and Va2+Vb5+ cell population represents up to 90% of CD4 SP T
cell population. In fact MHC-I restricted CD8SP T cells in OT1 mice are thought to engage
toward CD4SP development pathway (Barnden et al., 1998). DP T cells showed decreased
percentage of cells positive for Vα2/Vβ5, about 55% as well as decreased mean fluorescence
intensity of Vα2 and Vβ5. It has been previously reported that TCR expression level is lower in
DP and reaches its maximum expression level at SP stages.  A quarter of this DP population
does not express Vβ5 but is reduced by half at the following developmental stage of SP T cells.
It is noteworthy that among the CD4 SP T cell population a significant percentage of cells, about
7%, undergo TCR editing and downregulate Vα2 chain. This phenomenon is not observed in
the CD8 SP population. Eventually the highest expression level of Vα2/Vβ5 is found at the CD8
SP stage with 86% of cells displaying high mean fluorescence intensity.
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Figure 31: FACS analysis of thymic subpopulations from a Bl/6 OT1 mouse
The middle panel shows CD4 and CD8 expression on total thymocytes and Vβ5 and Vα2 expression on
gated CD4 SP T cells (upper left), gated DP (upper right), gated DN (lower left) and gated CD8 SP (lower
right). Numbers shown in each corner of the dot plots represents percentage of cells for each quadrant.
Eventually spleen and LN also showed normal numbers of lymphocytes compared to WT mice
but with considerable skewing towards CD8 T cell population unlike in the thymus (Figure 6).
The CD8 T cell population is more than 10 fold higher than the CD4 T cell population with
almost 95% of cells being OVA specific. In contrast the CD4 T cell population is very small and
the 20% of Vα2+Vβ5+ within CD4+ T cell population might be considered as MHC-I restricted
although this has not been checked. Again a minority of T cells showed TCR editing, being Vβ5+
but Vα2-.
125
Figure 32: FACS analysis of a spleen of a Bl/6 OT1 mouse
The middle panel shows CD4 and CD8 expression on total splenocytes. Each CD4 and CD8
subpopulations are stained for Vβ5 and Vα2 on gated CD4+T cells (upper left) and gated CD8+ T cells
(lower right).
OT2 mice
OT2 mice were a kind gift of Hans Acha-Orbea. These mice were originally developed by
Barnden et Al (Barnden et al., 1998; Hogquist et al., 1994). OT2 mice on a Bl/6 background
express also Vα2 and Vβ5 TCR that pairs with the CD4 co-receptor. This TCR is specific for
OVA323-339 peptide: ISQAVHAAHAEINEAGR in the context of I-Ab MHC molecule.
These mice possess lower numbers of thymocytes, but lymphocyte numbers in the periphery
are comparable to WT mice. FACS analysis of the thymus show forced TCR transgene
expression already at the DN stage albeit at low level, this concerns only 8% of DN cells (Figure
7). The DP thymocyte population of OT2 mice display a higher percentage of cells expressing
the transgenic TCR, about 20%, but again with lower mean fluorescence intensity. Eventually
transgenic TCR expression reaches its strongest level in the SP CD4+ T cell population.
Vα2+Vβ5+ OVA specific T cells stand for 80% of the CD4+ SP cells in the thymus. There is a
significant skewing of T cell development towards CD4+ T cell population since the transgenic
TCR expressed by the majority of the T cells is MHC-II restricted, hence CD8+ T cell
compartment is very small and represents only about 1% of the whole thymic population.
Moreover about 50% of the CD8+ SP cells in these mice are Vα2+Vβ5+ suggesting that they are
MHC-II restricted as well.
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It is noteworthy that almost all SP CD4 T cell that are Vβ5 are also Vα2 positive whereas
about 2% of the Vα2+ CD4+ SP are not Vβ5 positive. Since allelic exclusion process is almost
perfect in the TCRβ locus it seems unlikely that these cells would have edited their TCRβ chain.
It is probable that those cells represent γ/δ T cells since Vα2 mAb is known to cross-react with
Vγ8 TCR chain. It has to be noted that the percentage of Vα2+ T cell in CD4 SP of a WT thymus
is about 12%.
Figure 33: FACS analysis of thymic subpopulations from a Bl/6 OT2 mouse
The middle panel shows CD4 and CD8 expression on total thymocytes and Vβ5 and Vα2 expression on
gated CD4 SP T cells (upper left), gated DP (upper right), gated DN (lower left) and gated CD8 SP (lower
right). Numbers shown in each corner of the dot plots represents the percentage of cells for each
quadrant.
In the spleen, the pronounced skewing toward CD4 T cell population is again particularly
evident (Figure 8). CD4 T cell population is nearly four times bigger than the CD8 T cell
population. The majority of CD4 T cells, namely more than 80%, are OVA specific TCR bearing
T cells that are Vα2+ and Vβ5+, whereas it is not the case for the CD8 population where less
than 20% are Vα2+ and Vβ5+. LN of OT2 mice show a very similar pattern of expression in the
same populations.
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It is noticeable that very few T cells in these mice undergo spontaneous TCR editing since
nearly all Vβ5+ are also Vα2+.
Figure 34: FACS analysis of a spleen of a Bl/6 OT2 mouse
The middle panel shows CD4 and CD8 expression on total splenocytes. Each CD4 and CD8
subpopulations are stained for Vβ5 and Vα2 on gated CD4+T cells (upper left), and gated CD8+ T cells
(lower right). Numbers shown in each corner of the dot plots represents the percentage of cells for each
quadrant.
Results
CD11c-OVAxOT1 and KLC-OVAxOT1
Single Ova transgenic mice were crossed with OT1 transgenic animals. Hence F1 mice were
screened by PCR for OVA expression (as described earlier) and by FACS analysis for OT1
phenotype by using Vα2 and Vβ5 antibody.
Thymus, spleen and LN from these double transgenic animals were analyzed by flow cytometry
in order to monitor OVA specific T cell fate. Two founders from each mouse line CD11c-OVA
(designed as F3 and F4) or KLC-OVA (designed as F1 and F2) were selected for good negative
selection. The following figures show data from one or the other founder, as representative for
each mouse line since their phenotype were very similar. Cell numbers of thymus and spleen
are shown in Figure 9. Mice were used between 6 to 11 weeks of age.
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Figure 35: Thymocyte and splenocyte numbers of double transgenic mice KLC-OVAxOT1 and CD11c-
OVAxOT1 compared with OVA single transegnic mice.
Here is shown mean and standard deviation of thymocyte and splenocyte numbers from 7 to 11 week old
mice, either single or double transgenic: OT1 (n=2); KLC-OVA (n=6); CD11c-OVAxOT1 (n=6); KLC-
OVAxOT1 (n=6); CD11c-OVAxOT1 (n=11).
Double transgenic mice displayed numbers of thymocytes that are similar to single transgenic
OT1 mice. However, thymocyte numbers of double transgenic mice are lower than those of WT
or single transgenic CD11c-OVA or KLC-OVA. This can be explained by the relative immuno-
deficiency of OT1 mice, a feature that is common to several TCR transgenic mouse models
(Hogquist et al., 1994). Spleen and LN cell numbers did not differ between single and double
transgenic mice (Figure 9 and data not shown).
FACS analysis of the different thymic and peripheral T cell subpopulations showed that strong
negative selection is going on in these double transgenic mice (Figure 10). Thus the CD8 SP
compartment in the thymus dropped from about 23% in OT1 mice to 2% in double transgenic
mice Moreover a 4 - 6 fold reduction of peripheral CD8 T cells was observed.
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Figure 36: FACS analysis of thymic and spleen T cell subpopulations of single and double transgenic
mice.
Organs of OT1, CD11c-OVAxOT1 and KLC-OVAxOT1 were removed, washed, stained with fluorescent
anti-CD4 and anti-CD8 mAb and analysed by FACS. The upper row shows thymus cells and the lower
row represents spleen cells. All graphs are gated on lymphocyte population. Numbers shown in each
corner of the dot plots represents the percentage of cells for each quadrant.
The CD4 T cell compartment was affected as well, albeit to a lesser extent.
Along with percentages, cell numbers of CD8 SP population of double trangenic mice are also
greatly decreased compared to OT1 single transgenic mice, this illustrates faithfully the negative
selection mediated by OVA presentation in the thymus
CD11c-OVAxOT2 and KLC-OVAxOT2
The cellularity of the thymus in both double transgenic CD11c-OVAxOT2 and KLC-OVAxOT2
mice did not strongly differ from the single OT2 transgenic mice and was only slightly reduced
compared to single transgenics CD11c-OVA and KLC-OVA of the same age. However CD4 SP
population was absent in CD11c-OVAxOT2 and KLC-OVAxOT2 indicating strong negative
selection in double transgenic mice. FACS analysis of thymocytes showed that the CD4 SP
population dropped about 7 to 9 fold in double transgenic mice. Moreover, in the periphery the
number of CD4+ T cells was found to be 5 to 8 fold lower in double transgenic mice than in
single OT2 mice and practically none of them expressed the OVA specific OT2 TCR (data not
shown).
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Figure 37: double transgenic mice CD11c-OVAxOT2 and KLC-OVAxOT2 showed strong negative
selection of CD4 T cells.
A. Thymocyte numbers of double transgenic mice KLC-OVAxOT2 and CD11c-OVAxOT2. Here is
shown mean and standard deviation of thymocyte numbers from 6 to 14 week old mice, either
single or double transgenic: OT2 (n=2); CD11c-OVA (n=6), KLC-OVA (n=6); CD11c-OVAxOT2
(n=16); KLC-OVAxOT2 (n=8).
B. FACS analysis of thymic and spleen subpopulations of single and double transgenic mice.
Organs of OT2, CD11c-OVAxOT2 and KLC-OVAxOT2 were removed, washed, stained with
fluorescent anti-CD4 and anti-CD8 mAb and analysed by FACS. The upper row shows thymus
cells and the lower row represents spleen cells. All graphs are gated on lymphocyte population.
Numbers shown in each corner of the dot plots represents the percentage of cells for each
quadrant.
.
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OT2 cells proliferate in vivo when encountering CD11c-OVA APCs
and KLC-OVA B cells.
Given the results of the in vitro mixed lymphocyte reaction, we hypothesized that OT2 T cells
adoptively transferred in double transgenic host would show an anergic phenotype as well.
Interestingly OT2 cells, stained beforehand with CFSE to follow their division, show a high
degree of proliferation in the periphery of the double transgenic hosts as soon as day 3 after
adoptive transfer. In CD11c-OVA founder 3 and 4 after 3 days, only about 5% and less than 1%
respectively were still CFSE high whereas in Bl/6 hosts the same population represented 75 to
80% in spleen and LN. Similar results were obtained when KLC-OVA transgenic animal were
used as host mice. There is no difference between the proliferative capacity in the spleen or in
the LN and very little differences found between founders. When Bl/6 hosts were adoptively
transferred with OT2 cells and immunized 24 hours later subcutaneously by footpad injection
with OVA in CFA as a positive control, no proliferation could be recorded as shown by the high
MFI of the CFSE profile of OT2 cells in these mice. It might be due to early time point of
analysis since high dilution of CFSE staining could be seen a day 6 in the same mice (data not
shown). When markers for activation were analysed by FACS and despite extensive
proliferation of OT2 cells in the periphery of double transgenic mice, we could only characterise
naïve status of these cells. As a conclusion OVA specific T cells in the periphery of double
transgenic mice are not anergic in vivo and even able to proliferate in the periphery. It might be
interesting to examine further these adoptively transferred mice to follow development of any
pathology on a long-term basis.
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Figure 38: OT2 adoptively transferred into CD11c-OVA and KLC-OVA hosts proliferate in the periphery.
OT2 lymph node cells were stained with CFSE and injected intraveinously of CD11c-OVA (F3 and F4) or
KLC-OVA (F1 and F2) or Bl/6 hosts (n=2-3 for each group). 24hrs later half of the Bl/6 mice were
immunized subcutaneously with OVA/CFA and on day 3 after adoptive transfer spleen and lymph node
cells were isolated, stained with fluorescent labelled mAb to perform FACS analysis and examined for
CFSE dilution. Here is shown lymphocytes gated on CD4+Vα2+Vβ5+ T cells OT2 cells.
Discussion
We have generated four different mouse strains expressing the ovalbumin antigen in specific
cell subsets along with MHC I or MHC II restricted TCR specific for ovalbumin, i.e CD11c-
OVAxOT1, KLC-OVAxOT1 and CD11c-OVAxOT2, KLC-OVAxOT2. These mice represent
models to study central as well as peripheral T cell tolerance. We have shown that all these
mice are tolerant and do not display any sign of autoimmunity unlike previously observed in a
similar HA model using the same promoters (Curti et Al.). Sharp reductions of OVA specific CD8
SP or OVA specific CD4 SP T cells respectively for OT1 and OT2 systems in the thymus of
double transgenic mice show that these populations were negatively selected and that negative
selection is almost complete in these mice. However a few autoreactive T cells escape negative
selection. In the periphery these OVA specific Vβ5+ Vα2+ T cells represent 0.1 to 1x106 cells
(data not shown). This number can be considered relatively low, however in a WT mouse the
frequency of peripheral T cells specific for a given peptide epitope has been evaluated as 0.5 to
1x10-5 which is 150 to 1500 times less than the number of OVA specific T cells in double
transgenic mouse. Despite the presence of a few OVA specific T cells in the periphery, their
numbers do not seem to be sufficient for triggering autoimmunity, since no antinuclear
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autoantibodies, splenomegaly or sign of arthritis could be detected. Similar to double
transgenic OVA mice CD11c-HAxTCR-HA mice previously developed in our laboratory show
practically complete negative selection. However, in contrast to CD11c-OVAxOT2 mice,
significant numbers of phenotypically activated T cells expressing the TCR clonotype can be
found in the periphery of CD11c-HAxTCR-HA. In addition the number of antigen specific T cells
varies between the HA and the OVA model, whereas 6.5+ TCR cells represent about 10% of the
CD4+ T cell peripheral population in CD11c-HAxTCR-HA, only 3% CD4+ T peripheral T cells are
Va2+Vb5+ cells. The difference between the two models may lie in the efficiency of antigen
presentation. Despite clear evidence of thymus presentation of OVA shown by nearly complete
negative selection, it might be hypothesized that OVA presentation in the periphery is
qualitatively or quantitatively different from HA and is by consequence not able to activate and
trigger proliferation of OVA specific T cells in the periphery. Our last experiment showing
proliferation of naïve OT2 cells after adoptive transfer into CD11c-OVA as well as KLC-OVA
mice disproves this last hypothesis. OVA in CD11c-OVA or KLC-OVA mice is efficiently
presented and is able to trigger proliferation of OVA specific T cells. However double transgenic
mice show limited proliferation of OVA specific T cells, one of the probable explanations for this
lack of response despite efficient OVA presentation is that OVA specific T cells in double
transgenic mice may display anergic properties.
The characterization of the anergic state of OVA specific T cells in double transgenic cells could
be further analysed by measuring the response of these cells to ex vivo restimulation with OVA
or in vivo immunization with antigen pulsed DCs. Because of the very low numbers of OVA
specific T cells in the periphery of double transgenic mice, this experiment is technically
challenging and could not be performed.
To account for the difference observed between the two systems, it is noteworthy that already
single transgenic mice, namely TCR-HA and OT2 mice are different. Whereas the first strain
display only 30 to 40% of clonotype positive CD4+ T cells in the periphery, the second possess
about 90% of OVA specific T cells in the periphery. The low frequency of clonotype positive T
cells in TCR-HA mice could be interpreted as a result of a low probability of pairing between the
α and the β chain of the HA-TCR. Indeed T cells from TCR-HA single transgenic show a high
occurrence of TCR editing which is more pronounced in double transgenic mice. Conversely
TCR editing seems to be a minor event in OVA double transgenic mice (data not shown). In fact
TCR editing is supposed to be responsible for the development of autoimmunity in CD11c-
OVAxTCR-HA mice, it allows HA-TCR T cells to escape thymic negative selection but give rise
to dual TCR expressing cells which get activated in the periphery. Due to stronger negative
selection and minimum TCR editing, a lower number of OVA specific T cells are found in the
periphery, in addition these cells display anergic properties.
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We have shown that Ova presentation in the periphery of CD11c-OVA as well as KLC-OVA
mice is sufficient for triggering proliferation of naïve OT2 cells. However this proliferation does
not lead to hyperinflammation in double transgenic mice. What could account for the anergy of
OVA specific T cells compared to activation of HA specific T cells?
The nature of the antigen might influence the degree of activation in the periphery and could
explain the discrepancies observed between the two models. Indeed OVA is a large protein of
about 45kDa expressed intracellularly in CD11c-OVA as well as in KLC-OVA double transgenic
mice. On the opposite HA is a highly immunogenic protein isolated from a virus and attached to
the membrane. Because of its intracellular location, OVA would be expected to be processed
and presented through MHC class I mediated presentation pathway to CD8 T cells. In addition it
has been shown that professional APCs can capture antigen as debris from apoptotic antigen
expressing cells by either receptor mediated endocytosis, pinocytosis or phagocytosis.
Eventually if OVA is released extracellulary, APCs could load surface MHC-II molecules with
OVA peptide. It is known that OVA specific T cells become anergic upon encounter with a
soluble form of OVA (Lohr et al 2004). That is why OVA specific ELISA test was developed to
detect any possible presence of OVA in the serum of those mice, but OVA concentration was
below detection threshold of the ELISA (data not shown).
The relevance of the use of these two systems could also be discussed, in fact all double
transgenic systems mentioned previously used MHC-II restricted TCR and MHC-II ligand as
agonist antigen. In our case, the expression of the entire OVA protein displaying two different
epitopes, each of them being the ligand for either MHC-I or MHC-II allowed to study tolerance of
both CD4 and CD8 T cells by using OT1 and OT2 mice. We could show that negative selection
happens in both CD8 and CD4 population.
Considering these elements it is assumed that OVA peptide presentation in the thymus would
be relatively low especially in KLC-OVAxOT2 mice. In fact it is known that MHC products and
MHC-peptide complexes densities are 10 to 100 times higher on DC than on other APCs like
TECs through promiscuous gene expression (Inaba). This could explain the slight difference
observed between negative selection in CD11c-OVAxOT2 and KLC-OVAxOT2 mice. However
both levels of expression either on DCs or on TECs are sufficient to induce strong degree of
negative selection.
The mechanisms of tolerance in the periphery have been well described for OVA as an agonist
antigen by Kawahata et Al. (ref). They showed that OVA specific T cells in OVA expressing
mice are able to proliferate in the periphery to a limited extent and get activated without
triggering inflammation. The presence of negative selection in both double transgenic systems
is a direct proof for OVA expression in the thymus, however it is possible that OVA expression
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in the periphery of those mice would be weaker, this has been suggested by in vitro mixed
lymphocyte reaction in single transgenic mice (data not shown). Although the level of Ova
presentation is sufficient to provoke proliferation in vivo as shown by CFSE dilution of OVA
specific T cells after adoptive transfer experiment, it might be too low to break tolerance and
instead would induce anergy.
Furthermore the discrepancy between HA and OVA systems might lie in the affinity of the TCR
to its specific antigen or in the antigen dose available. Indeed CD4+ T cell stimulation with high
antigen concentration or strong agonist peptides can bypass the need for costimulation, more
specifically for CD28 signal (Teh hs 1997). This might well be the case in the HA double
transgenic mice since HA is considered to bind to HA-specific TCR with very high affinity (jordan
2001). Although the affinity of OT1 T cells for OVA257-264 peptide/Kb is relatively high with a Kd of
about 6.5µM and the one of OT2 T cells for OVA323-339 peptide/Kb is thought to be lower, this
difference of affinity between the two models could account for the difference in their capacity of
activating T cells.
Eventually the HA system developed previously in our lab and the OVA system described here
present many dissimilarities and might not be fully comparable.
Current experiments are ongoing to breed our double transgenic mice on the RAG deficient
background; this would lead to the production of only OVA specific T cells. Our prediction is that
this would not however trigger autoimmunity in these mice. Another way to induce hyper
inflammation would be to inject mice with CPG or LPS and see if activation of APCs would be
able to induce response of OVA specific T cells. Finally long term adoptive transfer of naïve
OT1 and OT2 cells into CD11c-OVA and KLC-OVA will allow us to check whether autoimmunity
develops or not in OVA expressing host.
Materials and methods
Mice
CD11c-OVA and KLC-OVA mice were generated as indicated above. CD11c-OVA and KLC-
OVA mice as well as C57Bl/6 mice were maintained in our own animal SPF facilities. Female
mice were used at 6 to 12 weeks of age and all experiments were carried out according to
Institutional guidelines.
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Reagents and antibodies.
The following mAb were purchased from PharMingen (San Diego, USA): anti-CD25FITC (7D4),
FITC or biotin-conjugated anti-CD8α (53-6.7). Anti-CD4PE (RM4-5).
Flow cytometric analysis
Single-cell suspensions of thymus, spleen and lymph nodes were prepared in PBS
supplemented with 2% FBS and 0.2% sodium azide as described previously (Balciunaite et al.,
2005b). Cells were adjusted to 20–10 _ 106 cells/ml and 0.5–1 _ 106 cells incubated for 30 min
at 4°C with the indicated reagents at saturating concentrations as previously described. Stained
cells resuspended in PBS 2% FBS 0.2% azide were analyzed using a FACSCalibur (Becton
Dickinson) and data analyzed using FlowJo (Tree Star). Viable lymphoid cells were defined by a
combination of FSC, SSC.
Adoptive transfer
LN cell suspensions from 3 to 5 OT2 donor mice were prepared. After red blood cell lysis, LN
cells were washed, stained with 10µM CFSE for 5 min at room temperature, washed again and
resuspended in DMEM prior to i.v. injection. CD11c-OVA and KLC-OVA or Bl/6 recipient mice
received about 10x106 cells LN OT2 cells. Twenty-four hours later Bl/6 mice were immunized by
footpad injection with OVA/CFA. Three days later mice were killed and spleen and LN were
analyzed by FACS.
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Abbreviations
3D Three-dimensional
AA Amino acids
AIRE Autoimmune regulator
ANA Antinuclear autoantibody
APECED Autoimmune Polyendocrine Syndrome type 1
APC Antigen presenting cells
ATOC Adult thymic organ culture
BCL-2 B-cell lymphoma 2 anti-apoptotic protein
BCR B cell receptor
BIM BCL-2 interacting mediator
Bl/6 C57 BL6 mice
BM Bone marrow
BMT Bone marrow transplantation
BMdDCs Bone marrow derived dendritic cells
BSA Bovine serum albumin
cAMP Cyclic adenosine monophosphate
CBP CREB binding protein
CD Cluster of differentiation
CLP Common lymphoid progenitor
CMP Common myeloid progenitor
CMLP Common myeloid lymphoid progenitor
CMV Cytomegalovirus
CRP C reactive protein
CSF Colony stimulating factor
CTL Cytotoxic T lymphocyte
CTLA4 Cytotoxic T-lymphocyte antigen 4
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DC Dendritic cell
DETC Dendritic epidermal T cell
DMEM Dulbecco’s modified Eagle’s medium
DN Double negative
DP Double positive
DsRNA Double strand ribonucleic acid
EAE Experimental autoimmune encephalomyelitis
EBF Early B cell factor
ELISA Enzyme-linked immunosorbent assay
ELP Early lymphoid progenitor
ERK Extracellular signal-regulated kinase
ETP Early thymic progenitor
FACS Fluorescence-activated cell sorting
FBS Fetal bovine serum
FcεR1γ High-affinity IgE receptor
FGF Fibroblast growth factor
FLT3 Fms-related tyrosine kinase 3
FoxP3 Forkhead box P3
FTOC Fetal thymic organ culture
GAD67 Glutamic acid decarboxylase
GC Germinal center
GDP/GTP Guanosine di/tri-phosphate
GFP Green fluorescent protein
GITR Glucocorticoid-induced tumor necrosis factor receptor
GMP Granulocyte/macrophage progenitor
GRB2 Growth factor receptor-bound protein 2
GvHD Graft versus host disease
HA Hemagglutinin
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HSC Haematopoietic stem cell
IBD Inflammatory bowel disease
ID2 Inhibitor of DNA binding 2
IEL Intraepithelial lymphocyte
IFN-g Interferon gamma
Ig Immunoglobulin
IL Interleukin
IP3 Inositol 1,4,5-triphosphate
IPEX Immunodysregulation polyendocrinopathy enteropathy X-linked syndrome
IRF IFN regulatory factor
ITAM Immunoreceptor tyrosine-based activation motif
JNK Jun-N terminal kinase
KD Kilodalton
KLC Kappa light chain
KI Knock in
KO Knock out
LAT Linker for activation of T cells
LEF1 Lymphoid enhancer binding factor 1
Lck Leukocyte specific tyrosine kinase
Lin- Lineage negative
LN Lymph node
LPS Lipopolysaccharide
LSL Lineage negative, stem-cell antigen 1 positive,  cKIT high
MAb Monoclonal antibody
MAPK Mitogen-activated protein kinase
MEP Megakaryocyte/erythroid progenitor
MFI Mean fluorescence intensity
MHC Major histocompatibility complex
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MPP Multipotential progenitor
MyD88 Myeloid differentiation primary response 88
NF-AT Nuclear factor of activated T cell
NFκB Nuclear factor kappa B
NK Natural killer cell
NTreg Natural regulatory T cell
Nurr-77 Nuclear orphan steroid receptor
OBF1 Octamer binding transcription factor- binding factor 1
OVA Ovalbumin
PAMPs Pathogen-associated molecular patterns
Pax-5 Paired box protein 5
PBS Phosphate buffered saline
PCR Polymerase chain reaction
PFA Paraformaldehyde
PGE Promicuous gene expression
PHSC Pluripotent haematopeitic stem cell
PI Propidium iodide
PLCγ Phospholipase C gamma 2
PNA Peanut agglutinin
PRR Pathogen recognition receptor
PTEN Phosphatase and tensin homologue
RAG Recombination activating gene
Sca1 Stem-cell antigen 1
SCF Stem cell factor
SOX-4 Sex determining region Y box 4
SP Single positive
TBI Total body irradiation
TCD T cell depleted
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TCR T cell receptor
TD Thymus dependant
TdT Terminal deoxynucleotidyl transferase
M/cTEC Medullary/cortical thymic epithelial cell
Teff Effector T cell
TGFβ Tramforming growth factor beta
Th Helper T cell
TI Thymus indepedant
Treg Regulatory T cell
TLR Toll like receptor
TNF-α Tumor necrosis factor
TSA Tissue-restricted self-antigen
TSLP Thymic stromal lymphopoietin
TSP Thymus settling progenitor
TX Thymectomised
NTX Non-thymectomised
WT Wild type
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